Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

843 records found for:
Title = Opioid Use

  1. Ilgen M, Blow F, Piette JD, Goldstick J, Lewis M, Myers MG, Lin LA. Targeting pain to improve opioid use disorder treatment outcomes: Results of a randomized trial. Journal of substance use and addiction treatment. 2026 Aug 3; 191:210079, DOI: 10.1016/j.josat.2026.210079.
  2. Vroom EB, Bolton CD, Finley EP, Potter JS. Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic. Journal of substance use and addiction treatment. 2026 Jul 28; 210082, DOI: 10.1016/j.josat.2026.210082.
  3. Wolde F, Martin BC, Acharya M, Gressler L, Li C, Painter JT, Hayes CJ. State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021-2023. American journal of preventive medicine. 2026 Jul 16; 108508, DOI: 10.1016/j.amepre.2026.108508.
  4. Cummings C, Diehl C, Clair K, Cannedy S, Olsen M, Farmer M, Gabrielian S. Substance use disorder service use and experiences among Veterans in permanent supportive housing. Drug and Alcohol Dependence. 2026 Jul 15; 286:113275, DOI: 10.1016/j.drugalcdep.2026.113275.
  5. Menees SB, Lipson R, Saini SD, Waljee AK, Kurlander JE. A Retrospective Study of the Real-World Effectiveness of 8-L Polyethylene Glycol-Electrolyte Lavage Solution (PEG-ELS) Prep After Failure of Standard Prep. Journal of clinical gastroenterology. 2026 Jul 1; 60(6):532-537, DOI: 10.1097/MCG.0000000000002316.
  6. Anderson TS, Purkayastha S, Bernstein EY, Parr A, Mor MK, Bachrach RL, Gellad WF, Hausmann LRM, Fine MJ, Essien UR. Initiation of Medications for Alcohol Use Disorder Among Hospitalized Veterans : A Retrospective Cohort Study. Annals of internal medicine. 2026 Jun 1; 179(6):794-803, DOI: 10.7326/ANNALS-26-00089.
  7. Chua KP, Bohnert AS, Conti RM, Lagisetty P, Nuliyalu U, Nguyen TD. High-Deductible Health Plan Enrollment and Buprenorphine Dispensing. JAMA Network Open. 2026 May 1; 9(5):e2615550, DOI: 10.1001/jamanetworkopen.2026.15550.
  8. Hsu M, Panadero T, Mooney LJ, Kim D, Lawrence D, Yuan A, Siddarth P, Gabrielian S. Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing. JAMA Network Open. 2026 May 1; 9(5):e2610831, DOI: 10.1001/jamanetworkopen.2026.10831.
  9. Lothumalla S, Tomlinson DC, Campbell M, Jannausch M, Wilkins C, Menke N, Walton MA, Bonar EE, Goldstick J, Lin LA, Coughlin LN. Exploring risk tolerance among individuals who use opioids. Experimental and clinical psychopharmacology. 2026 Aug 1; 34(4):453-459, DOI: 10.1037/pha0000844.
  10. Greenlett RLK, Mojtabai R, Steinman MA, Growdon ME, Li Y, Boscardin WJ, Li Y, Alexander GC, Boscardin WJ, Alexander GC, Byers A, Byers A. Psychotropic Medication Trends Before and After Suicide Attempt Among Mid-to Late Life U.S. Veterans With Bipolar Affective Disorder. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2026 Aug 1; 34(8):1054-1067, DOI: 10.1016/j.jagp.2026.04.003.
  11. Ervin-Sikhondze BA, Nguyen T, Lagisetty P, Hu HM, Waljee JF, Brummett CM, Li Y, Bicket MC. Treatment gaps for opioid use disorder among commercially insured US surgical patients, 2016-2022. Regional Anesthesia and Pain Medicine. 2026 Mar 19 DOI: 10.1136/rapm-2026-107625.
  12. Bollinger M, Thompson RG, Mancino MJ, Hasin DS, James GA. Geospatial ecological momentary assessment (GEMA) for opioid use disorder: Protocol for a just-in-time adaptive intervention. Journal of substance use and addiction treatment. 2026 Mar 18; 209946, DOI: 10.1016/j.josat.2026.209946.
  13. Bicket MC, McGee MF, Gunaseelan V, Englesbe MJ, Lagisetty P, Brummett CM, Bohnert A, Li Y, Waljee JF. Opioid Consumption and Fills after Surgery in Adults on High-Dose Prescription Opioids. Journal of the American College of Surgeons. 2026 Mar 13 DOI: 10.1097/XCS.0000000000001919.
  14. Hoggatt KJ, Kroenke K, Macia KS, Nevedal AL, Lor MC, Oliva EM, Breland JY, Timko C. Development and field testing of new tools to monitor and evaluate harms of continuing and discontinuing long-term opioid therapy. Pain. 2026 Mar 4 DOI: 10.1097/j.pain.0000000000003924.
  15. Kennedy AJ, Frost MC, Malte CA, Fletcher OV, Gray M, Kenny ME, Liu AW, Samawat S, Sinton TI, Tuegel C, Wyse JJ, Hagedorn HJ, Hawkins EJ, Chander G. A Pilot Evaluation of a Telemedicine Pharmacist-Physician Management Model to Increase Access to Medication for Alcohol and Opioid Use Disorders for Rural Veterans. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2026 Mar 1; 42(2):e70158, DOI: 10.1111/jrh.70158.
  16. Pleasant T, Ono S, Kansagara D, Lovejoy J, Lovejoy T, Wyse J. A qualitative study on cannabis use for harm reduction and pain among veterans enrolled in an SUD treatment program. Harm reduction journal. 2026 Feb 19; 23(1):DOI: 10.1186/s12954-026-01412-2.
  17. Macleod C, Logue C, Kumbier K, Shaw MA, Henneman J, Kehne A, Jarzebowski M, Powell VD, Sussman J, Bohnert A, Lagisetty P. Identifying the ''gray zone'': Developing scalable methods to detect opioid misuse in veterans on long-term opioid therapy for pain. Drug and Alcohol Dependence. 2026 Apr 1; 281:113080, DOI: 10.1016/j.drugalcdep.2026.113080.
  18. Falls C, Ludwig W, Dwan M, Macleod C, Grandinetti K, Lagisetty P, Kuzma E, Frank C, Dahlem CH. Evaluating an interprofessional curriculum: Educational strategies for addressing opioid use disorder. Journal of the American Association of Nurse Practitioners. 2026 Feb 1; 38(2):116-121, DOI: 10.1097/JXX.0000000000001221.
  19. Hamm ME, Emerson R, Rogal SS, Bulls HW, Nugent SM, Anderson A, Nash S, Salay M, Winstanley EL, de Abril Cameron F, DeMonte W, Debi P, Choo LY, Chan B, Weintraub E, Bachrach RL, van Oppen D, Edwards KA, Merlin JS. Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatment. Journal of substance use and addiction treatment. 2026 Jun 1; 185:209910, DOI: 10.1016/j.josat.2026.209910.
  20. Livingston NR, Malte CA, Frost MC, Saxon AJ, Gordon AJ, Hagedorn HJ, Kennedy AJ, Williams EC, Hawkins EJ. Differences in buprenorphine initiation and retention for opioid use disorder between primary care and substance use disorder specialty care settings. Journal of substance use and addiction treatment. 2026 Apr 1; 183:209895, DOI: 10.1016/j.josat.2026.209895.
  21. Tsui JI, Austin EJ, Dunn JA, Gojic AJ, Bhatraju EP, Darnton J, Grekin P, Soth S, Woolworth S, Williams EC, Hallgren KA. Acceptability of and Implementation Supports for Video Directly Observed Treatment to Enhance Methadone Dosing Flexibility in a Multisite Opioid Treatment Program: Qualitative Rapid Needs Assessment Study. JMIR formative research. 2026 Jan 12; 10:e84162, DOI: 10.2196/84162.
  22. Hayes CJ, Raciborski RA, Acharya M, Noor NB, Nunes EV, Winhusen TJ. Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction (Abingdon, England). 2026 Jan 7 DOI: 10.1111/add.70211.
  23. Day MA, Ciol MA, Ehde DM, Mendoza ME, Borckardt J, Newman AK, Chan JF, Friedly JL, Reed DE, Drever SA, Burns J, Thorn BE, Jensen MP. The Effects of Psychological Treatments for Chronic Pain on Reducing Opioid Use in People at Risk for Opioid Misuse: A Randomized Feasibility Trial. Pain practice : the official journal of World Institute of Pain. 2026 Jan 1; 26(1):e70107, DOI: 10.1111/papr.70107.
  24. Wachterman MW, O A, Chan J, Wang V, Jiang L, Bohnert A, Lorenz K, Friedman H, Gurewich D, Hebert P. Pain Management Among Veterans on Hemodialysis Before and After Implementation of the Veteran Health Administration's Opioid Safety Initiative. Journal of palliative medicine. 2026 Mar 1; 29(3):341-350, DOI: 10.1177/10966218251405298.
  25. Powell VD, Ha J, Galecki A, Clauw D, Lagisetty P, Silveira M, Logue C, Krein S. Association of Nociplastic Pain Features with Function in Aging Veterans with Chronic Low Back Pain. Research square. 2025 Dec 17 DOI: 10.21203/rs.3.rs-8376244/v1.
  26. Roy PJ, Colvin R, Nickel KB, Ross RK, Durkin MJ, Suda KJ, Atkinson A, Butler AM. Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder. Addiction (Abingdon, England). 2025 Dec 14 DOI: 10.1111/add.70288.
  27. Abrams TE, Gravely A, Danan E, Shiroma P, Thuras P, Westanmo A. Mental Health Disorders Associated with Mammography Receipt Among Women Veterans. Journal of general internal medicine. 2025 Dec 10 DOI: 10.1007/s11606-025-10070-2.
  28. Borsari B, Baxley C, Ladd BO, Delacruz J, Jackson KM, Fetterling T, Self KJ, Hassanbeigi Daryani S, Seal KH, Manuel JK. Adaptation of the Motivational Interviewing Skills Code to Identify Client Language Predicting Reduced Opioid Use Risk and Increased Use of Alternative Pain Care Strategies in Veterans. Methods and protocols. 2025 Dec 8; 8(6):DOI: 10.3390/mps8060149.
  29. Hong JJ, Wilson DL, Nguyen K, Gellad WF, Diiulio J, Militello L, Yan S, Harle CA, Nelson D, Rosenberg EI, Schmidt S, Chang CH, Cochran G, Wu Y, Staras SAS, Kuza C, Lo-Ciganic WH. Protocol for a Single-Arm Pilot Clinical Trial: Developing and Evaluating a Machine Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE). Journal of clinical medicine. 2025 Dec 1; 14(23):DOI: 10.3390/jcm14238522.
  30. Calder SG, Kenny ME, Alliu V, Jorgenson TL, Moore T, Hagedorn HJ, Hawkins EJ, Gordon AJ. The Roles, Activities, and Opportunities of Clinical Pharmacists in a National Initiative to Improve Office-Based Buprenorphine Care. Substance use : research and treatment. 2025 Nov 17; 19:29768357251381070, DOI: 10.1177/29768357251381070.
  31. Black AC, Zeliadt SB, Kerns RD, Douglas JH, Abel EA, Rajeevan H, Heapy AA, Kazemitabar M, Taylor SL, Becker WC. Use of Complementary and Integrative Health Therapies and Chiropractic Care Among Patients Receiving Long-Term Opioid Therapy in the Department of Veterans Affairs. Journal of integrative and complementary medicine. 2026 Apr 1; 32(4):385-392, DOI: 10.1177/27683605251396445.
  32. Huebler S, Jones AL, Zhao H, Nelson RE, Hagedorn HJ, Hawkins EJ, Gordon AJ. Buprenorphine Treatment for Opioid Use Disorder in Non-Addiction Specialty Settings. JAMA Network Open. 2025 Nov 3; 8(11):e2543543, DOI: 10.1001/jamanetworkopen.2025.43543.
  33. Smith JJ, Noonan M, Johnson CE, Humphreys K, Gupta R. Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis. Addiction (Abingdon, England). 2025 Nov 3 DOI: 10.1111/add.70170.
  34. Constantin J, Waljee J, Nguyen T, Bohnert A, Nuliyalu U, Brummett CM, Chua KP. Prescription drug monitoring programs and perioperative opioid prescribing and adverse events. Health Affairs Scholar. 2025 Nov 1; 3(11):qxaf218, DOI: 10.1093/haschl/qxaf218.
  35. Mayrer BM, Sabol RM, Shuey B, Roy PJ, Suda KJ, Park TW, Anderson TS. Trends in Initiation of Buprenorphine for Opioid Use Disorder Among Older Adults. Journal of the American Geriatrics Society. 2026 Feb 1; 74(2):581-584, DOI: 10.1111/jgs.70182.
  36. Cheng H, Abdel Magid M, McGovern MP, Ford JH, Manja V, Chokron Garneau H, Wagner TH. A pragmatic approach to estimating the cost to deliver and participate in implementation strategies. Implementation science : IS. 2025 Oct 17; 20(1):44, DOI: 10.1186/s13012-025-01459-y.
  37. Liu Y, Zouaidi K, Hubbard CC, Walji MF, Cooke MR, Rindal DB, Ray KN, Kalenderian E, Suda KJ. High-risk medications in pediatric dentistry: Patterns, outcomes, and clinical implications. Journal of the American Dental Association (1939). 2025 Dec 1; 156(12):1001-1013.e13, DOI: 10.1016/j.adaj.2025.08.007.
  38. Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Chase E, Rouvere J, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ. Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Clinical Trial. JAMA psychiatry. 2025 Oct 1; 82(10):956-966, DOI: 10.1001/jamapsychiatry.2025.2126.
  39. Naderalvojoud B, Curtin C, Asch SM, Humphreys K, Hernandez-Boussard T. Evaluating the impact of data biases on algorithmic fairness and clinical utility of machine learning models for prolonged opioid use prediction. JAMIA open. 2025 Oct 1; 8(5):ooaf115, DOI: 10.1093/jamiaopen/ooaf115.
  40. Bicket MC, Qi X, Buchwalder K, Chua KP, Lagisetty P, Gunaseelan V, Waljee JF, Brummett CM, Li Y, Nguyen T. Trends in Use of Medications for Opioid Use Disorder among Commercially Insured U.S. Surgical Patients, 2016 to 2022. Anesthesiology. 2026 Feb 1; 144(2):431-440, DOI: 10.1097/ALN.0000000000005771.
  41. Nateghi Haredasht F, Lopez I, Tate S, Ashtari P, Chan MM, Kulkarni D, Chen CA, Vangala M, Griffith K, Bunning B, Miner AS, Hernandez-Boussard T, Humphreys K, Lembke A, Vance LA, Chen JH. Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features. Journal of the American Medical Informatics Association : JAMIA. 2025 Sep 22 DOI: 10.1093/jamia/ocaf157.
  42. Ilgen M, Blow F, Piette JD, Goldstick J, Lewis M, Priest W, Matharu H, Bourgoise M, Young C, Ashe D, Price A, Lin LA. The psychosocial pain management to improve opioid use disorder treatment outcomes study: Protocol for a randomized controlled trial. Contemporary clinical trials. 2025 Nov 1; 158:108081, DOI: 10.1016/j.cct.2025.108081.
  43. Schapira MM, Chhatre S, Dow PM, Leonard CE, Groeneveld P, Prigge JM, Roberts C, Meisel ZF, Parikh RB, Jayadevappa R, Paulson EC, Krouse RS, Suda KJ, Kumar P, Muluk V, Hubbard RA. The impact of opioid use associated with curative-intent cancer surgery on safe opioid prescribing practice among veterans: An observational study. Cancer. 2025 Sep 15; 131(18):e70009, DOI: 10.1002/cncr.70009.
  44. Coughlin LN, Tomlinson DC, Zhang L, Kim HM, Frost MC, Khazanov G, McKay JR, DePhilippis D, Lin LA. Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study. The American journal of psychiatry. 2025 Nov 1; 182(11):1016-1023, DOI: 10.1176/appi.ajp.20250053.
  45. Walley AY, Wang J, To C, Duska M, Murray S, Wiggins M, Rolles A, Yan S, Kosakowski S, Bagley SM, Xuan Z, Hyde J, Formica SW. Post-overdose outreach programs in Massachusetts before and after the onset of the COVID-19 pandemic. Journal of substance use and addiction treatment. 2025 Dec 1; 179:209799, DOI: 10.1016/j.josat.2025.209799.
  46. Saloner B, Lagisetty P. The Opioid Crisis: Scaling Up Treatment And Harm Reduction Programs To Reach More People Who Would Benefit. Health affairs (Project Hope). 2025 Sep 1; 44(9):1034-1041, DOI: 10.1377/hlthaff.2025.00340.
  47. Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Bart G, Saxon AJ, Manhapra A, Gordon AJ. Factors associated with mortality following hospitalization among veterans with opioid use disorder. Journal of substance use and addiction treatment. 2025 Aug 25; 209797, DOI: 10.1016/j.josat.2025.209797.
  48. Beck EJ, Chua KP, Gunaseelan V, Bicket M, Brummett CM, Bohnert A, Waljee JF. National trends in naloxone codispensing with outpatient opioid prescriptions, 2013-2023. Regional Anesthesia and Pain Medicine. 2025 Aug 18 DOI: 10.1136/rapm-2025-106911.
  49. White DM, Kimmel PL, Dember LM, Wilkie C, Edwards DP, Williams J, Bernardo L, Quintana N, Cheatle MD, Lash JP, Fischer MJ, Schmidt R, Doorenbos A, Schrauben S, Johansen KL, HOPE Consortium, a member of the HEAL Initiative. Patient Engagement in the Design and Conduct of the HOPE Trial: Addressing Chronic Pain in Hemodialysis Patients. Clinical journal of the American Society of Nephrology : CJASN. 2025 Oct 1; 20(10):1461-1469, DOI: 10.2215/CJN.0000000866.
  50. Shuey B, Wharam JF, Burnett A, Thomas AM, Argetsinger S, Zhang F, Johnston KJ, Suda KJ, Liebschutz JM, Wen H. Postoperative Opioid Prescribing Among Adults with Disabilities After a Medicare Opioid Limit Policy. Annals of surgery. 2025 Aug 8 DOI: 10.1097/SLA.0000000000006901.
  51. Graham LA, Illarmo S, Wren SM, Mudumbai SC, Odden MC. Optimal multimodal analgesia combinations to reduce pain and opioid use following non-cardiac surgery: an instrumental variable analysis. Regional Anesthesia and Pain Medicine. 2025 Jul 17 DOI: 10.1136/rapm-2025-106720.
  52. Girard R, Tomlinson DC, Rodriguez CR, Frabizio K, Coughlin L, Lin LA, Spillane NS. Diversity in opioid-related stigma interventions: A systematic review. Addictive Behaviors. 2025 Nov 1; 170:108432, DOI: 10.1016/j.addbeh.2025.108432.
  53. Haskins C, Amspoker AB, Walder A, Hogan J, Ecker A, Lindsay J, Shore J. Telehealth Buprenorphine Initiation for Opioid Use Disorder Among American Indian and Alaska Native Veterans, April 2017-March 2023. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2025 Jul 10 DOI: 10.1089/tmj.2025.0038.
  54. Buys MJ, Anderson Z, Bayless K, Zhang C, Presson AP, Hales J, Brooke BS. Postsurgical opioid prescribing among veterans using community care for orthopedic surgery at non-VA hospitals compared to a VA hospital with a transitional pain service: a retrospective cohort study. Regional Anesthesia and Pain Medicine. 2025 Jul 4; 50(7):531-537, DOI: 10.1136/rapm-2023-105162.
  55. Gutermuth B, Jordan A, Hodish G, Sturgeon JA, DeJonckheere M, Berinstein JA, Sheehan J, Bishu S, Higgins PD, Cohen-Mekelburg S. Evaluation of a virtual reality-directed brain-gut behavioural treatment inpatient program for patients with inflammatory bowel disease: protocol for a pilot feasibility trial. BMJ open. 2025 Jul 3; 15(7):e098674, DOI: 10.1136/bmjopen-2024-098674.
  56. Krause JS, Dismuke-Greer CE, Grant B. The relationship of resilience with prescription opioid use and misuse among people with spinal cord injury. Rehabilitation Psychology. 2025 Jul 3 DOI: 10.1037/rep0000628.
  57. Jones KF, Mandavia AD, Gurewich D, Wyse JJ, Sung ML, Becker WC, Livingston NA. Characteristics of Veterans Receiving Medication for Opioid Use Disorder: An Observational Cohort Study. Journal of general internal medicine. 2025 Nov 1; 40(14):3452-3455, DOI: 10.1007/s11606-025-09657-6.
  58. Mandavia AD, Fonda JR, Banducci AN, Ameral VE, Sistad Hall RE, Loeffel LB, Roth CE, Simpson TL, Stein MD, Marx BP, Hyde J, Davenport M, Meng F, Livingston NA. Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021. Drug and Alcohol Dependence. 2025 Sep 1; 274:112764, DOI: 10.1016/j.drugalcdep.2025.112764.
  59. Ritter AZ, Roma C, Soske J, Merrick C, Kennedy KA, Nishar S, Kimmel S, Zullo AR, Dow PM. Optimizing care transitions to post-acute care following hospitalization for people with opioid use disorder. Innovation in aging. 2025 Aug 1; 9(8):igaf069, DOI: 10.1093/geroni/igaf069.
  60. Pope E, Ameral V, Falcón A, Smith J, Shoemaker-Hunt SJ, Bounthavong M, McCullough M, Kim B. Knowledge and attitudes regarding substance use disorder treatment and harm reduction practices among US pharmacists: A scoping review. Journal of the American Pharmacists Association : JAPhA. 2025 Jun 19; 65(5):102462, DOI: 10.1016/j.japh.2025.102462.
  61. Hagedorn HJ, Purcell N, DeRonne BM, Salameh H, Becker WC, Seal KH, Krebs EE. Incorporating Patient and Provider Voices into the Veterans Pain Care Organizational Improvement Comparative Effectiveness Study: Informing Future Implementation. Journal of general internal medicine. 2025 Dec 1; 40(16):3920-3932, DOI: 10.1007/s11606-025-09639-8.
  62. Rostam-Abadi Y, Liebschutz JM, Subramaniam G, Stone R, Appleton N, Mazel S, Alexander K, Brill SB, Case A, Gelberg L, Gordon AJ, Hong H, Incze MA, Kawasaki SS, Kim T, Kline M, Lovejoy TI, McCormack J, Zhang S, McNeely J. Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder Prevention" (STOP) Trial. Journal of general internal medicine. 2025 Jun 2 DOI: 10.1007/s11606-025-09613-4.
  63. Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Gordon AJ. Mortality Among Veterans With Opioid Use Disorder After Medical Hospitalization. JAMA internal medicine. 2025 Jun 1; 185(6):734-736, DOI: 10.1001/jamainternmed.2025.0356.
  64. Siantz E, Cabassa LJ, Gordon AJ. Promoting Health Equity Among People With Opioid Use Disorder and Serious Mental Illness Through the Chronic Disease Self-Management Program. Substance use : research and treatment. 2025 May 30; 19:29768357251342749, DOI: 10.1177/29768357251342749.
  65. Ameral V, Hickey TR, Reilly ED, Patterson JA, Sofuoglu M. Pharmacological and behavioral pain treatment strategies for patients with opioid use disorder. Expert Opinion On Pharmacotherapy. 2025 Jun 1; 26(9):1041-1054, DOI: 10.1080/14656566.2025.2506688.
  66. Chen A, Pleasants E, Lazatin J, Mekdessi N, Miller CJ, Higgins D, Levitt J. Factors Associated with Initiation of Opioid Use in a US Department of Veterans Affairs Pain Clinic: A Retrospective Study. Brain sciences. 2025 May 7; 15(5):DOI: 10.3390/brainsci15050491.
  67. Shuman CJ, Zhang X, Hall SV, Tilea A, Clark SJ, Vance AJ, Courant A, Zivin K. Relationship between opioid use disorder during pregnancy, delivery-related outcomes, and healthcare utilization in Michigan Medicaid, 2012-2021. Journal of substance use and addiction treatment. 2025 Aug 1; 175:209720, DOI: 10.1016/j.josat.2025.209720.
  68. Nguyen T, Jiao Y, Lee SS, Lagisetty P, Bohnert A, Kocher KE, Chua KP. Medicaid Patients With ED Visits For Overdose: Disparities In Initiation Of Medications For Opioid Use Disorder. Health affairs (Project Hope). 2025 May 1; 44(5):622-630, DOI: 10.1377/hlthaff.2024.00984.
  69. Lott A, Danner AN, Malte CA, Salameh HA, Bachowski D, Gordon AJ, Hagedorn HJ, Frost MC, Williams EC, Saxon AJ, Trim RS, Hawkins EJ. Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis. Addiction science & clinical practice. 2025 Apr 30; 20(1):38, DOI: 10.1186/s13722-025-00568-9.
  70. Finlay AK, Pivovarova E, Yu M, Timko C, Binswanger IA, Smelson D, Taylor E, Harris AHS. Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records. Health & justice. 2025 Apr 29; 13(1):28, DOI: 10.1186/s40352-025-00336-6.
  71. Xue L, Yin R, Cole ES, Lo-Ciganic WH, Gellad WF, Donohue J, Tang L. Development and evaluation of a machine learning model to predict acute care for opioid use disorder among Medicaid enrollees engaged in a community-based treatment program. Addiction (Abingdon, England). 2025 Apr 29 DOI: 10.1111/add.70079.
  72. Esmaeili A, Hagedorn HJ, Garcia CC, Bangerter A, Gustavson AM, Kenny ME, Miller W, Ackland PE, Clothier BA, Noorbaloochi S, Gordon AJ, Bounthavong M. Healthcare Expenditures Associated With Implementing an External Facilitation Program to Increase the Prescribing of Medications Used for the Treatment of Opioid Use Disorder Among Veterans. Substance use & addiction journal. 2025 Oct 1; 46(4):901-912, DOI: 10.1177/29767342251336035.
  73. Austin EJ, Bentley MJ, Ferro L, Saxon AJ, Fortney JC, Curran GM, Blanchard BE, Moghimi Y, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Experiences of Team Collaboration in Primary Care-Based Delivery of Opioid Use Disorder Treatment. The journal of behavioral health services & research. 2025 Oct 1; 52(4):560-572, DOI: 10.1007/s11414-025-09946-2.
  74. Cleary EN, Rollins AL, McGuire AB, Myers LJ, Quinn PD. Buprenorphine discontinuation and utilization of psychosocial services: a national study in the Veterans Health Administration. Addiction science & clinical practice. 2025 Apr 16; 20(1):35, DOI: 10.1186/s13722-025-00562-1.
  75. Bozoghlian MF, Wilkinson B, Hadlandsmyth K, Glass N, Nepola JV, Patterson BM. Preoperative education on pain self-management and opioid consumption does not significantly impact opioid use and disposal following shoulder arthroplasty: results of a prospective randomized controlled trial. JSES international. 2025 Jul 1; 9(4):1274-1281, DOI: 10.1016/j.jseint.2025.03.010.
  76. Dixit AA, Lagisetty PA, Odden MC, Bicket MC, Humphreys KR, Mackey SC, Sun EC. Association Between Opioid Use Disorder and Healthcare Spending and Utilization in Emergency Surgical Patients: A Retrospective Analysis Using Commercial Claims. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. 2025 Jun 1; 6(2):e568, DOI: 10.1097/AS9.0000000000000568.
  77. Becker WC, Seal KH, Nelson DB, DeRonne BM, Kats AM, Morasco BJ, Frank JW, Makris UE, Painter JT, Allen KD, Mixon AS, Bohnert A, Reznik TE, Hagedorn HJ, Hammett P, Borsari B, Baxley C, Krebs EE, VOICE Study Group. Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids: A Randomized Clinical Trial. JAMA internal medicine. 2025 Apr 1; 185(4):372-381, DOI: 10.1001/jamainternmed.2024.8361.
  78. Carpenter KA, Nguyen AT, Smith DA, Samori IA, Humphreys K, Lembke A, Kiang MV, Eichstaedt JC, Altman RB. Which social media platforms facilitate monitoring the opioid crisis? PLOS digital health. 2025 Apr 1; 4(4):e0000842, DOI: 10.1371/journal.pdig.0000842.
  79. Reese TJ, Wiese AD, Leech AA, Domenico HJ, McNeer EA, Davis SE, Matheny ME, Wright A, Patrick SW. Adapting a Risk Prediction Tool for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2025 Apr 1; 155(4):DOI: 10.1542/peds.2024-068673.
  80. Baylis JD, Jorgenson TL, Pals HE, Hwang CS, Colvard MD, Alliu V, Moore T, Lin LA, Wyse J, Hawkins EJ, Hagedorn HJ, Gordon AJ. Clinical pharmacist practitioners prescribing of buprenorphine for opioid use disorder. Drug and Alcohol Dependence. 2025 Jun 1; 271:112663, DOI: 10.1016/j.drugalcdep.2025.112663.
  81. Frost MC, Malte CA, Kennedy AJ, Saxon AJ, Gordon AJ, Hagedorn HJ, Williams EC, Trim RS, Lott A, Danner AN, Hawkins EJ. Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration. BMC psychiatry. 2025 Mar 26; 25(1):288, DOI: 10.1186/s12888-025-06722-6.
  82. Livingston NA, Mandavia AD, Banducci AN, Sistad Hall R, Loeffel LB, Davenport M, Mathes-Winnicki B, Ting M, Roth CE, Sarpong A, Newberger N, Hinds Z, Fonda JR, Chen D, Meng F. Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data. Journal of psychopathology and clinical science. 2025 May 1; 134(4):448-457, DOI: 10.1037/abn0000984.
  83. Banducci AN, Mandavia AD, Bovin MJ, Adams RS, Maloney MA, Roth CE, McClain L, Livingston NA. Opioid overdose, suicide mortality, and premature death among veterans with alcohol or opioid use disorders: The impact of military sexual trauma. Addictive Behaviors. 2025 Aug 1; 167:108330, DOI: 10.1016/j.addbeh.2025.108330.
  84. Mandavia AD, Banducci AN, Simpson TL, Marx BP, Hawn SE, Hyde J, Ameral VE, Sistad Hall RE, Roth CE, Sarpong AA, Davenport M, Meng F, Stein MD, Livingston NA. Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2025 Mar 19; 35(3):196-204, DOI: 10.1016/j.whi.2025.02.002.
  85. Buonora MJ, Mackey K, Khalid L, Hickey TR, Grimshaw AA, Moss M, Starrels JL, Alford DP, Becker WC, Weimer MB. Acute Pain Management in People With Opioid Use Disorder : A Systematic Review. Annals of internal medicine. 2025 Apr 1; 178(4):558-570, DOI: 10.7326/ANNALS-24-01917.
  86. Blanchard BE, Austin EJ, Chase E, Rouvere J, Sharma V, Johnson M, Sams N, Williams F, Frost MC, Leyde S, Tsui JI, Collins SE, Fortney JC. Primary Care Patient and Clinician Perspectives on Safer Use Strategies for Opioids and/or Stimulants: A Mixed-Method Study. Journal of general internal medicine. 2025 Sep 1; 40(12):2953-2961, DOI: 10.1007/s11606-025-09418-5.
  87. Iwashyna T, Viglianti EM, Canno J, Seelye SM, Bosch NA, Burry LD, Bijan T, Juurlink DN, Stelfox HT, Lu D, Hill AD, Walkey AJ, Wumscj J. Initial Opioid Exposure in the ICU and 1-Year Opioid-Related Outcomes in Patients Who Are Mechanically Ventilated. CHEST critical care. 2025 Mar 1; 3(1):1-10, DOI: DOI: 10.1016/j.chstcc.2024.100124.
  88. Scorsone KL, Nunnery MA, Calder S, Danner A, Hawkins EJ, Gordon AJ, Frank JW. Insights Into Recovery: A Qualitative Analysis of Primary Care Provider Perspectives on Treating Veterans With Opioid Use Disorder in the VA Primary Care Setting. Substance use & addiction journal. 2025 Jul 1; 46(3):633-642, DOI: 10.1177/29767342251320450.
  89. Rosa WE, Knaul FM, Touchton M, Bhadelia A, Humphreys K, Radbruch L, Rajagopal MR. Towards opioid access without excess. The Lancet. Public health. 2025 May 1; 10(5):e422-e427, DOI: 10.1016/S2468-2667(25)00035-0.
  90. Haddock CK, Elliott L, Kolodny A, Kaipust CM, Poston WSC, Oliva JD, Lewis ET, Oliva EM, Jitnarin N, Fong C. <i>Imagine the Possibilities Pain Coalition</i> and Opioid Marketing to Veterans: Lessons for Military and Veterans Healthcare. Healthcare (Basel, Switzerland). 2025 Feb 18; 13(4):DOI: 10.3390/healthcare13040434.
  91. Bernstein EY, Fu CX, Ayanian JZ, Curto VE, Anderson TS, Landon BE. Association of Medicare Advantage vs Traditional Medicare with Clinical Outcomes Among Patients Hospitalized for Substance Use Disorders. Journal of general internal medicine. 2025 Sep 1; 40(12):2964-2972, DOI: 10.1007/s11606-025-09413-w.
  92. Bin Noor N, Pro G, Acharya M, Eswaran H, Hayes CJ. Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study. Addictive behaviors reports. 2025 Jun 1; 21:100588.
  93. Ganz DA, Lai J, Cantor JH, Agniel D, Simon K, Stein BD, Taylor EA. Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. Health Affairs Scholar. 2025 Feb 1; 3(2):qxaf036, DOI: 10.1093/haschl/qxaf036.
  94. Kumar P, Moomtaheen F, Malec SA, Yang JJ, Bologa CG, Schneider KA, Zhu Y, Tohen M, Villarreal G, Perkins DJ, Fielstein EM, Davis SE, Matheny ME, Lambert CG. Detecting Opioid Use Disorder in Health Claims Data With Positive Unlabeled Learning. IEEE journal of biomedical and health informatics. 2025 Feb 1; 29(2):750-757, DOI: 10.1109/JBHI.2024.3515805.
  95. Dayer LE, Peng C, Williams AJ, Luciani L, Lowery J, Butterfield B, Painter JT. Factors Contributing to Opioid Overprescribing at Surgical Discharge. The Journal of surgical research. 2025 Jan 10; 306:224-229.
  96. Auty SG, Frakt AB, Shafer PR, Stein MD, Gordon SH. Severe Maternal Morbidity Among Pregnant People With Opioid Use Disorder Enrolled in Medicaid. JAMA Network Open. 2025 Jan 2; 8(1):e2453303, DOI: 10.1001/jamanetworkopen.2024.53303.
  97. Deem Bolton C, Finley EP, Karns-Wright T, Potter JS. Framework to Action: Developing and Implementing a Statewide Network to Expand Opioid Treatment Access Using SHIFT-Evidence in Texas. Substance use & addiction journal. 2025 Jul 1; 46(3):550-558, DOI: 10.1177/29767342241297435.
  98. Reynolds OC, Carlson KF, Gordon AJ, Handley RL, Morasco BJ, Korthuis TP, Lovejoy TI, Wyse JJ. Receipt of medications for opioid use disorder among rural and urban veterans health administration patients. Drug and Alcohol Dependence Reports. 2025 Mar 1; 14(0):100311, DOI: 10.1016/j.dadr.2024.100311.
  99. Palazzo L, Dorsey CN, Mogk J, Beatty T, King D, Stefanik-Guizlo K, Key D, Matson TE, Shea M, Caldeiro RM, McWethy AG, Wong ES, Idu AE, Glass JE. Formative evaluation of the implementation of digital therapeutics for opioids and other substance use disorders in primary care (DIGITS trial). Implementation research and practice. 2024 Dec 12; 5:26334895241301670, DOI: 10.1177/26334895241301670.
  100. Szczygiel LA, Hosea F, Kocher KE, Dahlem CH, Dora-Laskey A, Bicket MC, Waljee J, Byrnes ME. "Doing the best we can": Qualitative study of clinician experiences with opioid use disorder care in emergency departments. The American journal of emergency medicine. 2025 May 1; 91:195-197, DOI: 10.1016/j.ajem.2024.11.067.
  101. Vakkalanka JP, Lund BC, Arndt S, Carter KD, Carnahan R. The Association Between Telehealth Use During Buprenorphine Treatment for Opioid Use Disorder and Clinical Outcomes: A Retrospective Cohort Study. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2024 Nov 25.
  102. Sung ML, León C, Reisman JI, Gordon KS, Kerns RD, Li W, Liu W, Mitra A, Yu H, Bec ker WC. Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration. Substance use & addiction journal. 2025 Apr 1; 46(2):369-376, DOI: 10.1177/29767342241293334.
  103. Cochran GT, Brown JL, Yu Z, Gordon AJ, Frede S, Hardy C, Castora-Binkley M, Homsted F, Marsch LA, Holtyn AF, Winhusen TJ. CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paper. Addiction science & clinical practice. 2024 Nov 18; 19(1):82, DOI: 10.1186/s13722-024-00514-1.
  104. Timko C, Lor MC, Kertesz S, Kroenke K, Macia K, Nevedal A, Hoggatt KJ. Management of patients at risk of harms from both continuing and discontinuing their long-term opioid therapy: A qualitative study to inform the gap in clinical practice guidelines. Pain practice : the official journal of World Institute of Pain. 2025 Jan 1; 25(1):e13440, DOI: 10.1111/papr.13440.
  105. Stein BD, Saloner BK, Sheng F, Sorbero M, Dick AW, Gordon AJ. Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic : State Telehealth Policies and Buprenorphine. Journal of general internal medicine. 2025 Jul 1; 40(9):1986-1994, DOI: 10.1007/s11606-024-09188-6.
  106. Magel J, Siantz E, Blosser P, Fritz JM, Hartman P, Beneciuk JM, Gordon AJ. Practice Changes 6 Months Following a Physical Therapist Training Program Regarding Opioid Use and Misuse Screening and Assessment: A Qualitative Study. Substance use & addiction journal. 2025 Apr 1; 46(2):337-346, DOI: 10.1177/29767342241292259.
  107. Hall OT, Lagisetty P, Rausch J, Entrup P, Deaner M, Harte SE, Williams DA, Hassett AL, Clauw DJ. Fibromyalgia is associated with increased odds of prior pain-precipitated relapse among non-treatment-seeking individuals with opioid use disorder. Annals of Medicine. 2024 Dec 1; 56(1):2422050.
  108. Livingston NA, Mandavia AD, Banducci AN, Loeffel LB, Sistad Hall R, Maloney M, Roth CE, Fonda JR, Davenport M, Meng F, Hyde J, Stein M. Emergency Department Visits, Inpatient Hospitalizations, and Nonfatal and Fatal Drug Overdoses During COVID-19 Among Veterans With Opioid Use Disorder. Journal of studies on alcohol and drugs. 2025 Jul 1; 86(4):582-589, DOI: 10.15288/jsad.24-00184.
  109. Blalock DV, Greene L, Kane RM, Smith VA, Jacobs J, Rao M, Cohen AJ, Zulman DM, Maciejewski ML. Demographic, Social, Behavioral, and Clinical Characteristics Associated with Long-Term Opioid Therapy and Any Opioid Prescription in High-Risk VA Patients. Journal of general internal medicine. 2025 Sep 1; 40(12):2860-2869, DOI: 10.1007/s11606-024-09125-7.
  110. Staton MD, Bell JS, McGuire AB, Taylor LD, Watson DP. What happens after the funding ends?: A qualitative sustainability investigation of emergency department-based peer support programs implemented as part of Indiana's opioid state targeted response initiative. Journal of substance use and addiction treatment. 2025 Jan 1; 168:209540.
  111. Moriates C, Boulton A, Bottner R, Weems J, Christian N, Bazajou T, Olmos DI, Bolton CD, Karns-Wright TE, Lanham HJ, Finley EP, Potter JS. The Support Hospital Opioid Use Disorder Treatment (SHOUT) Texas program implementation strategy for expanding treatment for hospitalized adults with opioid use disorder. Journal of substance use and addiction treatment. 2024 Oct 10; 209539.
  112. Brooke BS, Bayless K, Anderson Z, Holeman TA, Zhang C, Hales J, Buys MJ. Opioid tapering after surgery and its association with patient-reported outcomes and behavioral changes: a mixed-methods analysis. Regional Anesthesia and Pain Medicine. 2024 Oct 8; 49(10):699-707, DOI: 10.1136/rapm-2023-104807.
  113. Hafen K, Wallace H, Fritz K, Fordham C, Haskell T, Kelley AT, Jones AL, Cochran G, Gordon AJ. A novel rural hospital/clinic-system practice-based research network: the Rural Addiction Implementation Network (RAIN) initiative and its goals, implementation, and early results. The American journal of drug and alcohol abuse. 2024 Nov 1; 50(6):786-797, DOI: 10.1080/00952990.2024.2394487.
  114. Seewald L, Bonar E, Bohnert ASB, Carter PM, King CA, Losman ED, Bacon L, Wheeler T, Walton M. Lifetime non-fatal overdose experiences among at-risk adolescents and young adults in the emergency department with past-year opioid use in the USA. Injury Prevention : Journal of The International Society For Child and Adolescent Injury Prevention. 2024 Oct 1; 30(5):373-380.
  115. Garcia-Vassallo G, Quinn NB, Moore BA, Chaudhry S, Moore DT, Sorenson ST, Braddock S, Edens EL. National Addiction Workshop: A Virtual Adaptation to Support Competency Development in Opioid Use Disorder Management. Substance use & addiction journal. 2024 Sep 19; 29767342241273423.
  116. Taylor E, Gray C, Stimmel M, Binswanger IA, Morse E, Timko C, Harris AHS, Smelson D, Finlay AK. Influences of the criminal justice system on use of medications for opioid use disorder: a qualitative study. BMC global and public health. 2024 Sep 19; 2(1):64.
  117. DiPiro ND, Dismuke-Greer CE, Krause JS. Self-reported benzodiazepine use among adults with chronic spinal cord injury in the southeastern USA: associations with demographic, injury, and opioid use characteristics. Spinal Cord. 2024 Nov 1; 62(11):667-673.
  118. Shearer R, Hagedorn H, Englander H, Siegler T, Kibben R, Fawole A, Patten A, Fitzpatrick A, Laes J, Fernando J, Appleton N, Oot E, Titus H, Krawczyk N, Weinstein Z, McNeely J, Baukol P, Ghitza U, Gustafson D, Bart G, Bazzi A. Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals. Journal of substance use and addiction treatment. 2024 Sep 10; 167:209520.
  119. Oberman RS, Huynh AK, Cummings K, Resnick A, Taylor SL, Bergman AA, Chang ET. Engaging healthcare teams to increase access to medications for opioid use disorder. Health services research. 2024 Dec 1; 59 Suppl 2(Suppl 2):e14371.
  120. Hayes CJ, Raciborski RA, Nowak M, Acharya M, Nunes EV, Winhusen TJ. Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type. Addiction (Abingdon, England). 2024 Sep 7.
  121. Aalsma MC, Bell LA, Schwartz K, Ouyang F, Kolak M, Monahan PO, Mermelstein SP, Carson I, Hulvershorn LA, Adams ZW. Clinician Willingness to Prescribe Medications for Opioid Use Disorder to Adolescents in Indiana. JAMA Network Open. 2024 Sep 3; 7(9):e2435416.
  122. Howell BA, Lin LA, Coughlin LN. Treatment for Co-Occurring Stimulant and Opioid Use Disorders: Overcoming Barriers in the Era of Polysubstance Use. [Editorial]. JAMA psychiatry. 2024 Sep 1; 81(9):853-854.
  123. Smid MC, Seliski N, Charles JE, Castro S, Humiston GE, Cash E, Allshouse A, Turner E, Carlston K, Gibson M, Gordon AJ, Cochran GT. Prevention of postpartum methamphetamine use with micronized progesterone trial (PROMPT): A pilot randomized controlled trial protocol. Contemporary clinical trials communications. 2024 Oct 1; 41:101359, DOI: 10.1016/j.conctc.2024.101359.
  124. Ashare RL, Worster B, Nugent SM, Smith DM, Morasco BJ, Leader AE, Case AA, Meghani SH. Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers. Journal of The National Cancer Institute. Monographs. 2024 Aug 15; 2024(66):267-274.
  125. Austin EJ, Chen J, Ferro L, Saxon AJ, Fortney JC, Curran GM, Ratzliff AD, Williams EC. Are we being equitable enough? Lessons learned from sites lost in an implementation trial. Implementation research and practice. 2024 Aug 14; 5:26334895241267023.
  126. Park TW, Shuey B, Liebschutz J, Cantor J, Anderson TS. Treatment Approaches for Opioid Use Disorder Offered in US Substance Use Treatment Facilities. JAMA. 2024 Aug 13; 332(6):502-504.
  127. Austin EJ, Chen J, Soyer E, Idrisov B, Briggs ES, Ferro L, Saxon AJ, Fortney JC, Curran GM, Moghimi Y, Blanchard BE, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Optimizing Patient Engagement in Treatment for Opioid Use Disorder: Primary Care Team Perspectives on Influencing Factors. Journal of general internal medicine. 2024 Jul 29.
  128. Hayes CJ, Martin BC, Hoggatt KJ, Cucciare MA, Hudson TJ, Gordon AJ. Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. Substance use & addiction journal. 2024 Oct 1; 45(4):727-735, DOI: 10.1177/29767342241263161.
  129. Austin EJ, Chen J, Soyer E, Idrisov B, Briggs ES, Moghimi Y, Saxon AJ, Fortney JC, Blanchard BE, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Primary care team perspectives on approaches to engaging patients in treatment for opioid use disorder. Journal of substance use and addiction treatment. 2024 Oct 1; 165:209456.
  130. Hayes CJ, Raciborski RA, Martin BC, Gordon AJ, Hudson TJ, Brown CC, Pro G, Cucciare MA. Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study. Journal of substance use and addiction treatment. 2024 Jul 25; 209461.
  131. Strong C, Burns SP, Arewasikporn A, Suri P, Hawkins EJ, Leipertz S, Haselkorn J, Turner AP. Chronic opioid prescription in veterans with spinal cord injury: Prevalence and associated factors. The journal of spinal cord medicine. 2024 Jul 25; 1-11.
  132. Daniels SI, Cave S, Wagner TH, Perez TA, Edmond SN, Becker WC, Midboe AM. Implementation, intervention, and downstream costs for implementation of a multidisciplinary complex pain clinic in the Veterans Health Administration. Health services research. 2024 Dec 1; 59 Suppl 2(Suppl 2):e14345, DOI: 10.1111/1475-6773.14345.
  133. Wyse JJ, Eckhardt A, Newell S, Gordon AJ, Morasco BJ, Carlson K, Korthuis PT, Ono SS, Lovejoy TI. Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings. Journal of general internal medicine. 2024 Sep 1; 39(12):2142-2149.
  134. Wyse JJ, Mackey K, Kauzlarich KA, Morasco BJ, Carlson KF, Gordon AJ, Korthuis PT, Eckhardt A, Newell S, Ono SS, Lovejoy TI. Improving access to buprenorphine for rural veterans in a learning health care system. Health services research. 2024 Jul 2.
  135. Williams EC, Matson TE, Hallgren KA, Oliver M, Wang X, Bradley KA. Assessing Substance Use Disorder Symptoms with a Checklist among Primary Care Patients with Opioid Use Disorder and/or Long-Term Opioid Treatment: An Observational Study. Journal of general internal medicine. 2024 Jul 1.
  136. J Hayes C, Bin Noor N, Raciborski RA, C Martin B, J Gordon A, J Hoggatt K, Hudson T, A Cucciare M. Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder. Journal of addictive diseases. 2024 Jun 30; 1-18.
  137. Couch JV, Whitcomb M, Buchheit BM, Dorr DA, Malinoski DJ, Korthuis PT, Ono SS, Levander XA. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis. Harm reduction journal. 2024 Jun 27; 21(1):125.
  138. Krause JS, DiPiro ND, Dismuke-Greer CE, Laursen-Roesler J. Relationships of self-reported opioid and benzodiazepine use with health-related quality of life among adults with spinal cord injury. Disability and health journal. 2025 Jan 1; 18(1):101668, DOI: 10.1016/j.dhjo.2024.101668.
  139. Nateghi Haredasht F, Fouladvand S, Tate S, Chan MM, Yeow JJL, Griffiths K, Lopez I, Bertz JW, Miner AS, Hernandez-Boussard T, Chen CA, Deng H, Humphreys K, Lembke A, Vance LA, Chen JH. Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning. Addiction (Abingdon, England). 2024 Oct 1; 119(10):1792-1802.
  140. Salay M, Edwards KA, Winstanley EL, Bachrach RL, Bulls HW, Hanmer J, Liebschutz JM, Robbins J, Wilson JD, Yu L, Merlin JS, Murray-Krezan C. Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial. Substance use & addiction journal. 2025 Jan 1; 46(1):201-207.
  141. Painter JT, Peng C, Burlette M, Clement C, Luciani L, Azhar G, Dayer L. The Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults. Journal of Pain & Palliative Care Pharmacotherapy. 2024 Jun 10; 1-7.
  142. Frost MC, Coughlin LN, Zhang L, Lin LA. Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2024 Sep 1; 18(5):561-566.
  143. Jaffe K, Patel S, Chen L, Slat S, Bohnert A, Lagisetty P. Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder. Substance use & addiction journal. 2024 Oct 1; 45(4):706-715, DOI: 10.1177/29767342241254591.
  144. Eckhardt A, Waller DE, Shull S, Lovejoy TI, Morasco BJ, Gordon AJ, Wyse JJ. "They Ask Questions, But They Don't Want the Answers"-Perceptions of Clinical Communication Among Veterans Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder. Substance use & addiction journal. 2024 May 20; 29767342241251761.
  145. Krause JS, DiPiro ND, Dismuke-Greer CE, Cao Y. Relations Between Self-reported Prescription Hydrocodone, Oxycodone, and Tramadol Use and Unintentional Injuries Among Those With Spinal Cord Injury. Archives of physical medicine and rehabilitation. 2024 Oct 1; 105(10):1829-1836.
  146. Lindsey AC, Deem-Bolton C, Finley E, Potter JS, Lanham H, Fleming S. Leveraging Project ECHO to Implement a Suite of Substance Use Learning Communities for Statewide Impact. Substance use & addiction journal. 2024 Oct 1; 45(4):690-697.
  147. Magel J, Siantz E, Blosser P, Fritz JM, Gordon AJ. The Development of an Opioid Misuse Training Program for Physical Therapists: A Learning Community Approach. Journal, physical therapy education. 2024 Dec 1; 38(4):340-347, DOI: 10.1097/JTE.0000000000000343.
  148. Jaffe K, Slat S, Chen L, Macleod C, Bohnert A, Lagisetty P. Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults. [Letter to the Editor]. Journal of substance use and addiction treatment. 2024 May 2; 209361.
  149. Blalock DV, Berlin SA, Berkowitz T, Smith VA, Wright C, Bachrach RL, Grubber JM. Associations Between a Primary Care-Delivered Alcohol-Related Brief Intervention and Subsequent Opioid-Related Outcomes. The American journal of psychiatry. 2024 May 1; 181(5):434-444.
  150. Ituk US, Dexter F, Hadlandsmyth KE. Lateness of Acetaminophen and Non-steroidal Anti-inflammatory Drug Administrations in a Retrospective Cohort of Medication Administration Records Among Patients After Cesarean Delivery. Cureus. 2024 May 1; 16(5):e61433.
  151. Rubin JB, Aby ES, Barman P, Tincopa M. Opioid use and risks in candidates and recipients of liver transplant. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2025 Feb 1; 31(2):231-241, DOI: 10.1097/LVT.0000000000000388.
  152. Irani E, Macleod C, Slat S, Kehne A, Madden E, Jaffe K, Bohnert A, Lagisetty P. The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder. Drug and Alcohol Dependence Reports. 2024 Jun 1; 11:100235.
  153. Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, Brown LS. Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial. JAMA. 2024 Apr 23; 331(16):1369-1378.
  154. Naderalvojoud B, Curtin CM, Yanover C, El-Hay T, Choi B, Park RW, Tabuenca JG, Reeve MP, Falconer T, Humphreys K, Asch SM, Hernandez-Boussard T. Towards global model generalizability: independent cross-site feature evaluation for patient-level risk prediction models using the OHDSI network. Journal of the American Medical Informatics Association : JAMIA. 2024 Apr 19; 31(5):1051-1061.
  155. Sides TL, Jensen AC, Argust MM, Amundson EC, Thomas GR, Keller R, Mahaffey M, Krebs EE. Experiences and lessons learned from a patient-engagement service established by a national research consortium in the U.S. Veterans Health Administration. Learning health systems. 2024 Jul 1; 8(3):e10421.
  156. Lewis KN, Zhang D, Corrales G, Eswaran H, Hayes CJ, Gressler LE. Telehealth Utilization for Opioid Use Disorder: A Nationwide Analysis Before and After the COVID-19 Public Health Emergency Declaration. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2024 Apr 15.
  157. Bart G, Korthuis PT, Donohue JM, Hagedorn HJ, Gustafson DH, Bazzi AR, Enns E, McNeely J, Ghitza UE, Magane KM, Baukol P, Vena A, Harris J, Voronca D, Saitz R. Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder. Addiction science & clinical practice. 2024 Apr 11; 19(1):29.
  158. Hadlandsmyth K, Lund BC, Gao Y, Strayer AL, Davila H, Hausmann LRM, Schmidt S, Shireman PK, Jacobs MA, Mader MJ, Tessler RA, Duncan CA, Hall DE, Sarrazin MV. Social Determinants of Long-Term Opioid Use Following Total Knee Arthroplasty. The Journal of Knee Surgery. 2024 Aug 1; 37(10):742-748.
  159. Bergman AA, Oberman RS, Taylor SL, Kranke B, Chang ET. Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives. Journal of general internal medicine. 2024 Apr 8.
  160. Krause JS, Dismuke-Greer CE, DiPiro ND, Clark JMR, Laursen-Roesler J. Relationships of Self-reported Opioid Use and Misuse and Pain Severity With Probable Major Depression Among Participants With Spinal Cord Injury. Archives of physical medicine and rehabilitation. 2024 Aug 1; 105(8):1506-1512.
  161. Nugent SM, Anderson J, Young SK. Behavioural mental health interventions delivered in the emergency department for suicide, overdose and psychosis: a scoping review. BMJ open. 2024 Mar 25; 14(3):e080023.
  162. MacLean RR, Ankawi B, Driscoll MA, Gordon MA, Frankforter TL, Nich C, Szollosy SK, Loya JM, Brito L, Ribeiro MIP, Edmond SN, Becker WC, Martino S, Sofuoglu M, Heapy AA. Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment. JMIR research protocols. 2024 Mar 20; 13:e54342.
  163. Wyse JJ, Eckhardt A, Waller D, Gordon AJ, Shull S, Lovejoy TI, Mackey K, Morasco BJ. Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder. Journal of addiction medicine. 2024 May 1; 18(3):300-305.
  164. Black AC, Edmond SN, Frank JW, Abelleira A, Snow JL, Wesolowicz DM, Becker WC. Pain Care at Home to Amplify Function: Protocol Article. Substance use & addiction journal. 2025 Jan 1; 46(1):155-159, DOI: 10.1177/29767342241236032.
  165. Anderson TS, Wang BX, Lindenberg JH, Herzig SJ, Berens DM, Schonberg MA. Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain. JAMA Network Open. 2024 Mar 4; 7(3):e241342.
  166. Chung DH, Slat S, Rao A, Thomas J, Kehne A, Macleod C, Madden EF, Lagisetty P. Improving Medical Student Knowledge and Reducing Stigmatizing Attitudes Toward Treating Patients With Opioid Use Disorder. Substance use : research and treatment. 2024 Feb 29; 18:11782218241234808.
  167. Krause JS, DiPiro ND, Dismuke-Greer CE. Self-Reported Prescription Opioid Use Among Participants with Chronic Spinal Cord Injury. Topics in spinal cord injury rehabilitation. 2024 Feb 29; 30(1):131-139.
  168. Mudumbai SC, He H, Chen JQ, Kapoor A, Regala S, Mariano ER, Stafford RS, Abnet CC, Pfeiffer RM, Freedman ND, Etemadi A. Opioid use in cancer patients compared with noncancer pain patients in a veteran population. JNCI cancer spectrum. 2024 Feb 29; 8(2).
  169. Williams EC, Frost MC, Danner AN, Lott AMK, Achtmeyer CE, Hood CL, Malte CA, Saxon AJ, Hawkins EJ. "The Only Reason I Am Willing to Do It at All": Evaluation of VA's SUpporting Primary care Providers in Opioid Risk reduction and Treatment (SUPPORT) Center. Journal of addiction medicine. 2024 Feb 29.
  170. Hawkins EJ, Malte CA, Hagedorn HJ, Gordon AJ, Williams EC, Trim RS, Blanchard BE, Lott A, Danner AN, Saxon AJ. Buprenorphine Receipt and Retention for Opioid Use Disorder Following an Initiative to Increase Access in Primary Care. Journal of addiction medicine. 2024 May 1; 18(3):240-247.
  171. Takada S, Seamans MJ, Javanbakht M, Bone C, Ijadi-Maghsoodi R, Shoptaw S, Gelberg L. Nativity and the risk of opioid use disorder among Hispanic/Latinx women in primary care in Los Angeles, CA. Journal of ethnicity in substance abuse. 2024 Feb 7; 1-15.
  172. Billig JI, Bicket MC, Yazdanfar M, Gunaseelan V, Sears ED, Brummett CM, Waljee JF. Cohort study of new off-label gabapentin prescribing in chronic opioid users. Regional Anesthesia and Pain Medicine. 2024 Feb 5; 49(2):88-93.
  173. Qian G, Humphreys K, Goldhaber-Fiebert JD, Brandeau ML. Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis. Drug and Alcohol Dependence. 2024 Mar 1; 256:111112.
  174. Hurlocker MC, Kirouac M, Gillezeau C, Hijaz D, Moniz-Lewis DIK, Carlon HA, Coleman GC, Ilgen MA, Pearson MR, Vowles KE, Witkiewitz K. Study Protocol for the Healing Opioid Misuse and Pain Through Engagement Trial: Integrated Treatment for Individuals With Co-occurring Chronic Pain and Opioid Use Disorder. Substance use & addiction journal. 2025 Jan 1; 46(1):192-196, DOI: 10.1177/29767342241228126.
  175. Resnick A, Bergman AA, Oberman RS, Taylor SL, Chuang E, Cummings KM, Chang ET. Knowledge and Attitudes Towards Use of Complementary and Integrative Health Therapies for Veterans with Opioid Use Disorder in the Veterans Health Administration. OBM Integrative and Complementary Medicine. 2024 Jan 31; 9(1):doi:10.21926/obm.icm.2401012.
  176. Goodman-Meza D, Goto M, Salimian A, Shoptaw S, Bui AAT, Gordon AJ, Goetz MB. Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject Drugs. Open forum infectious diseases. 2024 Feb 1; 11(2):ofae030.
  177. Lopez I, Fouladvand S, Kollins S, Chen CA, Bertz J, Hernandez-Boussard T, Lembke A, Humphreys K, Miner AS, Chen JH. Predicting premature discontinuation of medication for opioid use disorder from electronic medical records. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2024 Jan 11; 2023:1067-1076.
  178. Watson DP, Tillson M, Taylor L, Xu H, Ouyang F, Beaudoin FL, O'Donnell D, McGuir e AB. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose. Substance use & addiction journal. 2024 Jul 1; 45(3):378-389.
  179. Weiner M, Liu Z, Schelfhout J, Dexter P, Roberts AR, Griffith A, Bali V, Weaver J. Prescriptions of opioid-containing drugs in patients with chronic cough. Therapeutic Advances in Respiratory Disease. 2024 Jan 1; 18:17534666241259373.
  180. Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare. Journal of substance use and addiction treatment. 2024 Feb 1; 157:209271.
  181. Watson DP, Swartz JA, Magee LA, Bray BC, Phalen P, Medcalf S, McGuire AB. Latent class analysis of emergency department patients engaged in telehealth peer recovery support services and associations of identified classes with post-discharge outcomes. Journal of substance use and addiction treatment. 2024 May 1; 160:209282.
  182. Dember LM, Hsu JY, Bernardo L, Cavanaugh KL, Charytan DM, Crowley ST, Cukor D, Doorenbos AZ, Edwards DA, Esserman D, Fischer MJ, Jhamb M, Joffe S, Johansen KL, Kalim S, Keefe FJ, Kimmel PL, Krebs EE, Kuzla N, Mehrotra R, Mishra P, Pellegrino B, Steel JL, Unruh ML, White DM, Yabes JG, Becker WC, HOPE Consortium. The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis. Contemporary clinical trials. 2024 Jan 1; 136:107409.
  183. Chen L, Sethi S, Poland C, Frank C, Tengelitsch E, Goldstick J, Sussman JB, Bohnert ASB, Lin LA. Prescriptions for Buprenorphine in Michigan Following an Education Intervention. JAMA Network Open. 2023 Dec 1; 6(12):e2349103.
  184. Maust DT, Petzold K, Strominger J, Kim HM, Bohnert ASB. Benzodiazepine Discontinuation and Mortality Among Patients Receiving Long-Term Benzodiazepine Therapy. JAMA Network Open. 2023 Dec 1; 6(12):e2348557.
  185. Yoo M, Buys MJ, Nelson RE, Patel S, Bayless KM, Anderson Z, Hales JB, Brooke BS. Effect of Multidisciplinary Transitional Pain Service on Health Care Use and Costs Following Orthopedic Surgery. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2023 Dec 1; 40(12):418-425.
  186. Liebschutz JM, Subramaniam GA, Stone R, Appleton N, Gelberg L, Lovejoy TI, Bunting AM, Cleland CM, Lasser KE, Beers D, Abrams C, McCormack J, Potter GE, Case A, Revoredo L, Jelstrom EM, Kline MM, Wu LT, McNeely J. Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods. Addiction science & clinical practice. 2023 Nov 18; 18(1):70.
  187. Chui PW, Khokhar A, Gordon KS, Dziura J, Burg MM, Brandt C, Haskell SG, Malm B, Bastian LA, Gandhi PU. Opioid prescription and risk of atrial fibrillation in younger veterans. American heart journal. 2024 Feb 1; 268:61-67.
  188. Simonetti JA, Holliday R, Mignogna J, Thomas S, Smith A, Betz M, Brenner LA, Sayre G. Patients' Perspectives on Medication-Related Suicide Prevention Interventions Delivered in Emergency Settings. Psychiatric services (Washington, D.C.). 2024 Mar 1; 75(3):275-282.
  189. Livingston NA, Sarpong A, Sistad R, Roth C, Banducci AN, Simpson T, Hyde J, Davenport M, Weisberg R. Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study. Journal of substance use and addiction treatment. 2024 Jan 1; 156:209188.
  190. Carr MM, Wolkowicz NR, Cave S, Martino S, Masheb R, Midboe AM. Weight change in a national cohort of U.S. Military Veterans engaged in medication treatment for opioid use disorder. Journal of psychiatric research. 2023 Dec 1; 168:204-212.
  191. Christine PJ, Larochelle MR, Lin LA, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA health forum. 2023 Oct 6; 4(10):e233549.
  192. Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis? Annals of internal medicine. 2023 Oct 1; 176(10):1431-1433.
  193. Percy A, Kelley AT, Valentino N, Butz A, Baylis JD, Suo Y, Gordon AJ, Jones AL. Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders. Substance Abuse. 2023 Oct 1; 44(4):330-336.
  194. Drexler K, Edens EL, Trafton JA, Compton WM. In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long-term opioid therapy. Addiction (Abingdon, England). 2024 Jan 1; 119(1):6-8.
  195. Mosher HJ, Hadlandsmyth K, Alexander B, Lund BC. Continuation of Buprenorphine During Hospitalization and Subsequent Retention in Therapy: an Observational Study in Veterans Administration Hospitals. Journal of general internal medicine. 2024 Feb 1; 39(2):207-213.
  196. O'Donoghue AL, Reichheld A, Anderson TS, Zera CA, Dechen T, Steven s JP. Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States. Journal of addiction medicine. 2023 Nov 1; 17(6):e399-e402.
  197. Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of substance use and addiction treatment. 2023 Sep 24; 209175.
  198. Miller WA, Gordon AJ, Clothier BA, Ackland PE, Bounthavong M, Garcia C, Kenny ME, Noorbaloochi S, Hagedorn HJ. Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study. Implementation research and practice. 2023 Sep 14; 4:26334895231199463.
  199. Huang LC, Bleicher J, Torre M, Johnson JE, Presson A, Millar MM, Gordon AJ, Brooke BS, Kaphingst KA, Harris AHS. Evaluating a health system-wide opioid disposal intervention distributing home-disposal bags. Health services research. 2023 Dec 1; 58(6):1256-1265.
  200. Austin EJ, O'Brien QE, Ruiz MS, Ratzliff AD, Williams EC, Ko ch U. Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review. Community mental health journal. 2023 Sep 5.
  201. Zammit A, Coquet J, Hah J, El Hajouji O, Asch SM, Carroll I, Curtin CM, Hernandez-Boussard T. Postoperative opioid prescribing patients with diabetes: Opportunities for personalized pain management. PLoS ONE. 2023 Aug 24; 18(8):e0287697.
  202. Garcia CC, Bounthavong M, Gordon AJ, Gustavson AM, Kenny ME, Miller W, Esmaeili A, Ackland PE, Clothier BA, Bangerter A, Noorbaloochi S, Harris AHS, Hagedorn HJ. Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. Implementation science communications. 2023 Aug 10; 4(1):91.
  203. Bridges NC, Taber R, Foulds AL, Bear TM, Cloutier RM, McDonough BL, Gordon AJ, Cochran GT, Donohue JM, Adair D, DiDomenico E, Pringle JL, Gellad WF, Kelley D, Cole ES. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences. Journal of substance use and addiction treatment. 2023 Nov 1; 154:209133.
  204. Austin EJ, Chen J, Briggs ES, Ferro L, Barry P, Heald A, Merrill JO, Curran GM, Saxon AJ, Fortney JC, Ratzliff AD, Williams EC. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Network Open. 2023 Aug 1; 6(8):e2328627.
  205. Roberts E, Humphreys K. Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment? Drug and Alcohol Review. 2024 Jan 1; 43(1):261-264.
  206. Joyce VR, Oliva EM, Garcia CC, Trafton J, Asch SM, Wagner TH, Humphreys K, Owens DK, Bounthavong M. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Addiction (Abingdon, England). 2023 Nov 1; 118(11):2203-2214.
  207. Darlington CK, Lipsky RK, Teitelman AM, Koblin BA, Davis A, Walcott M, Compton PA, Tieu HV. HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs. Journal of substance use and addiction treatment. 2023 Sep 1; 152:209119.
  208. Nugent SM, Slatore CG, Winchell K, Handley R, Clayburgh D, Chandra R, Hooker ER, Knight SJ, Morasco BJ. Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer. Head & neck. 2023 Aug 1; 45(8):2058-2067.
  209. Pogoda TK, Adams RS, Carlson KF, Dismuke-Greer CE, Amuan M, Pugh MJ. Risk of Adverse Outcomes Among Veterans Who Screen Positive for Traumatic Brain Injury in the Veterans Health Administration But Do Not Complete a Comprehensive Evaluation: A LIMBIC-CENC Study. The Journal of head trauma rehabilitation. 2024 May 1; 39(3):171-182.
  210. Austin AE, Tang L, Kim JY, Allen L, Barnes AJ, Chang CH, Clark S, Cole ES, Durrance CP, Donohue JM, Gordon AJ, Huskamp HA, McDuffie MJ, Mehrotra A, Mohamoud S, Talbert J, Ahrens KA, Applegate M, Hammerslag LR, Lanier P, Tossone K, Zivin K, Burns ME. Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs. JAMA health forum. 2023 Jun 2; 4(6):e231422.
  211. French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care. Families, systems & health : the journal of collaborative family healthcare. 2023 Sep 1; 41(3):377-388.
  212. Ahrens K, Sharbaugh M, Jarlenski MP, Tang L, Allen L, Austin AE, Barnes AJ, Burns ME, Clark S, Zivin K, Mack A, Liu G, Mohamoud S, McDuffie MJ, Hammerslag L, Gordon AJ, Donohue JM, Writing Committee for Medicaid Outcomes Distributed Research Network. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2023 May 24; 76(10):1793-1801.
  213. Byrd CT, Kim RK, Manapat P, He H, Tsui BCH, Shrager JB, Berry MF, Backhus LM, Lui NS, Liou DZ. Characterization of Epidural Analgesia Interruption and Associated Outcomes After Esophagectomy. The Journal of surgical research. 2023 Oct 1; 290:92-100.
  214. Carr MM, Lou R, Macdonald-Gagnon G, Peltier MR, Funaro MC, Martino S, Masheb RM. Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review. The American journal of drug and alcohol abuse. 2023 May 18; 1-15.
  215. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clinical breast cancer. 2023 Aug 1; 23(6):598-619.
  216. Claypool AL, DiGennaro C, Russell WA, Yildirim MF, Zhang AF, Reid Z, Stringfellow EJ, Bearnot B, Schackman BR, Humphreys K, Jalali MS. Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids. JAMA health forum. 2023 May 5; 4(5):e231080.
  217. Frost MC, Soyer EM, Achtmeyer CE, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Addiction science & clinical practice. 2023 May 4; 18(1):26.
  218. Wyse JJ, Lovejoy TI, Gordon AJ, Mackey K, Herreid-O'Neill A, Morasc o BJ. "I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment. Substance Abuse. 2023 May 3; 44(1):41-50.
  219. Gordon AJ, Saxon AJ, Kertesz S, Wyse JJ, Manhapra A, Lin LA, Chen W, Hansen J, Pinnell D, Huynh T, Baylis JD, Cunningham FE, Ghitza UE, Bart G, Yu H, Sauer BC. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence. 2023 Jul 1; 248:109902.
  220. Frost MC, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2023 May 1; 17(3):278-285.
  221. Turner AP, Arewasikporn A, Hawkins EJ, Suri P, Burns SP, Leipertz SL, Haselkorn JK. Risk Factors for Chronic Prescription Opioid Use in Multiple Sclerosis. Archives of physical medicine and rehabilitation. 2023 May 1.
  222. Gao YA, Krans EE, Chen Q, Rothenberger SD, Zivin K, Jarlenski MP. Sex-related differences in the prevalence of substance use disorders, treatment, and overdose among parents with young children. Addictive behaviors reports. 2023 Jun 1; 17:100492.
  223. Somohano VC, Smith CL, Saha S, McPherson S, Morasco BJ, Ono SS, Zaccari B, Lovejoy J, Lovejoy T. Patient-Provider Shared Decision-Making, Trust, and Opioid Misuse Among US Veterans Prescribed Long-Term Opioid Therapy for Chronic Pain. Journal of general internal medicine. 2023 Sep 1; 38(12):2755-2760.
  224. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. Journal of substance use and addiction treatment. 2023 Jul 1; 150:209055.
  225. Dhinsa J, Roman-Urrestarazu A, van Kessel R, Humphreys K. Understanding predictors of mental health and substance use treatment utilization among US adults: A repeated cross-sectional study. Global epidemiology. 2023 Dec 1; 5:100109.
  226. Reed DE, Chen C, Harvey K, Engel CC, Kroenke K, Defaccio R, Coggeshall S, Taylor SL, Bokhour BG, Zeliadt SB. Utilization of Whole Health and Longitudinal Outcomes After Screening Positive for Possible Depression Documented in Veterans Health Administration's Electronic Health Record. Journal of integrative and complementary medicine. 2023 Dec 1; 29(12):781-791, DOI: 10.1089/jicm.2022.0772.
  227. Ackland PE, Kenny ME, Clothier BA, Salameh HA, Boening N, Gordon AJ, Noorbaloochi S, Gustavson AM, Miller W, Hagedorn HJ. What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. Journal of general internal medicine. 2023 Sep 1; 38(12):2647-2654.
  228. Goulet J, Cheng Y, Becker W, Brandt C, Sandbrink F, Workman TE, Ma P, Libin A, Shara N, Spevak C, Kupersmith J, Zeng-Treitler Q. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers. Frontiers in public health. 2023 Apr 4; 11:1148189.
  229. Thompson RG, Bollinger M, Mancino MJ, Hasin D, Han X, Bush KA, Kilts CD, James GA. Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Trials. 2023 Apr 4; 24(1):255.
  230. Bounthavong M. Is Providing Medications for Opioid Use Disorder to Incarcerated Individuals a Cost-effective Strategy? JAMA Network Open. 2023 Apr 3; 6(4):e237001.
  231. Nguemeni Tiako MJ, Shofer F, Dolan A, Goldberg EB, Rhodes KV, Hess EP, Bellamkonda VR, Perrone J, Cannuscio CC, Becker L, Rodgers MA, Zyla MM, Bell JJ, McCollum S, Engel-Rebitzer E, Schapira MM, Meisel ZF. Personalized risk communication and opioid prescribing in association with nonprescribed opioid use: A secondary analysis of a randomized controlled trial. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Aug 1; 30(8):851-858.
  232. MacLean RR, Heapy AA, Waters AJ, Wolkowicz N, Szollosy SK, Meyerovich J, Sofuoglu M. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results. Drug and Alcohol Dependence. 2023 May 1; 246:109857.
  233. Zaman T, Bravata DM, Byers AL, Krebs EE, Leonard SJ, Sandbrink F, Barker W, Keyhani S. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care. BMC psychiatry. 2023 Mar 17; 23(1):177.
  234. Nichols MA, Riley EG, Chao AS, Sales CG, Miller ML, Curran GM, Ott CA, Snyder ME, Hudmon KS. Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs. American Journal of Pharmaceutical Education. 2023 Jun 1; 87(6):100061.
  235. Sasson C, Dieujuste N, Klocko R, Basrai Z, Celedon M, Hsiao J, Himstreet J, Hoffman J, Pfaff C, Malmstrom R, Smith J, Holstein A, Johnson-Koenke R. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Apr 1; 30(4):289-298.
  236. Lott AM, Danner AN, Malte CA, Williams EC, Gordon AJ, Halvorson MA, Saxon AJ, Hagedorn HJ, Sayre GG, Hawkins EJ. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. Journal of addiction medicine. 2023 Jul 1; 17(4):e262-e268.
  237. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. The Clinical Journal of Pain. 2023 Mar 1; 39(3):107-118.
  238. Riggs KR, Cherrington AL, Kertesz SG, Richman JS, DeRussy AJ, Varley AL, Becker WC, Morris MS, Singh JA, Markland AD, Goodin BR. Higher Pain Catastrophizing and Preoperative Pain is Associated with Increased Risk for Prolonged Postoperative Opioid Use. Pain physician. 2023 Mar 1; 26(2):E73-E82.
  239. Stringfellow EJ, Lim TY, DiGennaro C, Zhang Z, Paramasivam P, Bearnot B, Humphreys K, Jalali MS. Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities: A Model-based Analysis. Journal of addiction medicine. 2023 Jul 1; 17(4):439-446.
  240. DeBar LL, Bushey MA, Kroenke K, Bobb JF, Schoenbaum M, Thompson EE, Justice M, Zatzick D, Hamilton LK, McMullen CK, Hallgren KA, Benes LL, Forman DP, Caldeiro RM, Brown RP, Campbell NL, Anderson ML, Son S, Haggstrom DA, Whiteside L, Schleyer TKL, Bradley KA. A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trial. Contemporary clinical trials. 2023 Apr 1; 127:107124.
  241. Watson DP, Phalen P, Medcalf S, Messmer S, McGuire A. Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services. Substance abuse treatment, prevention, and policy. 2023 Feb 11; 18(1):9.
  242. Bray BC, Watson DP, Salisbury-Afshar E, Taylor L, McGuire A. Patterns of opioid use behaviors among patients seen in the emergency department: Latent class analysis of baseline data from the POINT pragmatic trial. Journal of substance use and addiction treatment. 2023 Mar 1; 146:208979.
  243. Glass JE, Dorsey CN, Beatty T, Bobb JF, Wong ES, Palazzo L, King D, Mogk J, Stefanik-Guizlo K, Idu A, Key D, Fortney JC, Thomas R, McWethy AG, Caldeiro RM, Bradley KA. Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implementation science : IS. 2023 Feb 1; 18(1):3.
  244. McGowan MG, Taylor SL. Registry of Current Research on Veterans and Complementary and Integrative Health Therapies and Chiropractic Care. Research Registry. Whitehead A, Taylor SL, editors. Los Angeles CA: Produced by VA Complementary and Integrative Health Evaluation Center for the VA Office of Patient Centered Care and Cultural Transformation; 2023 Feb 1. 1-15 p.
  245. Wyse JJ, Shull S, Lindner S, Morasco BJ, Gordon AJ, Carlson KF, Korthuis PT, Ono SS, Liberto JG, Lovejoy TI. Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities. Journal of general internal medicine. 2023 Jun 1; 38(8):1871-1876.
  246. Auty SG, Barr KD, Frakt AB, Garrido MM, Strombotne KL. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Addiction (Abingdon, England). 2023 May 1; 118(5):870-879.
  247. Conrad M, Steffensmeier KS, Van Tiem J, Obrecht A, Mares J, Mosher HJ, Weg MWV, Sibenaller Z, Stout L, Patel P, Hadlandsmyth K. Military Veterans' Perspectives on Postoperative Opioid Use: A Secondary Analysis of Qualitative Data. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses. 2023 Jun 1; 38(3):483-487.
  248. Margraf AM, Davoodi NM, Chen K, Shield RR, McAuliffe LM, Collins CM, Zullo AR. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023 Jan 5; 80(2):53-60.
  249. Lynch KA, McCoy M, Gabrielian S. Veterans Finding Community and a "Home" Within an Emergency Housing Environment. Journal of primary care & community health. 2023 Jan 1; 14:21501319231180448.
  250. Qian G, Rao I, Humphreys K, Owens DK, Brandeau ML. Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence. 2023 Feb 1; 243:109762.
  251. Baxley C, Borsari B, Reavis JV, Manuel JK, Herbst E, Becker W, Pennington D, Batki SL, Seal K. Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors. 2023 Apr 1; 139:107589.
  252. Mulumba KY, Mariano ER, Leng JC, Kou A, Hunter OO, Tamboli M, Memtsoudis SG, Mudumbai SC. Changing a clinical pathway to increase spinal anesthesia use for elective hip arthroplasty: a single-centre historical cohort study. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2023 Feb 1; 70(2):211-218.
  253. Coquet J, Zammit A, Hajouji OE, Humphreys K, Asch SM, Osborne TF, Curtin CM, Hernandez-Boussard T. Changes in postoperative opioid prescribing across three diverse healthcare systems, 2010-2020. Frontiers in digital health. 2022 Dec 6; 4:995497.
  254. Kelley AT, Wilcox J, Baylis JD, Crossnohere NL, Magel J, Jones AL, Gordon AJ, Bridges JFP. Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. Journal of general internal medicine. 2023 Jul 1; 38(9):2147-2155.
  255. Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder. JAMA psychiatry. 2022 Dec 1; 79(12):1173-1179.
  256. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance Abuse. 2022 Dec 1; 43(1):1286-1299.
  257. Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. 2022 Dec 1; 28(12):1904-1914.
  258. Sung ML, Viera A, Esserman D, Tong G, Davidson D, Aiudi S, Bailey GL, Buchanan AL, Buchelli M, Jenkins M, John B, Kolakowski J, Lame A, Murphy SM, Porter E, Simone L, Paris M, Rash CJ, Edelman EJ. Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemporary clinical trials. 2023 Feb 1; 125:107037.
  259. Krebs EE, Becker WC, Nelson D, DeRonne BM, Nugent S, Jensen AC, Amundson EC, Manuel JK, Borsari B, Kats AM, Seal KH. Design, methods, and recruitment outcomes of the Veterans' Pain Care Organizational Improvement Comparative Effectiveness (VOICE) study. Contemporary clinical trials. 2023 Jan 1; 124:107001.
  260. Livingston NA, Davenport M, Head M, Henke R, LeBeau LS, Gibson TB, Banducci AN, Sarpong A, Jayanthi S, Roth C, Camacho-Cook J, Meng F, Hyde J, Mulvaney-Day N, White M, Chen DC, Stein MD, Weisberg R. The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Drug and Alcohol Dependence. 2022 Dec 1; 241:109678.
  261. Medicaid Outcomes Distributed Research Network (MODRN), Cole ES, Allen L, Austin A, Barnes A, Chang CH, Clark S, Crane D, Cunningham P, Fry CE, Gordon AJ, Hammerslag L, Idala D, Kennedy S, Kim JY, Krishnan S, Lanier P, Mahakalanda S, Mauk R, McDuffie MJ, Mohamoud S, Talbert J, Tang L, Zivin K, D onohue JM. Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states. Drug and Alcohol Dependence. 2022 Dec 1; 241:109670.
  262. Hsiao JJ, Celedon MA, Basrai ZI, Sasson C, Cordasco KM. Medications for Opioid Use Disorder Program in a VA Emergency Department. MDEdge: Federal Practioner [Internet]. 2022 Oct 20:(MDedge):258618. Available from: https://www.mdedge.com/fedprac/article/258618/addiction-medicine/medications-opioid-use-disorder-program-va-emergency.
  263. Nichols MA, Kepley KL, Rosko KS, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Community pharmacist-provided opioid intervention frequencies and barriers. Journal of the American Pharmacists Association : JAPhA. 2022 Oct 14; 63(1):336-342.
  264. Barrett AK, Sandbrink F, Mardian A, Oliva EM, Torrise V, Zhang R, Bukowski K, Burk M, Cunningham FE. Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers. Journal of general internal medicine. 2022 Dec 1; 37(16):4037-4046.
  265. Ward R, Rauch SAM, Axon RN, Saenger MS. Evaluation of a non-pharmacological interdisciplinary pain rehabilitation and functional restoration program for chronic pain in veterans. Health services research. 2023 Apr 1; 58(2):365-374.
  266. Moyo P, Eliot M, Shah A, Goodyear K, Jutkowitz E, Thomas K, Zullo AR. Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries. Addiction science & clinical practice. 2022 Oct 8; 17(1):57.
  267. Edelman EJ, Gan G, Dziura J, Esserman D, Porter E, Becker WC, Chan PA, Cornman DH, Helfrich CD, Reynolds J, Yager JE, Morford KL, Muvvala SB, Fiellin DA. Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics: A Randomized Clinical Trial. JAMA Network Open. 2022 Oct 3; 5(10):e2236904.
  268. Frost MC, Zhang L, Kim HM, Lin LA. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open. 2022 Oct 3; 5(10):e2236298.
  269. Kember RL, Vickers-Smith R, Xu H, Toikumo S, Niarchou M, Zhou H, Hartwell EE, Crist RC, Rentsch CT, Million Veteran Program, Davis LK, Justice AC, Sanchez-Roige S, Kampman KM, Gelernter J, Kranzler HR. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction. Nature neuroscience. 2022 Oct 1; 25(10):1279-1287.
  270. Edmond SN, Snow JL, Pomeranz J, Van Cleve R, Black AC, Compton P, Becker WC. Delphi study to explore a new diagnosis for "ineffective" long-term opioid therapy for chronic pain. Pain. 2023 Apr 1; 164(4):870-876.
  271. Subramaniam S, Stryczek KC, Ball S, Stevenson L, Ho PM, Aron DC. Workforce Development to Improve Access to Pain Care for Veterans: A Qualitative Analysis of VA-ECHO Participant Experiences. Health services research and managerial epidemiology. 2022 Sep 7; 9:23333928221124806.
  272. Johnson DG, Ho VT, Hah JM, Humphreys K, Carroll I, Curtin C, Asch SM, Hernandez-Boussard T. Prescription quantity and duration predict progression from acute to chronic opioid use in opioid-naïve Medicaid patients. PLOS digital health. 2022 Aug 25; 1(8).
  273. Zeliadt SB, Douglas JH, Gelman H, Coggeshall S, Taylor SL, Kligler B, Bokhour BG. Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC health services research. 2022 Aug 17; 22(1):1053.
  274. Epperson MV, VanHorn A, Kim HM, Kim JC, Zopf D. Pain management after microtia repair with costal cartilage: De-escalation and opioid use reduction. International journal of pediatric otorhinolaryngology. 2022 Oct 1; 161:111270.
  275. Zhang IY, Wong ES, Rosen JE, Gordon DB, Flum DR, Liao JM. Association Between Statewide Medicaid Opioid Policy and Postoperative Opioid Prescribing among Surgeons at a Large Safety-Net Hospital. Journal of the American College of Surgeons. 2022 Sep 1; 235(3):519-528.
  276. Mosher H. Treating hospitalized people who have opioid use disorder: Coming to consensus. Journal of hospital medicine. 2022 Sep 1; 17(9):774-775.
  277. Dolan AR, Goldberg EB, Cannuscio CC, Abrams MP, Feuerstein-Simon R, Luna Marti X, Mazique J, Schapira MM, Meisel ZF. Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial. JAMA Network Open. 2022 Aug 1; 5(8):e2227650.
  278. Hepner KA, Roth CP, Sherry TB, McBain RK, Ruder T, Engel CC. Assessing the Quality of Outpatient Pain Care and Opioid Prescribing in the Military Health System. Rand health quarterly. 2022 Aug 1; 9(4):19.
  279. Lin LA, Zhang L, Kim HM, Frost MC. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder. The American journal of psychiatry. 2022 Oct 1; 179(10):740-747.
  280. Deak JD, Zhou H, Galimberti M, Levey DF, Wendt FR, Sanchez-Roige S, Hatoum AS, Johnson EC, Nunez YZ, Demontis D, Børglum AD, Rajagopal VM, Jennings MV, Kember RL, Justice AC, Edenberg HJ, Agrawal A, Polimanti R, Kranzler HR, Geler nter J. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Molecular Psychiatry. 2022 Oct 1; 27(10):3970-3979.
  281. Sousa JL, Raja P, Huskamp HA, Mehrotra A, Busch AB, Barnett ML, Uscher-Pines L. Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences. Journal of addiction medicine. 2022 Nov 1; 16(6):702-708.
  282. Yan CH, Ramanathan S, Suda KJ, Khouja T, Rowan SA, Evans CT, Lee TA, Calip GS, Gellad WF, Sharp LK, National Dental Practice-Based Research Network Collaborative Group. Barriers to and facilitators of opioid prescribing by dentists in the United States: A qualitative study. Journal of the American Dental Association (1939). 2022 Oct 1; 153(10):957-969.e1.
  283. Edmond SN, Wesolowicz DM, Moore BA, Ibarra J, Chhabra M, Fraenkel L, Becker WC. Opioid tapering support using a web-based app: Development and protocol for a pilot randomized controlled trial. Contemporary clinical trials. 2022 Aug 1; 119:106857.
  284. Zivin K, Allen L, Barnes AJ, Junker S, Kim JY, Tang L, Kennedy S, Ahrens KA, Burns M, Clark S, Cole E, Crane D, Idala D, Lanier P, Mohamoud S, Jarlenski M, McDuffie MJ, Talbert J, Gordon AJ, Donohue JM. Design, Implementation, and Evolution of the Medicaid Outcomes Distributed Research Network (MODRN). Medical care. 2022 Sep 1; 60(9):680-690.
  285. Fernandez AC, Bohnert A, Gunaseelan V, Motamed M, Waljee JF, Brummett CM. Identifying Persistent Opioid Use After Surgery: The Reliability of Pharmacy Dispensation Databases. Annals of surgery. 2023 Jul 1; 278(1):e20-e26.
  286. Powell VD, Macleod C, Sussman J, Lin LA, Bohnert ASB, Lagisetty P. Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes. Journal of general internal medicine. 2023 Feb 1; 38(3):699-706.
  287. Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC. Association between opioid therapy trajectories and potential opioid-related adverse health events. Pharmacoepidemiology and drug safety. 2022 Oct 1; 31(10):1075-1090.
  288. Candon M, Strominger J, Gotlieb E, Maust DT. Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer's Disease and Related Dementias: A Cross-Sectional Analysis. Journal of The American Medical Directors Association. 2022 Nov 1; 23(11):1780-1786.e2.
  289. Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, Kelly J, Glos L, Eggers SL, Kazemi R, Jalali MS. Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis. Science advances. 2022 Jun 24; 8(25):eabm8147.
  290. Wyse JJ, Mackey K, Lovejoy TI, Kansagara D, Tuepker A, Gordon AJ, Todd Korthuis P, Herreid-O'Neill A, Williams B, Morasc o BJ. Expanding access to medications for opioid use disorder through locally-initiated implementation. Addiction science & clinical practice. 2022 Jun 20; 17(1):32.
  291. Lin LA, Powell VD, Macleod C, Bohnert ASB, Lagisetty P. Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder. Journal of substance abuse treatment. 2022 Oct 1; 141:108827.
  292. Burns M, Tang L, Chang CH, Kim JY, Ahrens K, Allen L, Cunningham P, Gordon AJ, Jarlenski MP, Lanier P, Mauk R, McDuffie MJ, Mohamoud S, Talbert J, Zivin K, Donohue J. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study. Addiction (Abingdon, England). 2022 Dec 1; 117(12):3079-3088.
  293. Holeman TA, Buys MJ, Bayless K, Anderson Z, Hales J, Brooke BS. Complete opioid cessation after surgery improves patient-reported pain measures among chronic opioid users. Surgery. 2022 Sep 1; 172(3):943-948.
  294. Frost MC, Richards JE, Blosnich JR, Hawkins EJ, Tsui JI, Edelman EJ, Williams EC. Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder. Drug and Alcohol Dependence. 2022 Aug 1; 237:109521.
  295. Hadlandsmyth K, Mosher HJ, Bayman EO, Mares JG, Odom AS, Lund BC. Opioid prescribing patterns for acute pain. European journal of pain (London, England). 2022 Aug 1; 26(7):1523-1531.
  296. Hadlandsmyth K, Burgess DJ, Leparski RF, Odom AS, Campbell EJ, Obrecht AA, Adamowicz JL, Cho H, Steffensmeier KS, Johnson NL, Richards CC, Vander Weg MW, Lund BC, Yoon P, Mosher HJ. The Perioperative Pain Self-Management (PePS) randomized controlled trial protocol: Preventing chronic post-surgical pain and prolonged opioid use. Contemporary clinical trials. 2022 Jul 1; 118:106810.
  297. Lim TY, Stringfellow EJ, Stafford CA, DiGennaro C, Homer JB, Wakeland W, Eggers SL, Kazemi R, Glos L, Ewing EG, Bannister CB, Humphreys K, Throckmorton DC, Jalali MS. Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences of the United States of America. 2022 Jun 7; 119(23):e2115714119.
  298. Austin EJ, Briggs ES, Ferro L, Barry P, Heald A, Curran GM, Saxon AJ, Fortney J, Ratzliff AD, Williams EC. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics. Journal of general internal medicine. 2023 Feb 1; 38(2):332-340.
  299. Love T, Shabalin AA, Kember RL, Docherty AR, Zhou H, Koppelmans V, Gelernter J, Baker AK, Hartwell E, Dubroff J, Zubieta JK, Kranzler HR. Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022 Sep 1; 47(10):1784-1790.
  300. Vitzthum LK, Nalawade V, Riviere P, Marar M, Furnish T, Lin LA, Thompson R, Murphy JD. Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment. Journal of the National Cancer Institute. 2022 May 9; 114(5):753-760.
  301. Gomes T, Kim KC, Suda KJ, Garg R, Tadrous M. International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID-19 pandemic: A cross-sectional analysis of 66 countries. Pharmacoepidemiology and drug safety. 2022 Jul 1; 31(7):779-787.
  302. Lo-Ciganic WH, Hincapie-Castillo J, Wang T, Ge Y, Jones BL, Huang JL, Chang CY, Wilson DL, Lee JK, Reisfield GM, Kwoh CK, Delcher C, Nguyen KA, Zhou L, Shorr RI, Guo J, Marcum ZA, Harle CA, Park H, Winterstein A, Yang S, Huang PL, Adkins L, Gellad WF. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models. Addiction (Abingdon, England). 2022 Jul 1; 117(7):1982-1997.
  303. Zaller N, Gardner A, Borders T, Drummond KL. A Qualitative Exploration of Primary Care Practitioner Views About Training to Treat Opioid Use Disorder. SSRN Electronic Journal. 2022 Apr 15; http://dx.doi.org/10.2139/ssrn.4078644.
  304. Copeland LA, Pugh MJ, Bollinger MJ, Wang CP, Amuan ME, Rivera JC, Shireman PK. The VA vascular injury study: A glimpse at quality of care in Veterans with traumatic vascular injury repair. Injury. 2022 Jun 1; 53(6):1947-1953.
  305. Boyer TL, Blosnich JR, Hubbard CC, Sharp LK, Cashy JP, Suda KJ. Comparing Outpatient Opioids, High-Risk Prescribing, and Opioid Poisoning Between Transgender and Cisgender Veterans: A Cross-sectional Analysis. American journal of preventive medicine. 2022 Aug 1; 63(2):168-177.
  306. Grant AD, Miller MM, Anastas TM, Quinn P, Lok B, Hirsh AT. Opioid-related risk perceptions in chronic pain: influence of patient gender and previous misuse behaviors. Pain. 2022 Apr 1; 163(4):711-718.
  307. Radmall AO, Calder S, Codell N, Kelley AT, Hawkins E, Jones AL, Hagedorn HJ, Reynolds MA, Gordon AJ. Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of addictions nursing. 2022 Apr 1; 33(2):70-79.
  308. Bergen AW, Baurley JW, Ervin CM, McMahan CS, Bible J, Stafford RS, Mudumbai SC, Saxon AJ. Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials. International journal of environmental research and public health. 2022 Mar 30; 19(7).
  309. Pickard JG, van den Berk-Clark C, Matthieu MM. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities. Military medicine. 2022 Mar 28; 187(3-4):504-512.
  310. Mattocks KM, Moore DT, Wischik DL, Lazar CM, Rosen MI. Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic. Journal of substance abuse treatment. 2022 Aug 1; 139:108777.
  311. Chanfreau-Coffinier C, Tuteja S, Hull LE, MacDonald S, Efimova O, Bates J, Voora D, Oslin DW, DuVall SL, Lynch JA. Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans Affairs. Pain. 2022 Dec 1; 163(12):2390-2397.
  312. Perry C, Liberto J, Milliken C, Burden J, Hagedorn H, Atkinson T, McKay JR, Mooney L, Sall J, Sasson C, Saxon A, Spevak C, Gordon AJ, VA/DoD Guideline Development G roup. The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of internal medicine. 2022 May 1; 175(5):720-731.
  313. Meerwijk EL, Adams RS, Larson MJ, Highland KB, Harris AHS. Dose of Exercise Therapy Among Active Duty Soldiers With Chronic Pain Is Associated With Lower Risk of Long-Term Adverse Outcomes After Linking to the Veterans Health Administration. Military medicine. 2022 Mar 21.
  314. Beckman KL, Williams EC, Hebert P, Hawkins EJ, Littman AJ, Lehavot K. The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder. Journal of substance abuse treatment. 2022 Aug 1; 139:108775.
  315. Oldfield BJ, Li Y, Vickers-Smith R, Barry DT, Crystal S, Gordon KS, Kerns RD, Williams EC, Marshall BDL, Edelman EJ. Longitudinal analysis of the prevalence and correlates of heavy episodic drinking and self-reported opioid use among a national cohort of patients with HIV. Alcoholism, clinical and experimental research. 2022 Apr 1; 46(4):600-613.
  316. Stein BD, Saloner B, Kerber R, Sorbero M, Gordon AJ. Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020. Annals of Emergency Medicine. 2022 May 1; 79(5):441-450.
  317. Bokhour BG, Hyde J, Kligler B, Gelman H, Gaj L, Barker AM, Douglas J, DeFaccio R, Taylor SL, Zeliadt SB. From patient outcomes to system change: Evaluating the impact of VHA's implementation of the Whole Health System of Care. Health services research. 2022 Jun 1; 57 Suppl 1:53-65.
  318. Van Cleve R, Edmond S, Snow J, Black AC, Pomeranz JL, Becker W. Classification of Patients for Whom Benefit of Long-term Opioid Therapy No Longer Outweighs Harm: Protocol for a Delphi Study. JMIR research protocols. 2022 Mar 4; 11(3):e33310.
  319. Bicket MC, Gunaseelan V, Lagisetty P, Fernandez AC, Bohnert A, Assenmacher E, Sequeira M, Englesbe MJ, Brummett CM, Waljee JF. Association of opioid exposure before surgery with opioid consumption after surgery. Regional Anesthesia and Pain Medicine. 2022 Jun 1; 47(6):346-352.
  320. Cochran G, Cole ES, Sharbaugh M, Nagy D, Gordon AJ, Gellad WF, Pringle J, Bear T, Warwick J, Drake C, Chang CH, DiDomenico E, Kelley D, Donohue J. Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder. Journal of addiction medicine. 2022 Mar 1; 16(2):e87-e96.
  321. Navathe AS, Liao JM, Yan XS, Delgado MK, Isenberg WM, Landa HM, Bond BL, Small DS, Rareshide CAL, Shen Z, Pepe RS, Refai F, Lei VJ, Volpp KG, Patel MS. The Effect Of Clinician Feedback Interventions On Opioid Prescribing. Health affairs (Project Hope). 2022 Mar 1; 41(3):424-433.
  322. Thakrar AP. Short-Acting Opioids for Hospitalized Patients With Opioid Use Disorder. JAMA internal medicine. 2022 Mar 1; 182(3):247-248.
  323. Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug and Alcohol Dependence. 2022 Apr 1; 233:109379.
  324. Gordon AJ, Kenny M, Dungan M, Gustavson AM, Kelley AT, Jones AL, Hawkins E, Frank JW, Danner A, Liberto J, Hagedorn H. Are x-waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x-waiver trainings. The American journal on addictions. 2022 Mar 1; 31(2):152-158.
  325. Bicket MC, Lin LA, Waljee J. New Persistent Opioid Use After Surgery: A Risk Factor for Opioid Use Disorder? Annals of surgery. 2022 Feb 1; 275(2):e288-e289.
  326. Pro G, Hayes C, Brown CC, Goree J, Zaller N. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018. American journal of public health. 2022 Feb 1; 112(S1):S66-S76.
  327. Kramer JR, Puenpatom A, Cao Y, Yu X, El-Serag HB, Kanwal F. Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. The American journal of drug and alcohol abuse. 2022 Jul 4; 48(4):445-453.
  328. Faiz J, Bernstein E, Dugas JN, Schechter-Perkins EM, Nentwich L, Nelson KP, Cleveland Manchanda EC, Young L, Pare JR. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care. The American journal of emergency medicine. 2022 Apr 1; 54:221-227.
  329. Rubin JB, Lai JC, Leonard S, Seal K, Hoggatt KJ, Keyhani S. Long-Term Opioid Use Among Veterans with Cirrhosis: High-Dose Prescriptions in an Exceedingly High-Risk Population. Journal of general internal medicine. 2022 Sep 1; 37(12):3205-3207.
  330. Incze MA, Kelley AT, Gordon AJ. Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. Journal of general internal medicine. 2022 May 1; 37(7):1771-1773.
  331. Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of addiction medicine. 2022 Sep 1; 16(5):505-513.
  332. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Jordan N, Keefer LA, Lambert BL. Opioid-related emergency department visits and hospitalizations among patients with chronic gastrointestinal symptoms and disorders dually enrolled in the Department of Veterans Affairs and Medicare Part D. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022 Jan 5; 79(2):78-93.
  333. Ervin-Sikhondze BA, Moser SE, Pierce J, Dickens JR, Lagisetty PA, Urquhart AG, Hallstrom BR, Brummett CM, McAfee J. Reasons for Preoperative Opioid Use Are Associated with Persistent Use following Surgery Among Patients Undergoing Total Knee and Hip Arthroplasty. Pain medicine (Malden, Mass.). 2022 Jan 3; 23(1):19-28.
  334. Hagedorn HJ, Gustavson AM, Ackland PE, Bangerter A, Bounthavong M, Clothier B, Harris AHS, Kenny ME, Noorbaloochi S, Salameh HA, Gordon AJ. Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities. Journal of general internal medicine. 2022 Nov 1; 37(14):3594-3602.
  335. Frank CJ, Lin LA. Defining and supporting high-quality telehealth for patients with opioid use disorder: The promise and potential pitfalls of telehealth expansion. Substance Abuse. 2022 Jan 1; 43(1):1370-1373.
  336. Hadlandsmyth K, Conrad M, Steffensmeier KS, Van Tiem J, Obrecht A, Cullen JJ, Vander Weg MW. Enhancing the Biopsychosocial Approach to Perioperative Care: A Pilot Randomized Trial of the Perioperative Pain Self-management (PePS) Intervention. Annals of surgery. 2022 Jan 1; 275(1):e8-e14.
  337. Hayes CJ, Cucciare MA, Martin BC, Hudson TJ, Bush K, Lo-Ciganic W, Yu H, Charron E, Gordon AJ. Using data science to improve outcomes for persons with opioid use disorder. Substance Abuse. 2022 Jan 1; 43(1):956-963.
  338. Priest KC, King CA, Englander H, Lovejoy TI, McCarty D. Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis. Substance Abuse. 2022 Jan 1; 43(1):1251-1259.
  339. Thakrar AP, Jablonski L, Ratner J, Rastegar DA. Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists. Journal of addiction medicine. 2022 Jan 1; 16(1):122-124.
  340. Edmond SN, Snow JL, Pomeranz J, Van Cleve R, Becker WC. Arguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits. The journal of pain. 2022 Jun 1; 23(6):958-966.
  341. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study. Drug and Alcohol Dependence. 2022 Feb 1; 231:109236.
  342. Vakkalanka JP, Lund BC, Arndt S, Field W, Charlton M, Ward MM, Carnahan RM. Therapeutic relationships between Veterans and buprenorphine providers and effects on treatment retention. Health services research. 2022 Apr 1; 57(2):392-402.
  343. Potter JS, Finley EP, King VL, Lanham HJ, Schmidt S, Schneegans S, Rosen KD. Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX. Journal of substance abuse treatment. 2022 Jun 1; 137:108688.
  344. Bushey MA, Wu J, Outcalt SD, Krebs EE, Ang D, Kline M, Yu Z, Bair MJ. Opioid Use as a Predictor of Pain Outcomes in Iraq and Afghanistan Veterans with Chronic Pain: Analysis of a Randomized Controlled Trial. Pain medicine (Malden, Mass.). 2021 Dec 11; 22(12):2964-2970.
  345. Hagan S, Achtmeyer CE, Hood C, Hawkins EJ, Williams EC. Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report. Addiction science & clinical practice. 2021 Dec 3; 16(1):71.
  346. Adams MA, Saini SD, Gao Y, Wiitala WL, Rubenstein JH. Endoscopist-directed sedation rarely fails: implications for the value of anesthesia assistance for routine GI endoscopy. The American journal of managed care. 2021 Dec 1; 27(12):e413-e419.
  347. Hawkins EJ, Malte CA, Gordon AJ, Williams EC, Hagedorn HJ, Drexler K, Blanchard BE, Burden JL, Knoeppel J, Danner AN, Lott A, Liberto JG, Saxon AJ. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. JAMA Network Open. 2021 Dec 1; 4(12):e2137238.
  348. Melmed GY, Oliver B, Hou JK, Lum D, Singh S, Crate D, Almario C, Bray H, Bresee C, Gerich M, Gerner D, Heagy E, Holthoff M, Hudesman D, McCutcheon Adams K, Mattar MC, Metwally M, Nelson E, Ostrov A, Rubin DT, Scott F, Samir S, van Deen W, Younes Z, Oberai R, Weaver A, Siegel CA, IBD Qorus. Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. The American journal of gastroenterology. 2021 Dec 1; 116(12):2410-2418.
  349. Lin LA, Bonar EE, Zhang L, Girard R, Coughlin LN. Alcohol-involved overdose deaths in US veterans. Drug and Alcohol Dependence. 2022 Jan 1; 230:109196.
  350. Khouja T, Zhou J, Gellad WF, Mitsantisuk K, Hubbard CC, Yan CH, Sharp LK, Calip GS, Evans CT, Suda KJ. Serious opioid-related adverse outcomes associated with opioids prescribed by dentists. Pain. 2022 Aug 1; 163(8):1571-1580.
  351. Hatoum AS, Johnson EC, Colbert SMC, Polimanti R, Zhou H, Walters RK, Gelernter J, Edenberg HJ, Bogdan R, Agrawal A. The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022 Sep 1; 47(10):1739-1745.
  352. Beckman KL, Williams EC, Hebert PL, Frost MC, Rubinsky AD, Hawkins EJ, Littman AJ, Lehavot K. Associations Among Military Sexual Trauma, Opioid Use Disorder, and Gender. American journal of preventive medicine. 2022 Mar 1; 62(3):377-386.
  353. Goldsmith E, Koffel E, Ackland P, Hill J, Landsteiner A, Miller W, Stroebel B, Ullman K, Wilt TJ, Duan-Porter WD. Implementation of Psychotherapies and Mindfulness-based Stress Reduction for Chronic Pain and Chronic Mental Health Conditions: A Systematic Review. 2021 Nov 1.
  354. Jones AL, Gelberg L, deRussy AJ, Varley AL, Riggs KR, Gordon AJ, Kertesz SG. Low Uptake of Secure Messaging Among Veterans With Experiences of Homelessness and Substance Use Disorders. Journal of addiction medicine. 2021 Nov 1; 15(6):508-511.
  355. Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. Journal of general internal medicine. 2022 Jan 1; 37(1):162-167.
  356. Bounthavong M, Suh K, Li M, Spoutz PM, Stottlemyer BA, Sepassi A. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017. Substance abuse treatment, prevention, and policy. 2021 Oct 20; 16(1):80.
  357. Townsend TN, Salz T, Haffajee RL, Caram MEV, Chino F, Bohnert ASB. Has Declining Opioid Dispensing to Cancer Patients Been Tailored to Risk of Opioid Harms? Journal of pain and symptom management. 2022 Feb 1; 63(2):179-188.
  358. Han BH, Tuazon E, Y Wei M, Paone D. Multimorbidity and Inpatient Utilization Among Older Adults with Opioid Use Disorder in New York City. Journal of general internal medicine. 2022 May 1; 37(7):1634-1640.
  359. Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addiction science & clinical practice. 2021 Oct 11; 16(1):62.
  360. Hatoum AS, Wendt FR, Galimberti M, Polimanti R, Neale B, Kranzler HR, Gelernter J, Edenberg HJ, Agrawal A. Ancestry may confound genetic machine learning: Candidate-gene prediction of opioid use disorder as an example. Drug and Alcohol Dependence. 2021 Dec 1; 229(Pt B):109115.
  361. Fernandez AC, Lin LA, Bazzi AR, Boissoneault J, Borsari B, Blow F. Beliefs About Perioperative Opioid and Alcohol Use among Elective Surgical Patients Who Report Unhealthy Drinking: A Qualitative Study. Pain medicine (Malden, Mass.). 2021 Oct 8; 22(10):2384-2392.
  362. Timko C, Kroenke K, Nevedal A, Lor MC, Oliva E, Drexler K, Sandbrink F, Hoggatt K. Development and field testing of primary care screening tools for harms of long-term opioid therapy continuation and tapering to discontinuation: a study protocol. BMJ open. 2021 Oct 7; 11(10):e053524.
  363. Spelman JF, Edens EL, Maya S, Moore BA, Boggs A, MacLean RR, Ackland P, Becker WC, Lynch D, Garcia-Vassallo M, Burgo AL, Rosen MI, Gordon AJ. A Facility-Wide Plan to Increase Access to Medication for Opioid Use Disorder in Primary Care and General Mental Health Settings. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2021 Oct 1; 38(10):460-464.
  364. Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Substance Abuse. 2021 Sep 29; 43(1):556-563.
  365. Ward R, Tang YL, Axon RN, Casarella J, Whitfield N, Rauch SAM. Effectiveness of a substance use treatment program for veterans with chronic pain and opioid use disorder. Journal of substance abuse treatment. 2022 Jan 1; 132:108635.
  366. Cochran G, Brown J, Yu Z, Frede S, Bryan MA, Ferguson A, Bayyari N, Taylor B, Snyder ME, Charron E, Adeoye-Olatunde OA, Ghitza UE, Winhusen T. Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test. Drug and Alcohol Dependence. 2021 Nov 1; 228:109067.
  367. Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug and Alcohol Dependence. 2021 Nov 1; 228:109081.
  368. Wyse JJ, Herreid-O'Neill A, Dougherty J, Shull S, Mackey K, Priest KC, Englander H, Thoma J, Lovejo y TI. Perioperative Management of Buprenorphine/Naloxone in a Large, National Health Care System: a Retrospective Cohort Study. Journal of general internal medicine. 2022 Sep 1; 37(12):2998-3004.
  369. Magel J, Kietrys D, Kruger ES, Fritz JM, Gordon AJ. Physical therapists should play a greater role in managing patients with opioid use and opioid misuse. Substance Abuse. 2021 Sep 15; 42(3):255-260.
  370. Quinlan TAG, Roberts AW, Frank JW, Whittington MD. Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use. Health services research. 2021 Dec 1; 56(6):1233-1244.
  371. Wyse JJ, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Kennedy AJ, Oldfield BJ, Gaither JR, Gordon KS, Skanderson M, Barry DT, Bryant K, Crystal S, Justice AC, Kraemer KL. Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS and behavior. 2022 Mar 1; 26(3):975-985.
  372. Hawkins EJ, Danner AN, Malte CA, Blanchard BE, Williams EC, Hagedorn HJ, Gordon AJ, Drexler K, Burden JL, Knoeppel J, Lott A, Sayre GG, Midboe AM, Saxon AJ. Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities. Addiction science & clinical practice. 2021 Sep 6; 16(1):55.
  373. Holmer HK, Gilbert TA, Ashraf AJ, O'Neil ME, Carlso n KF. Opioid and Sedative-Hypnotic Prescriptions Among Post-9/11 Veteran VA Users Nationwide With Traumatic Brain Injury, 2012-2020. The Journal of head trauma rehabilitation. 2021 Sep 1; 36(5):354-363.
  374. Kelley AT, Dungan MT, Gordon AJ. Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. Journal of addiction medicine. 2021 Sep 1; 15(5):439-440.
  375. Ly DP. Association of Patient Race and Ethnicity With Differences in Opioid Prescribing by Primary Care Physicians for Older Adults With New Low Back Pain. JAMA health forum. 2021 Sep 1; 2(9):e212333.
  376. Powell VD, Rosenberg JM, Yaganti A, Garpestad C, Lagisetty P, Shannon C, Silveira MJ. Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review. JAMA Network Open. 2021 Sep 1; 4(9):e2124152.
  377. Shover CL, Falasinnu TO, Freedman RB, Humphreys K. Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study. Journal of addiction medicine. 2021 Sep 1; 15(5):429-431.
  378. Baker JF, Stokes A, Pedro S, Mikuls TR, George M, England BR, Sayles H, Wolfe F, Michaud K. Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis. Arthritis care & research. 2021 Oct 1; 73(10):1405-1412.
  379. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Keefer LA, Jordan N. Characteristics of Opioid Prescriptions to Veterans With Chronic Gastrointestinal Symptoms and Disorders Dually Enrolled in the Department of Veterans Affairs and Medicare Part D. Military medicine. 2021 Aug 28; 186(9-10):943-950.
  380. Riedel L, Uscher-Pines L, Mehrotra A, Busch AB, Barnett ML, Raja P, Huskamp HA. Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians. Drug and Alcohol Dependence. 2021 Nov 1; 228:108999.
  381. Karlsson Linnér R, Mallard TT, Barr PB, Sanchez-Roige S, Madole JW, Driver MN, Poore HE, de Vlaming R, Grotzinger AD, Tielbeek JJ, Johnson EC, Liu M, Rosenthal SB, Ideker T, Zhou H, Kember RL, Pasman JA, Verweij KJH, Liu DJ, Vrieze S, COGA Collaborators, Kranzler HR, Gelernter J, Harris KM, Tucker-Drob EM, Waldman ID, Palmer AA, Harden KP, Koellinger PD, D ick DM. Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. Nature neuroscience. 2021 Oct 1; 24(10):1367-1376.
  382. Goree JH, Srinivasan N, Cucciare MA, Zaller N, Byers L, Boateng B, Hayes CJ. Video-Based, Patient-Focused Opioid Education in the Perioperative Period Increases Self-Perceived Opioid-Related Knowledge: A Pilot Study. Journal of pain research. 2021 Aug 24; 14:2583-2592.
  383. Chow SL, Sasson C, Benjamin IJ, Califf RM, Compton WM, Oliva EM, Robson C, Sanchez EJ. Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association. Circulation. 2021 Sep 28; 144(13):e218-e232.
  384. Brown-Taylor L, Beckner A, Scaff KE, Fritz JM, Buys MJ, Patel S, Bayless K, Brooke BS. Relationships between physical therapy intervention and opioid use: A scoping review. PM & R : the journal of injury, function, and rehabilitation. 2022 Jul 1; 14(7):837-854.
  385. Blevins D, Henry BF, Sung M, Edelman EJ, Black AC, Dawes M, Molfenter T, Hagle H, Drexler K, Cates-Wessel K, Levin FR. Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National Survey. Psychiatric services (Washington, D.C.). 2022 Apr 1; 73(4):374-380.
  386. Gustavson AM, Kenny ME, Wisdom JP, Salameh HA, Ackland PE, Gordon AJ, Hagedorn HJ. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention. Addiction science & clinical practice. 2021 Aug 6; 16(1):51.
  387. Bonar EE, Kidwell KM, Bohnert ASB, Bourque CA, Carter PM, Clark SJ, Glantz MD, King CA, Losman ED, McCabe SE, Philyaw-Kotov ML, Prosser LA, Voepel-Lewis T, Zheng K, Walton MA. Optimizing scalable, technology-supported behavioral interventions to prevent opioid misuse among adolescents and young adults in the emergency department: A randomized controlled trial protocol. Contemporary clinical trials. 2021 Sep 1; 108:106523.
  388. Magaletta PR, Morasco BJ. Perspectives on opioid misuse from public service psychology: An introduction. Psychological Services. 2021 Aug 1; 18(3):285-286.
  389. Rao IJ, Humphreys K, Brandeau ML. Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. Lancet Regional Health. Americas. 2021 Nov 1; 3.
  390. Wyse JJ, Morasco BJ, Dougherty J, Edwards B, Kansagara D, Gordon AJ, Korthuis PT, Tuepker A, Lindner S, Mackey K, Williams B, Herreid-O'Neill A, Paynter R, Lovejo y TI. Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence. Drug and Alcohol Dependence. 2021 Nov 1; 228:108923.
  391. Medicaid Outcomes Distributed Research Network (MODRN) , Donohue JM, Jarlenski MP, Kim JY, Tang L, Ahrens K, Allen L, Austin A, Barnes AJ, Burns M, Chang CH, Clark S, Cole E, Crane D, Cunningham P, Idala D, Junker S, Lanier P, Mauk R, McDuffie MJ, Mohamoud S, Pauly N, Sheets L, Talbert J, Zivin K, Gordon AJ, Kennedy S. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. JAMA. 2021 Jul 13; 326(2):154-164.
  392. Khan MR, Ban K, Caniglia EC, Edelman JE, Gaither J, Crystal S, Chichetto NE, Young KE, Tate J, Justice AC, Braithwaite RS. Brief original report: Does smoking status provide information relevant to screening for other substance use among US adults?. Preventive medicine reports. 2021 Sep 1; 23:101483.
  393. Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA psychiatry. 2021 Jul 1; 78(7):767-777.
  394. Rogal S, Youk A, Agbalajobi O, Zhang H, Gellad W, Fine MJ, Belperio P, Morgan T, Good CB, Kraemer K. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. The American journal of gastroenterology. 2021 Jul 1; 116(7):1406-1413.
  395. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran G. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction science & clinical practice. 2021 Jun 25; 16(1):40.
  396. Khouja T, Tadrous M, Matusiak L, Suda K. Opioid Prescribing in United States Health Systems, 2015 to 2019. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2021 Sep 1; 24(9):1279-1284.
  397. Vakkalanka JP, Lund BC, Ward MM, Arndt S, Field RW, Charlton M, Carnahan RM. Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans. Journal of general internal medicine. 2022 May 1; 37(7):1610-1618.
  398. Oldfield BJ, Li Y, Vickers-Smith R, Becker WC, Barry DT, Crystal S, Gordon KS, Kerns RD, Rentsch CT, Marshall BDL, Edelman EJ. Sociodemographic and clinical correlates of gabapentin receipt with and without opioids among a national cohort of patients with HIV. AIDS Care. 2022 Aug 1; 34(8):1053-1063.
  399. Frost MC, Sweek EW, Austin EJ, Corcorran MA, Juarez AM, Frank ND, Prohaska SM, LaKosky PA, Asher AK, Broz D, Jarlais DCD, Williams EC, Glick SN. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S. AIDS and behavior. 2022 Jan 1; 26(1):57-68.
  400. Ching JH, Owens DK, Trafton JA, Goldhaber-Fiebert JD, Salomon JA. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration. Addiction (Abingdon, England). 2021 Dec 1; 116(12):3494-3503.
  401. Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin DA, Kraemer KL. Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of substance abuse treatment. 2022 Jan 1; 132:108509.
  402. Lin LA, Fortney JC, Bohnert ASB, Coughlin LN, Zhang L, Piette JD. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder. Journal of substance abuse treatment. 2022 Feb 1; 133:108492.
  403. Vakkalanka P, Lund BC, Arndt S, Field W, Charlton M, Ward MM, Carnahan RM. Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk. American journal of preventive medicine. 2021 Sep 1; 61(3):418-427.
  404. Robles M, Mortazavi L, Vannerson J, Matthias MS. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder. Teaching and learning in medicine. 2021 May 11; 34(5):514-521.
  405. Moore DT, Wischik DL, Lazar CM, Vassallo GG, Rosen MI. The intertwined expansion of telehealth and buprenorphine access from a prescriber hub. Preventive medicine. 2021 Nov 1; 152(Pt 2):106603.
  406. Chen J, Cabudol M, Williams EC, Merrill JO, Tsui JI, Klein JW. Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care. Journal of substance abuse treatment. 2021 Jul 1; 126:108463.
  407. Goldstone LW, DiPaula BA, Werremeyer A, Botts S, Hepburn B, Liu HY, Duckworth K, Young AS, Kelly DL. The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient Outcomes. Psychiatric services (Washington, D.C.). 2021 Jul 1; 72(7):794-801.
  408. Udayachalerm S, Bair MJ, Illingworth Plake KS, Huang CY, Murray MD, Foster DR. Opioid prescribing and health outcomes in opioid-naive patients: Analysis of a statewide health information exchange. Journal of the American Pharmacists Association : JAPhA. 2021 Sep 1; 61(5):623-631.e3.
  409. Brown CR, Groeneveld P, Desai N. Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing-Reply. JAMA cardiology. 2021 May 1; 6(5):602-603.
  410. Burgess DJ, Vallone D, Bair MJ, Matthias MS, Taylor BC, Taylor SL. Shifting the National Consciousness about Pain Treatment: The Critical Need for a National Public Education Campaign. The journal of pain. 2021 Oct 1; 22(10):1129-1133.
  411. Lagisetty P, Macleod C, Thomas J, Slat S, Kehne A, Heisler M, Bohnert ASB, Bohnert KM. Assessing reasons for decreased primary care access for individuals on prescribed opioids: an audit study. Pain. 2021 May 1; 162(5):1379-1386.
  412. Moore MN, Wallace BI. Glucocorticoid and opioid use in rheumatoid arthritis management. Current opinion in rheumatology. 2021 May 1; 33(3):277-283.
  413. Feinberg TM, Coleman B, Innes KE, Kerns RD, Jackson B, Lisi A, Majoris N, Brandt C. Correlates of Manual Therapy and Acupuncture Use Among Rural Patients Seeking Conventional Pain Management: A Cross-sectional Study. Journal of Manipulative and Physiological Therapeutics. 2021 May 1; 44(4):330-343.
  414. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2021 Apr 1; 15(2):143-149.
  415. Bryson WC, Morasco BJ, Cotton BP, Thielke SM. Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment. Substance use & misuse. 2021 Mar 22; 56(5):697-703.
  416. Polusny MA, Hintz S, Mallen M, Thuras P, Krebs EE, Erbes CR, Arbisi PA. Pre-deployment personality traits predict prescription opioid receipt over 2-year post-deployment period in a longitudinal cohort of deployed National Guard soldiers. Addictive Behaviors. 2021 Aug 1; 119:106919.
  417. Benintendi A, Kosakowski S, Lagisetty P, Larochelle M, Bohnert ASB, Bazzi AR. "I felt like I had a scarlet letter": Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. Drug and Alcohol Dependence. 2021 May 1; 222:108664.
  418. Maust DT, Strominger J, Kim HM, Langa KM, Bynum JPW, Chang CH, Kales HC, Zivin K, Solway E, Marcus SC. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021 Mar 9; 325(10):952-961.
  419. Dezfulian C, Orkin AM, Maron BA, Elmer J, Girotra S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks MA, van Diepen S, Lavonas EJ, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Council on Clinical Cardiology. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation. 2021 Apr 20; 143(16):e836-e870.
  420. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. Journal of substance abuse treatment. 2021 Oct 1; 129:108353.
  421. Sherva R, Zhu C, Wetherill L, Edenberg HJ, Johnson E, Degenhardt L, Agrawal A, Martin NG, Nelson E, Kranzler HR, Gelernter J, Farrer LA. Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes. Exploration of medicine. 2021 Feb 28; 2:60-73.
  422. Harris RA, Mandell DS, Kampman KM, Bao Y, Campbell K, Cidav Z, Coviello DM, French R, Livesey C, Lowenstein M, Lynch KG, McKay JR, Oslin DW, Wolk CB, Bogner HR. Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol. Contemporary clinical trials. 2021 Apr 1; 103:106325.
  423. Spencer NE, Taubenberger SP, Roberto R, Krishnamurti LS, Chang JC, Hacker K. "Stories of starting": Understanding the complex contexts of opioid misuse initiation. Substance Abuse. 2021 Feb 22; 1-16.
  424. Cole ES, Drake C, DiDomenico E, Sharbaugh M, Kim JY, Nagy D, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kmiec J, Kelley D, Donohue JM. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population. Drug and Alcohol Dependence. 2021 Apr 1; 221:108633.
  425. Gustavson AM, Wisdom JP, Kenny ME, Salameh HA, Ackland PE, Clothier B, Noorbaloochi S, Gordon AJ, Hagedorn HJ. Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration. Implementation science communications. 2021 Feb 15; 2(1):20.
  426. Watson DP, Weathers T, McGuire A, Cohen A, Huynh P, Bowes C, O'Donnell D, Brucker K, Gup ta S. Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes. Drug and Alcohol Dependence. 2021 Apr 1; 221:108595.
  427. Lagisetty P, Garpestad C, Larkin A, Macleod C, Antoku D, Slat S, Thomas J, Powell V, Bohnert ASB, Lin LA. Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence. 2021 Apr 1; 221:108583.
  428. Adams JW, Li Y, Barry DT, Gordon KS, Kerns RD, Oldfield BJ, Rentsch CT, Marshall BDL, Edelman EJ. Long-term Patterns of Self-reported Opioid Use, VACS Index, and Mortality Among People with HIV Engaged in Care. AIDS and behavior. 2021 Sep 1; 25(9):2951-2962.
  429. DeRonne BM, Wong KR, Schultz E, Jones E, Krebs EE. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021 Feb 8; 78(4):354-359.
  430. Incze MA, Kelley AT, Gordon AJ. Improving Opioid Use Disorder Treatment through Quality Assessment. Journal of general internal medicine. 2021 Sep 1; 36(9):2820-2822.
  431. Dir AL, Watson DP, Zhiss M, Taylor L, Bray BC, McGuire A. Barriers impacting the POINT pragmatic trial: the unavoidable overlap between research and intervention procedures in "real-world" research. Trials. 2021 Feb 4; 22(1):114.
  432. Giannitrapani KF, Fereydooni S, Silveira MJ, Azarfar A, Glassman PA, Midboe A, Zenoni M, Becker WC, Lorenz KA. How Patients and Providers Weigh the Risks and Benefits of Long-Term Opioid Therapy for Cancer Pain. JCO oncology practice. 2021 Jul 1; 17(7):e1038-e1047.
  433. Gadd S, Cox N, Samuelson J, Kenney A, Turner K, Cochran G. Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective. Therapeutic Drug Monitoring. 2021 Feb 1; 43(1):35-41.
  434. Borsari B, Li Y, Tighe J, Manuel JK, Gökbayrak NS, Delucchi K, Morasco BJ, Abadjian L, Cohen BE, Baxley C, Sea l KH. A pilot trial of collaborative care with motivational interviewing to reduce opioid risk and improve chronic pain management. Addiction (Abingdon, England). 2021 Sep 1; 116(9):2387-2397.
  435. Guo J, Lo-Ciganic WH, Yang Q, Huang JL, Weiss JC, Cochran G, Malone DC, Kuza CC, Gordon AJ, Donohue JM, Gellad WF. Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose. Journal of general internal medicine. 2021 Apr 1; 36(4):908-915.
  436. Vina ER, Quinones C, Hausmann LRM, Ibrahim SA, Kwoh CK. Association of Patients' Familiarity and Perceptions of Efficacy and Risks With the Use of Opioid Medications in the Management of Osteoarthritis. The Journal of rheumatology. 2021 Dec 1; 48(12):1863-1870.
  437. Becker WC, Heimer R, Dormitzer CM, Doernberg M, D'Onofrio G, Grau LE, Hawk K, Lin HJ, Secora AM, Fielli n DA. Merging statewide data in a public/university collaboration to address opioid use disorder and overdose. Addiction science & clinical practice. 2021 Jan 4; 16(1):1.
  438. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Jordan N, Keefer LA. High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Digestive diseases and sciences. 2021 Nov 1; 66(11):3938-3950.
  439. Bleicher J, Esplin J, Blumling AN, Cohan JN, Savarise Md M, Wetter DW, Harris AHS, Kaphingst KA, Huang LC. Expectation-setting and patient education about pain control in the perioperative setting: A qualitative study. Journal of opioid management. 2021 Jan 1; 17(6):455-464.
  440. Brintz CE, Cheatle MD, Dember LM, Heapy AA, Jhamb M, Shallcross AJ, Steel JL, Kimmel PL, Cukor D, HOPE Consortium. Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease. Seminars in Nephrology. 2021 Jan 1; 41(1):68-81.
  441. Cron DC, Tincopa MA, Lee JS, Waljee AK, Hammoud A, Brummett CM, Waljee JF, Englesbe MJ, Sonnenday CJ. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. Transplantation. 2021 Jan 1; 105(1):100-107.
  442. Von Korff M, DeBar LL, Deyo RA, Mayhew M, Kerns RD, Goulet JL, Brandt C. Identifying Multisite Chronic Pain with Electronic Health Records Data. Pain medicine (Malden, Mass.). 2020 Dec 25; 21(12):3387-3392.
  443. Khatri UG, Aronowitz SV. Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment. Journal of substance abuse treatment. 2021 Apr 1; 123:108258.
  444. Bryan JL, Hogan J, Lindsay JA, Ecker AH. Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts. Journal of substance abuse treatment. 2021 Mar 1; 122:108254.
  445. George SZ, Coffman CJ, Allen KD, Lentz TA, Choate A, Goode AP, Simon CB, Grubber JM, King H, Cook CE, Keefe FJ, Ballengee LA, Naylor J, Brothers JL, Stanwyck C, Alkon A, Hastings SN. Improving Veteran Access to Integrated Management of Back Pain (AIM-Back): Protocol for an Embedded Pragmatic Cluster-Randomized Trial. Pain medicine (Malden, Mass.). 2020 Dec 12; 21(Suppl 2):S62-S72.
  446. Montgomery AE, Rahman FAKM, Cusack M, Varley A, Byrne T. Correlates of Transitions Into Housing Instability Among Veterans Accessing Veterans Health Administration Health Care. Medical care. 2020 Dec 1; 58(12):1105-1110.
  447. Maciejewski ML, Zepel L, Hale SL, Wang V, Diamantidis CJ, Blaz JW, Olin S, Wilson-Frederick SM, James CV, Smith VA. Opioid Prescribing in the 2016 Medicare Fee-for-Service Population. Journal of the American Geriatrics Society. 2021 Feb 1; 69(2):485-493.
  448. Howell BA, Abel EA, Park D, Edmond SN, Leisch LJ, Becker WC. Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study. Journal of general internal medicine. 2021 May 1; 36(5):1264-1270.
  449. Manhapra A, Sullivan MD, Ballantyne JC, MacLean RR, Becker WC. Complex Persistent Opioid Dependence with Long-term Opioids: a Gray Area That Needs Definition, Better Understanding, Treatment Guidance, and Policy Changes. [Editorial]. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):964-971.
  450. Becker WC, Krebs EE, Edmond SN, Lin LA, Sullivan MD, Weiss RD, Gordon AJ. A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):978-982.
  451. Chang ET, Oberman RS, Cohen AN, Taylor SL, Gumm E, Mardian AS, Toy S, Revote A, Lewkowitz B, Yano EM. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):918-926.
  452. Frank JW, Bohnert ASB, Sandbrink F, McGuire M, Drexler K. Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):983-987.
  453. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):954-963.
  454. Priest KC, McCarty D, Lovejoy TI. Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):886-890.
  455. Veazie S, Mackey K, Peterson K, Bourne D. Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):945-953.
  456. Hah JM, Trafton JA, Narasimhan B, Krishnamurthy P, Hilmoe H, Sharifzadeh Y, Huddleston JI, Amanatullah D, Maloney WJ, Goodman S, Carroll I, Mackey SC. Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): A prospective, assessor-blind, randomized controlled pilot trial. EClinicalMedicine. 2020 Nov 1; 28:100596.
  457. Buys MJ, Bayless K, Romesser J, Anderson Z, Patel S, Zhang C, Presson AP, Beckstrom J, Brooke BS. Multidisciplinary Transitional Pain Service for the Veteran Population. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2020 Oct 1; 37(10):472-478.
  458. Zhou H, Rentsch CT, Cheng Z, Kember RL, Nunez YZ, Sherva RM, Tate JP, Dao C, Xu K, Polimanti R, Farrer LA, Justice AC, Kranzler HR, Gelernter J, Veterans Affairs Million Veteran Program. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. JAMA psychiatry. 2020 Oct 1; 77(10):1072-1080.
  459. Jacobs JC, Jarvik JG, Chou R, Boothroyd D, Lo J, Nevedal A, Barnett PG. Observational Study of the Downstream Consequences of Inappropriate MRI of the Lumbar Spine. Journal of general internal medicine. 2020 Dec 1; 35(12):3605-3612.
  460. Gordon KS, Manhapra A, Crystal S, Dziura J, Edelman EJ, Skanderson M, Kerns RD, Justice AC, Tate J, Becker WC. All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors. Drug and Alcohol Dependence. 2020 Nov 1; 216:108291.
  461. Gustavson AM, Gordon AJ, Kenny ME, McHenry H, Gronek J, Ackland PE, Hagedorn HJ. Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder. Substance Abuse. 2020 Sep 16; 41(4):413-418.
  462. Roddy MK, Boykin DM, Hadlandsmyth K, Marchman JN, Green DM, Buckwalter JA, Garvin L, Zimmerman B, Bae J, Cortesi J, Rodrigues M, Embree J, Rakel BA, Dindo L. One-day Acceptance and Commitment Therapy workshop for preventing persistent post-surgical pain and dysfunction in at-risk veterans: A randomized controlled trial protocol. Journal of psychosomatic research. 2020 Nov 1; 138:110250.
  463. Steffens C, Sung M, Bastian LA, Edelman EJ, Brackett A, Gunderson CG. The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis. Journal of general internal medicine. 2020 Nov 1; 35(11):3315-3322.
  464. Giannitrapani KF, Ackland PE, Holliday J, Zeliadt S, Olson J, Kligler B, Taylor SL. Provider Perspectives of Battlefield Acupuncture: Advantages, Disadvantages and Its Potential Role in Reducing Opioid Use for Pain. Medical care. 2020 Sep 1; 58 Suppl 2 9S:S88-S93.
  465. Hirsh AT, Anastas TM, Miller MM, Quinn PD, Kroenke K. Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems. The American Psychologist. 2020 Sep 1; 75(6):784-795.
  466. Lobo CP, Cochran G, Chang CH, Gellad WF, Gordon AJ, Jalal H, Lo-Ciganic WH, Karp JF, Kelley D, Donohue JM. Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes. Pain medicine (Malden, Mass.). 2020 Sep 1; 21(9):1871-1890.
  467. Wilson AC, Morasco BJ, Holley AL, Feldstein Ewing SW. Patterns of opioid use in adolescents receiving prescriptions: The role of psychological and pain factors. The American Psychologist. 2020 Sep 1; 75(6):748-760.
  468. Zeliadt SB, Thomas ER, Olson J, Coggeshall S, Giannitrapani K, Ackland PE, Reddy KP, Federman DG, Drake DF, Kligler B, Taylor SL. Patient Feedback on the Effectiveness of Auricular Acupuncture on Pain in Routine Clinical Care: The Experience of 11,406 Veterans. Medical care. 2020 Sep 1; 58 Suppl 2 9S:S101-S107.
  469. Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. Journal of substance abuse treatment. 2020 Nov 1; 118:108124.
  470. Womack JA, Murphy TE, Bathulapalli H, Smith A, Bates J, Jarad S, Redeker NS, Luther SL, Gill TM, Brandt CA, Justice AC. Serious Falls in Middle-Aged Veterans: Development and Validation of a Predictive Risk Model. Journal of the American Geriatrics Society. 2020 Dec 1; 68(12):2847-2854.
  471. Buys MJ, Bayless K, Romesser J, Anderson Z, Patel S, Zhang C, Presson AP, Brooke BS. Opioid use among veterans undergoing major joint surgery managed by a multidisciplinary transitional pain service. Regional Anesthesia and Pain Medicine. 2020 Nov 1; 45(11):847-852.
  472. Bokhour BG, Gelman H, Gaj L, Thomas E, Barker A, Whittington M, Douglas J, DeFaccio R, Taylor S, Zeliadt S. Addressing Consumer and Patients' Preferences and Needs Whole Health System of Care Improves Health and Well-Being and Reduces Opioid Use for Veterans with Chronic Pain. [Abstract]. Health services research. 2020 Aug 20; 55(51):7-8.
  473. Jarlenski M, Krans EE, Chen Q, Rothenberger SD, Cartus A, Zivin K, Bodnar LM. Substance use disorders and risk of severe maternal morbidity in the United States. Drug and Alcohol Dependence. 2020 Nov 1; 216:108236.
  474. Qaseem A, McLean RM, O'Gurek D, Batur P, Lin K, Kansagar a DL. Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of Family Physicians. Annals of internal medicine. 2020 Nov 3; 173(9):739-748.
  475. Wells K, Amaro HD, Benjamin T, Bryan G, Cropsey K, Duwve J, Gupta R, Horvitz-Lennon M, Love RC, Olsen Y, Reif S. Measuring Success in Substance Use Grant Programs: Outcomes and Metrics for Improvement. A Consensus Study Report of the National Academies of Sciences, Engineering and Medicine (2020). Washington, DC: National Academies of Sciences, Engineering and Medicine; 2020 Aug 7. 52 p.
  476. Brown CR, Chen Z, Khurshan F, Groeneveld PW, Desai ND. Development of Persistent Opioid Use After Cardiac Surgery. JAMA cardiology. 2020 Aug 1; 5(8):889-896.
  477. Chan B, Freeman M, Ayers C, Korthuis PT, Paynter R, Kondo K, Kansagara D. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug and Alcohol Dependence. 2020 Nov 1; 216:108193.
  478. Lagisetty P, Bohnert A, Goesling J, Hu HM, Travis B, Lagisetty K, Brummett CM, Englesbe MJ, Waljee J. Care Coordination for Patients on Chronic Opioid Therapy Following Surgery: A Cohort Study. Annals of surgery. 2020 Aug 1; 272(2):304-310.
  479. Kwan SY, Lancaster E, Dixit A, Inglis-Arkell C, Manuel S, Suh I, Shen WT, Seib CD. Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns. The Journal of surgical research. 2020 Dec 1; 256:303-310.
  480. Gicquelais RE, Bohnert ASB, Fernandez AC. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids. Substance Abuse. 2020 Jul 21; 1-5.
  481. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Kwoh CK, Donohue JM, Gordon AJ, Cochran G, Malone DC, Kuza CC, Gellad WF. Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study. PLoS ONE. 2020 Jul 17; 15(7):e0235981.
  482. Bishop MO, Bayman EO, Hadlandsmyth K, Lund BC, Kang S. Opioid use trajectories after thoracic surgery among veterans in the United States. European journal of pain (London, England). 2020 Sep 1; 24(8):1569-1584.
  483. Lin LA, Bohnert ASB, Blow FC, Gordon AJ, Ignacio RV, Kim HM, Ilgen MA. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction (Abingdon, England). 2021 Jan 1; 116(1):96-104.
  484. Terman SW, Aubert CE, Hill CE, Maust DT, Betjemann JP, Boyd CM, Burke JF. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study. Epilepsy & Behavior : E&B. 2020 Oct 1; 111:107261.
  485. Hser YI, Mooney LJ. Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2021 Jan 1; 37(1):246-248.
  486. Khatri UG, Perrone J. Opioid Use Disorder and COVID-19: Crashing of the Crises. Journal of addiction medicine. 2020 Jul 1; 14(4):e6-e7.
  487. Shover CL, Vest NA, Chen D, Stueber A, Falasinnu TO, Hah JM, Kim J, Mackey I, Weber KA, Ziadni M, Humphreys K. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication. JAMA Network Open. 2020 Jul 1; 3(7):e2010001.
  488. Young SR, Azari S, Becker WC, Edelman EJ, Liebschutz JM, Roy P, Starrels JL, Merlin JS. Common and Challenging Behaviors Among Individuals on Long-term Opioid Therapy. Journal of addiction medicine. 2020 Jul 1; 14(4):305-310.
  489. Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. Journal of general internal medicine. 2020 Sep 1; 35(9):2529-2536.
  490. Caulkins JP, Humphreys KN. Preventing opioid use and addiction: New thinking and the latest evidence. The Opioid Crisis In America: A paper series from the Foreign Policy and Global Economy & Development programs at Brookings [Internet]. 2020 Jun 22: Available from: Washington, DC.
  491. Azad AD, Bozkurt S, Wheeler AJ, Curtin C, Wagner TH, Hernandez-Boussard T. Acute pain after breast surgery and reconstruction: A two-institution study of surgical factors influencing short-term pain outcomes. Journal of Surgical Oncology. 2020 Jun 20.
  492. Dora-Laskey AD, Goldstick JE, Arterberry BJ, Roberts SJ, Haffajee RL, Bohnert ASB, Cunningham RM, Carter PM. Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample. The western journal of emergency medicine. 2020 Jun 19; 21(4):831-840.
  493. Baldassarri SR, Beitel M, Zinchuk A, Redeker NS, Oberleitner DE, Oberleitner LMS, Carrasco D, Madden LM, Lipkind N, Fiellin DA, Bastian LA, Chen K, Yaggi HK, Barry DT. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep & Breathing = Schlaf & Atmung. 2020 Dec 1; 24(4):1729-1737.
  494. Mazurenko O, Andraka-Christou BT, Bair MJ, Kara AY, Harle CA. Clinical perspectives on hospitals' role in the opioid epidemic. BMC health services research. 2020 Jun 8; 20(1):521.
  495. Vu JV, Cron DC, Lee JS, Gunaseelan V, Lagisetty P, Wixson M, Englesbe MJ, Brummett CM, Waljee JF. Classifying Preoperative Opioid Use for Surgical Care. Annals of surgery. 2020 Jun 1; 271(6):1080-1086.
  496. Billig JI, Sears ED, Gunaseelan V, Santosa KB, Iwashyna TJ, Englesbe MJ, Brummett CM, Waljee JF. Inappropriate Preoperative Gabapentinoid Use Among Patients With Carpal Tunnel Syndrome. The Journal of hand surgery. 2020 Aug 1; 45(8):677-689.e5.
  497. Timko C, Hoggatt K. Commentary on Gibson et al. (2020): Medications for opioid use disorder- access, retention, and safety. Addiction (Abingdon, England). 2020 Nov 1; 115(11):2077-2078.
  498. Ball S, Stryczek K, Stevenson L, Hearns R, Au DH, Ho PM, Aron DC. A Qualitative Evaluation of the Pain Management VA-ECHO Program Using the RE-AIM Framework: The Participant's Perspective. Frontiers in public health. 2020 May 15; 8:169.
  499. Lagisetty P, Zhang K, Haffajee RL, Lin LA, Goldstick J, Brownlee R, Bohnert A, Larochelle MR. Opioid prescribing history prior to heroin overdose among commercially insured adults. Drug and Alcohol Dependence. 2020 Jul 1; 212:108061.
  500. Hand Surgery Quality Consortium. Quality Measures to Reduce Opioid Use After Common Soft Tissue Hand and Wrist Procedures. The Journal of hand surgery. 2020 Jul 1; 45(7):582-588.e4.
  501. Maciejewski ML, Smith VA, Berkowitz TSZ, Arterburn DE, Bradley KA, Olsen MK, Liu CF, Livingston EH, Funk LM, Mitchell JE. Long-term opioid use after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2020 Aug 1; 16(8):1100-1110.
  502. Vangala C, Niu J, Montez-Rath ME, Yan J, Navaneethan SD, Naik AD, Winkelmayer WC. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. Journal of the American Society of Nephrology : JASN. 2020 Jun 1; 31(6):1325-1334.
  503. Foster SD, Lee K, Edwards C, Pelullo AP, Khatri UG, Lowenstein M, Perrone J. Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing. Annals of Emergency Medicine. 2020 Aug 1; 76(2):206-214.
  504. Edelman EJ, Li Y, Barry D, Brennan Braden J, Crystal S, Kerns RD, Gaither JR, Gordon KS, Manhapra A, Merlin JS, Moore BA, Oldfield BJ, Park LS, Rentsch CT, Skanderson M, Williams EC, Justice AC, Tate JP, Becker WC, Marshall BDL. Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2020 May 1; 84(1):26-36.
  505. Mattocks K, Rosen MI, Sellinger J, Ngo T, Brummett B, Higgins DM, Reznik TE, Holtzheimer P, Semiatin AM, Stapley T, Martino S. Pain Care in the Department of Veterans Affairs: Understanding How a Cultural Shift in Pain Care Impacts Provider Decisions and Collaboration. Pain medicine (Malden, Mass.). 2020 May 1; 21(5):970-977.
  506. Becker WC, Gordon KS, Edelman EJ, Goulet JL, Kerns RD, Marshall BDL, Fiellin DA, Justice AC, Tate JP. Are we missing opioid-related deaths among people with HIV? Drug and Alcohol Dependence. 2020 Jul 1; 212:108003.
  507. Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis. Journal of general internal medicine. 2020 Aug 1; 35(8):2365-2374.
  508. Hadlandsmyth K, Mosher HJ, Vander Weg MW, O'Shea AM, McCoy KD, Lun d BC. Utility of accumulated opioid supply days and individual patient factors in predicting probability of transitioning to long-term opioid use: An observational study in the Veterans Health Administration. Pharmacology research & perspectives. 2020 Apr 1; 8(2):e00571.
  509. Stokes A, Lundberg DJ, Hempstead K, Berry KM, Baker JF, Preston SH. Obesity and Incident Prescription Opioid Use in the U.S., 2000-2015. American journal of preventive medicine. 2020 Jun 1; 58(6):766-775.
  510. Peahl AF, Morgan DM, Dalton VK, Zivin K, Lai YL, Hu HM, Langen E, Low LK, Brummett CM, Waljee JF, Bauer ME. New persistent opioid use after acute opioid prescribing in pregnancy: a nationwide analysis. American journal of obstetrics and gynecology. 2020 Oct 1; 223(4):566.e1-566.e13.
  511. Marcial LH, Blumenfeld B, Harle C, Jing X, Keller MS, Lee V, Lin Z, Dover A, Midboe AM, Al-Showk S, Bradley V, Breen J, Fadden M, Lomotan E, Marco-Ruiz L, Mohamed R, O'Connor P, Rosendale D, Solomon H, Kawamo to K. Barriers, Facilitators, and Potential Solutions to Advancing Interoperable Clinical Decision Support: Multi-Stakeholder Consensus Recommendations for the Opioid Use Case. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2020 Mar 4; 2019:637-646.
  512. Marsch LA, Campbell A, Campbell C, Chen CH, Ertin E, Ghitza U, Lambert-Harris C, Hassanpour S, Holtyn AF, Hser YI, Jacobs P, Klausner JD, Lemley S, Kotz D, Meier A, McLeman B, McNeely J, Mishra V, Mooney L, Nunes E, Stafylis C, Stanger C, Saunders E, Subramaniam G, Young S. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. Journal of substance abuse treatment. 2020 Mar 1; 112S:4-11.
  513. Mudumbai SC, Chung P, Nguyen N, Harris B, Clark JD, Wagner TH, Giori NJ, Stafford RS, Mariano ER. Perioperative Opioid Prescribing Patterns and Readmissions After Total Knee Arthroplasty in a National Cohort of Veterans Health Administration Patients. Pain medicine (Malden, Mass.). 2020 Mar 1; 21(3):595-603.
  514. Young SD, Lee SJ, Perez H, Gill N, Gelberg L, Heinzerling K. Social media as an emerging tool for reducing prescription opioid misuse risk factors. Heliyon. 2020 Mar 1; 6(3):e03471.
  515. Jones AL, Kertesz SG, Hausmann LRM, Mor MK, Suo Y, Pettey WBP, Schaefer JH, Gundlapalli AV, Gordon AJ. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. Journal of substance abuse treatment. 2020 Jun 1; 113:107996.
  516. Moon AM, Jiang Y, Rogal SS, Becker J, Barritt AS. In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge. PLoS ONE. 2020 Feb 26; 15(2):e0229497.
  517. Polimanti R, Walters RK, Johnson EC, McClintick JN, Adkins AE, Adkins DE, Bacanu SA, Bierut LJ, Bigdeli TB, Brown S, Bucholz KK, Copeland WE, Costello EJ, Degenhardt L, Farrer LA, Foroud TM, Fox L, Goate AM, Grucza R, Hack LM, Hancock DB, Hartz SM, Heath AC, Hewitt JK, Hopfer CJ, Johnson EO, Kendler KS, Kranzler HR, Krauter K, Lai D, Madden PAF, Martin NG, Maes HH, Nelson EC, Peterson RE, Porjesz B, Riley BP, Saccone N, Stallings M, Wall TL, Webb BT, Wetherill L, Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Edenberg HJ, Agrawal A, Gelernter J. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. Molecular Psychiatry. 2020 Aug 1; 25(8):1673-1687.
  518. Timko C, Nash A, Owens MD, Taylor E, Finlay AK. Systematic Review of Criminal and Legal Involvement After Substance Use and Mental Health Treatment Among Veterans: Building Toward Needed Research. Substance abuse : research and treatment. 2020 Feb 24; 14:1178221819901281.
  519. Chui PW, Gordon KS, Dziura J, Burg MM, Brandt CA, Sico JJ, Leapman MS, Cavanagh CE, Rosman L, Haskell S, Becker WC, Bastian LA. Association of prescription opioids and incident cardiovascular risk factors among post-9/11 Veterans. Preventive medicine. 2020 May 1; 134:106036.
  520. Melnick ER, Nath B, Ahmed OM, Brandt C, Chartash D, Dziura JD, Hess EP, Holland WC, Hoppe JA, Jeffery MM, Katsovich L, Li F, Lu CC, Maciejewski K, Maleska M, Mao JA, Martel S, Michael S, Paek H, Patel MD, Platts-Mills TF, Rajeevan H, Ray JM, Skains RM, Soares WE, Deutsch A, Solad Y, D'Onofr io G. Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder. Journal of psychiatry and brain science. 2020 Feb 21; 5.
  521. Brunet N, Moore DT, Lendvai Wischik D, Mattocks KM, Rosen MI. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Substance Abuse. 2020 Feb 20; 1-8.
  522. Zullo AR, Moyo P, Jutkowitz E, Zhang W, Thomas KS. Opioid Use Disorder Among Hospitalized Older Adults: Prevalence, Characteristics, and Discharge Status. Journal of The American Medical Directors Association. 2020 Apr 1; 21(4):557-559.
  523. Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020 Apr 1; 23(4):451-460.
  524. Corcoran KL, Bastian LA, Gunderson CG, Steffens C, Brackett A, Lisi AJ. Association Between Chiropractic Use and Opioid Receipt Among Patients with Spinal Pain: A Systematic Review and Meta-analysis. Pain medicine (Malden, Mass.). 2020 Feb 1; 21(2):e139-e145.
  525. Hung A, Bush C, Greiner M, Campbell H, Hammill B, Maciejewski ML, McKethan A. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. Journal of managed care & specialty pharmacy. 2020 Feb 1; 26(2):169-175.
  526. Lin LA, Brummett CM, Waljee JF, Englesbe MJ, Gunaseelan V, Bohnert ASB. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults. Journal of general internal medicine. 2020 Feb 1; 35(2):420-427.
  527. Essien UR, Sileanu FE, Zhao X, Liebschutz JM, Thorpe CT, Good CB, Mor MK, Radomski TR, Hausmann LRM, Fine MJ, Gellad WF. Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. Journal of general internal medicine. 2020 May 1; 35(5):1537-1544.
  528. Moon AM, Jiang Y, Rogal SS, Tapper EB, Lieber SR, Barritt AS. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis. Alimentary pharmacology & therapeutics. 2020 Mar 1; 51(6):652-660.
  529. Frank JW, Binswanger IA. Commentary on Rhee & Rosenheck (2019): Buprenorphine prescribing for opioid use disorder in medical practice - can office-based out-patient care address the opiate crisis in the United States?. [Letter to the Editor]. Addiction (Abingdon, England). 2020 Apr 1; 115(4):786-787.
  530. Athey AJ, Beale EE, Overholser JC, Stockmeier CA, Bagge CL. Acute stressors and clinical characteristics differentiate death by suicide, accident, or natural causes among illicit and prescription opiate users. Drug and Alcohol Dependence. 2020 Mar 1; 208:107847.
  531. Cox JW, Sherva RM, Lunetta KL, Johnson EC, Martin NG, Degenhardt L, Agrawal A, Nelson EC, Kranzler HR, Gelernter J, Farrer LA. Genome-Wide Association Study of Opioid Cessation. Journal of clinical medicine. 2020 Jan 9; 9(1).
  532. Kilaru AS, Perrone J, Kelley D, Siegel S, Lubitz SF, Mitra N, Meisel ZF. Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder. JAMA Network Open. 2020 Jan 3; 3(1):e1918511.
  533. Chin KK, Carroll I, Desai K, Asch S, Seto T, McDonald KM, Curtin C, Hernandez-Boussard T. Integrating Adjuvant Analgesics into Perioperative Pain Practice: Results from an Academic Medical Center. Pain medicine (Malden, Mass.). 2020 Jan 1; 21(1):161-170.
  534. Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse. 2020 Jan 1; 41(3):269-274.
  535. Gordon AJ, Drexler K, Hawkins EJ, Burden J, Codell NK, Mhatre-Owens A, Dungan MT, Hagedorn H. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse. 2020 Jan 1; 41(3):275-282.
  536. Burke LG, Zhou X, Boyle KL, Orav EJ, Bernson D, Hood ME, Land T, Bharel M, Frakt AB. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction (Abingdon, England). 2020 Mar 1; 115(3):493-504.
  537. Seal KH, Rife T, Li Y, Gibson C, Tighe J. Opioid Reduction and Risk Mitigation in VA Primary Care: Outcomes from the Integrated Pain Team Initiative. Journal of general internal medicine. 2020 Apr 1; 35(4):1238-1244.
  538. Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. Journal of the American Pharmacists Association : JAPhA. 2020 Jan 1; 60(1):244-247.
  539. Cuellar MF, Humphreys KN. The Political Economy of the Opioid Epidemic. Yale Law & Policy Review. 2020 Jan 5; 38(1):SSRN: https://ssrn.com/abstract=3503149.
  540. Turvey CL, Lund BC, Jones D, Arndt S. Community Treatment for Opioid Use Disorders in Urban and Rural Veterans. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2020 Mar 1; 36(2):167-176.
  541. Andrews CM, Humphreys K, Grogan CM. How Medicaid work requirements could exacerbate the opioid epidemic. The American journal of drug and alcohol abuse. 2019 Dec 4; 46(1):1-3.
  542. Jasuja GK, Ameli O, Reisman JI, Rose AJ, Miller DR, Berlowitz DR, Bhasin S. Health Outcomes Among Long-term Opioid Users With Testosterone Prescription in the Veterans Health Administration. JAMA Network Open. 2019 Dec 2; 2(12):e1917141.
  543. Lund BC, Ohl ME, Hadlandsmyth K, Mosher HJ. Regional and Rural-Urban Variation in Opioid Prescribing in the Veterans Health Administration. Military medicine. 2019 Dec 1; 184(11-12):894-900.
  544. Rentsch CT, Edelman EJ, Justice AC, Marshall BDL, Xu K, Smith AH, Crystal S, Gaither JR, Gordon AJ, Smith RV, Kember RL, Polimanti R, Gelernter J, Fiellin DA, Tate JP, Kranzler HR, Becker WC, VACS Project Team. Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study. AIDS and behavior. 2019 Dec 1; 23(12):3340-3349.
  545. Snell DB, Cohen-Mekelburg S, Weg R, Ghosh G, Buckholz AP, Mehta A, Ma X, Christos PJ, Jesudian AB. Gastric food retention at endoscopy is associated with severity of liver cirrhosis. World journal of hepatology. 2019 Nov 27; 11(11):725-734.
  546. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug and Alcohol Dependence. 2020 Feb 1; 207:107732.
  547. Rosen IM, Aurora RN, Kirsch DB, Carden KA, Malhotra RK, Ramar K, Abbasi-Feinberg F, Kristo DA, Martin JL, Olson EJ, Rosen CL, Rowley JA, Shelgikar AV, American Academy of Sleep Medicine Board of Directors. Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2019 Nov 15; 15(11):1671-1673.
  548. Krause JS, Dismuke-Greer CE, Reed KS, Li C. Employment status, hours working, and gainful earnings after spinal cord injury: relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord. 2020 Mar 1; 58(3):275-283.
  549. Agnoli A, Jerant A, Becker W, Franks P. Opioid Prescriptions and Short-Term Mortality: a U.S. National Study. Journal of general internal medicine. 2020 Mar 1; 35(3):656-661.
  550. Mooney LJ, Valdez J, Cousins SJ, Yoo C, Zhu Y, Hser YI. Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results. Journal of substance abuse treatment. 2020 Jan 1; 108:115-122.
  551. Derefinko KJ, Salgado García FI, Johnson KC, Hand S, Murphy JG, McDevitt-Murphy M, Suda KJ, Andrasik F, Bursac Z, Chiu CY, Talley K, Bro oks JH. A randomized pilot program to reduce opioid use following dental surgery and increase safe medication return. Addictive Behaviors. 2020 Mar 1; 102:106190.
  552. Maruti S, Desjardins I, Bagge CL, Althoff RR. Commentary: Opioid use disorder and suicide: An important opportunity to address two significant public health epidemics. Preventive medicine. 2019 Nov 1; 128:105854.
  553. Melnick ER, Holland WC, Ahmed OM, Ma AK, Michael SS, Goldberg HS, Lagier C, D'Onofrio G, Stachowiak T, Brandt C, Sol ad Y. An integrated web application for decision support and automation of EHR workflow: a case study of current challenges to standards-based messaging and scalability from the EMBED trial. JAMIA open. 2019 Dec 1; 2(4):434-439.
  554. Wang MC, Lozen AM, Laud PW, Nattinger AB, Krebs EE. Factors associated with chronic opioid use after cervical spine surgery for degenerative conditions. Journal of neurosurgery. Spine. 2019 Oct 11; 1-8.
  555. Moyo P, Gellad WF, Sabik LM, Cochran GT, Cole ES, Gordon AJ, Kelley DK, Donohue JM. Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer. American journal of preventive medicine. 2019 Oct 1; 57(4):540-544.
  556. Thornhill MH, Suda KJ, Durkin MJ, Lockhart PB. Is it time US dentistry ended its opioid dependence?. Journal of the American Dental Association (1939). 2019 Oct 1; 150(10):883-889.
  557. Shover CL, Humphreys K. Predictors of availability of long-acting medication for opioid use disorder. Drug and Alcohol Dependence. 2019 Nov 1; 204:107586.
  558. Brunette MF, Oslin DW, Dixon LB, Adler DA, Berlant J, Erlich M, First MB, Goldman B, Levine B, Siris S, Winston H. The Opioid Epidemic and Psychiatry: The Time for Action Is Now. Psychiatric services (Washington, D.C.). 2019 Dec 1; 70(12):1168-1171.
  559. Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatric services (Washington, D.C.). 2020 Jan 1; 71(1):35-42.
  560. Banerjee G, Edelman EJ, Barry DT, Crystal S, Gordon KS, Gordon AJ, Gaither JR, Green TC, Kerns RD, Manhapra A, Moore BA, Fiellin DA, Marshall BDL. High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans. Pain. 2019 Sep 1; 160(9):2126-2135.
  561. Giannitrapani KF, Holliday JR, Miake-Lye IM, Hempel S, Taylor SL. Synthesizing the Strength of the Evidence of Complementary and Integrative Health Therapies for Pain. Pain medicine (Malden, Mass.). 2019 Sep 1; 20(9):1831-1840.
  562. Giannitrapani KF, Fereydooni S, Azarfar A, Silveira MJ, Glassman PA, Midboe AM, Bohnert ABS, Zenoni MA, Kerns RD, Pearlman RA, Asch SM, Becker WC, Lorenz KA. Signature Informed Consent for Long-Term Opioid Therapy in Patients With Cancer: Perspectives of Patients and Providers. Journal of pain and symptom management. 2020 Jan 1; 59(1):49-57.
  563. Gibson CJ, Li Y, Huang AJ, Rife T, Seal KH. Menopausal Symptoms and Higher Risk Opioid Prescribing in a National Sample of Women Veterans with Chronic Pain. Journal of general internal medicine. 2019 Oct 1; 34(10):2159-2166.
  564. Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2?years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of substance abuse treatment. 2019 Nov 1; 106:19-28.
  565. Chen Q, Hsia HL, Overman R, Bryan W, Pepin M, Mariano ER, Mudumbai SC, Buchheit T, Krishnamoorthy V, Good CB, Brookhart MA, Raghunathan K. Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis. Anesthesiology. 2019 Aug 1; 131(2):369-380.
  566. Cochran G, Cole ES, Warwick J, Donohue JM, Gordon AJ, Gellad WF, Bear T, Kelley D, DiDomenico E, Pringle J. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers. Addiction science & clinical practice. 2019 Aug 1; 14(1):25.
  567. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder. 2019 Aug 1.
  568. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health affairs (Project Hope). 2019 Aug 1; 38(8):1289-1297.
  569. Veazie S, Mackey K, Bourne D, Peterson K. Evidence Brief: Managing Acute Pain in Patients with Opioid Use Disorder on Medication-assisted Treatment. 2019 Aug 1.
  570. Klueh MP, Sloss KR, Dossett LA, Englesbe MJ, Waljee JF, Brummett CM, Lagisetty PA, Lee JS. Postoperative opioid prescribing is not my job: A qualitative analysis of care transitions. Surgery. 2019 Nov 1; 166(5):744-751.
  571. Lagisetty PA, Healy N, Garpestad C, Jannausch M, Tipirneni R, Bohnert ASB. Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids. JAMA Network Open. 2019 Jul 3; 2(7):e196928.
  572. Gonzales-Castaneda R, Mooney LJ, Rawson RA. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks, Offering a Public Health Perspective-A Commentary on Camenga et al. Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):403-405.
  573. Vest N, Humphreys KN. Do We Know Enough to Prescribe Opioid-Agonist Therapies to Adolescents With Problematic Opioid Use? A Commentary on Camenga et al. (2019). Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):406-407.
  574. Hernandez-Boussard T, Graham LA, Carroll I, Dasinger EA, Titan AL, Morris MS, Hawn MT. Perioperative opioid use and pain-related outcomes in the Veterans Health Administration. American journal of surgery. 2020 Jun 1; 219(6):969-975.
  575. McGuire AB, Powell KG, Treitler PC, Wagner KD, Smith KP, Cooperman N, Robinson L, Carter J, Ray B, Watson DP. Emergency department-based peer support for opioid use disorder: Emergent functions and forms. Journal of substance abuse treatment. 2020 Jan 1; 108:82-87.
  576. Larochelle MR, Bohnert ASB. Opportunities to Address First Opioid Prescriptions to Reduce Incident Long-Term Opioid Use. Annals of internal medicine. 2019 Jul 16; 171(2):129-130.
  577. Tas B, Humphreys K, McDonald R, Strang J. Should we worry that take-home naloxone availability may increase opioid use? Addiction (Abingdon, England). 2019 Oct 1; 114(10):1723-1725.
  578. Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW. Perspectives and Practice in the Identification and Treatment of Opioid Use, Alcohol Use, and Depressive Disorders. Psychiatric services (Washington, D.C.). 2019 Oct 1; 70(10):940-943.
  579. Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder. JAMA Network Open. 2019 Jun 5; 2(6):e196373.
  580. Herman PM, Yuan AH, Cefalu MS, Chu K, Zeng Q, Marshall N, Lorenz KA, Taylor SL. The use of complementary and integrative health approaches for chronic musculoskeletal pain in younger US Veterans: An economic evaluation. PLoS ONE. 2019 Jun 5; 14(6):e0217831.
  581. Young SG, Hayes CJ, Aram J, Tait MA. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiology and drug safety. 2019 Aug 1; 28(8):1117-1124.
  582. Duncan MH, Ratzliff AD, Powers DM, Banta-Green CJ, Saxon AJ. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Annals of internal medicine. 2019 Jun 4; 170(11):820-821.
  583. Lagisetty PA, Bohnert A. Role of an Accurate Treatment Locator and Cash-Only Practices in Access to Buprenorphine for Opioid Use Disorders. [Editorial]. Annals of internal medicine. 2019 Jul 2; 171(1):58-59.
  584. Hadlandsmyth K, Stewart KR, Paez MB, Steffen M, Meth M, Reisinger HS, Mosher HJ. Patient Perspectives on Opioids: Views of Inpatient Veterans with Chronic Pain. Pain medicine (Malden, Mass.). 2019 Jun 1; 20(6):1141-1147.
  585. Merlin JS, Long D, Becker WC, Cachay ER, Christopolous KA, Claborn KR, Crane HM, Edelman EJ, Lovejoy TI, Mathews WC, Morasco BJ, Napravnik S, O'Cleirigh C, Saag MS, Starrels JL, Gross R, Liebschut z JM. Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain. Journal of acquired immune deficiency syndromes (1999). 2019 Jun 1; 81(2):231-237.
  586. Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor MK, Radomski TR, Hausmann LRM, Good CB, Gellad WF. Emergency Physician Opioid Prescribing and Risk of Long-term Use in the Veterans Health Administration: an Observational Analysis. Journal of general internal medicine. 2019 Aug 1; 34(8):1522-1529.
  587. Bixler FR, Radomski TR, Zickmund SL, Roman KM, Hausmann LRM, Thorpe CT, Hale JA, Sileanu FE, Gellad WF. Primary care physicians' perspectives on Veterans who obtain prescription opioids from multiple healthcare systems. Journal of opioid management. 2019 May 1; 15(3):183-191.
  588. Mudumbai SC, Lewis ET, Oliva EM, Chung PD, Harris B, Trafton J, Mariano ER, Wagner T, Clark JD, Stafford RS. Overdose Risk Associated with Opioid Use upon Hospital Discharge in Veterans Health Administration Surgical Patients. Pain medicine (Malden, Mass.). 2019 May 1; 20(5):1020-1031.
  589. Harbaugh CM, Lee JS, Chua KP, Kenney B, Iwashyna TJ, Englesbe MJ, Brummett CM, Bohnert AS, Waljee JF. Association Between Long-term Opioid Use in Family Members and Persistent Opioid Use After Surgery Among Adolescents and Young Adults. JAMA surgery. 2019 Apr 17; 154(4):e185838.
  590. Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, Fox AD. A conceptual model for understanding post-release opioid-related overdose risk. Addiction science & clinical practice. 2019 Apr 15; 14(1):17.
  591. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. Reply. [Letter to the Editor]. The New England journal of medicine. 2019 Apr 4; 380(14):1380.
  592. Kroenke K, Alford DP, Argoff C, Canlas B, Covington E, Frank JW, Haake KJ, Hanling S, Hooten WM, Kertesz SG, Kravitz RL, Krebs EE, Stanos SP, Sullivan M. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report. Pain medicine (Malden, Mass.). 2019 Apr 1; 20(4):724-735.
  593. Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Journal of general internal medicine. 2019 Jun 1; 34(6):936-943.
  594. Godersky ME, Saxon AJ, Merrill JO, Samet JH, Simoni JM, Tsui JI. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence. Addiction science & clinical practice. 2019 Mar 13; 14(1):11.
  595. Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study. Annals of internal medicine. 2019 Apr 2; 170(7):433-442.
  596. Wyse JJ, Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Gaither JR, Gordon K, Skanderson M, Barry DT, Crystal S, Justice A, Kraemer KL. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug and Alcohol Dependence. 2019 May 1; 198:70-75.
  597. Brummett CM, Moser SE, Nallamothu BK. Errors in Analysis in Study of New Persistent Opioid Use After Surgery. JAMA surgery. 2019 Mar 1; 154(3):268-269.
  598. Hah JM, Cramer E, Hilmoe H, Schmidt P, McCue R, Trafton J, Clay D, Sharifzadeh Y, Ruchelli G, Goodman S, Huddleston J, Maloney WJ, Dirbas FM, Shrager J, Costouros JG, Curtin C, Mackey SC, Carroll I. Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2019 Mar 1; 2(3):e190168.
  599. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kuza CC, Gellad WF. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions. JAMA Network Open. 2019 Mar 1; 2(3):e190968.
  600. Dasinger EA, Graham LA, Wahl TS, Richman JS, Baker SJ, Hawn MT, Hernandez-Boussard T, Rosen AK, Mull HJ, Copeland LA, Whittle JC, Burns EA, Morris MS. Preoperative opioid use and postoperative pain associated with surgical readmissions. American journal of surgery. 2019 Nov 1; 218(5):828-835.
  601. McKee MM, Meade MA, Zazove P, Stewart HJ, Jannausch ML, Ilgen MA. The Relationship Between Hearing Loss and Substance Use Disorders Among Adults in the U.S. American journal of preventive medicine. 2019 Apr 1; 56(4):586-590.
  602. Kumthekar A, Shull S, Lovejoy TI, Morasco BJ, Chang M, Barton J. Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis. International journal of rheumatic diseases. 2019 Apr 1; 22(4):592-598.
  603. Vina ER, Hausmann LRM, Obrosky DS, Youk A, Ibrahim SA, Weiner DK, Gallagher RM, Kwoh CK. Social & psychological factors associated with oral analgesic use in knee osteoarthritis management. Osteoarthritis and cartilage. 2019 Jul 1; 27(7):1018-1025.
  604. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Journal of general internal medicine. 2019 Aug 1; 34(8):1419-1426.
  605. Dasinger EA, Branch-Elliman W, Pizer SD, Abdulkerim H, Rosen AK, Charns MP, Hawn MT, Itani KMF, Mull HJ. Association between postoperative opioid use and outpatient surgical adverse events. American journal of surgery. 2019 Apr 1; 217(4):605-612.
  606. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. The New England journal of medicine. 2019 Jan 3; 380(1):71-79.
  607. Hser YI, Saxon AJ, Mooney LJ, Miotto K, Zhu Y, Yoo CK, Liang D, Huang D, Bell DS. Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder. Journal of addiction medicine. 2019 Jan 1; 13(1):41-46.
  608. Morasco BJ, Dobscha SK, Hyde S, Mitchell SH. Exploratory study examining associations between prescription opioid dose and delay discounting in patients with chronic pain. Journal of opioid management. 2019 Jan 1; 15(1):19-25.
  609. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Substance use & misuse. 2018 Dec 21; 54(2):331-339.
  610. Seal KH, Borsari B, Tighe J, Cohen BE, Delucchi K, Morasco BJ, Li Y, Sachs E, Abadjian L, Watson EC, Manuel JK, Vella L, Trafton J, Midboe A. Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety-Rationale, methods, and lessons learned. Contemporary clinical trials. 2019 Feb 1; 77:76-85.
  611. Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction science & clinical practice. 2018 Dec 13; 13(1):25.
  612. Shields CG, Fuzzell LN, Christ SL, Matthias MS. Patient and provider characteristics associated with communication about opioids: An observational study. Patient education and counseling. 2019 May 1; 102(5):888-894.
  613. Noureldin M, Higgins PDR, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, Waljee JF, Waljee AK. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Alimentary pharmacology & therapeutics. 2019 Jan 1; 49(1):74-83.
  614. Hadlandsmyth K, Lund BC, Mosher HJ. Associations between initial opioid exposure and the likelihood for long-term use. Journal of the American Pharmacists Association : JAPhA. 2019 Jan 1; 59(1):17-22.
  615. Finlay AK, Wong JJ, Ellerbe LS, Rubinsky A, Gupta S, Bowe TR, Schmidt EM, Timko C, Burden JL, Harris AHS. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs. Journal of studies on alcohol and drugs. 2018 Nov 1; 79(6):909-917.
  616. Frost MC, Williams EC, Kingston S, Banta-Green CJ. Interest in Getting Help to Reduce or Stop Substance Use Among Syringe Exchange Clients Who Use Opioids. Journal of addiction medicine. 2018 Nov 1; 12(6):428-434.
  617. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. The American journal of managed care. 2018 Nov 1; 24(11):536-540.
  618. Brescia AA, Harrington CA, Mazurek AA, Ward ST, Lee JSJ, Hu HM, Brummett CM, Waljee JF, Lagisetty PA, Lagisetty KH. Factors Associated With New Persistent Opioid Usage After Lung Resection. The Annals of thoracic surgery. 2019 Feb 1; 107(2):363-368.
  619. Chui PW, Bastian LA, DeRycke E, Brandt CA, Becker WC, Goulet JL. Dual Use of Department of Veterans Affairs and Medicare Benefits on High-Risk Opioid Prescriptions in Veterans Aged 65 Years and Older: Insights from the VA Musculoskeletal Disorders Cohort. Health services research. 2018 Dec 1; 53 Suppl 3:5402-5418.
  620. Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. Journal of substance abuse treatment. 2018 Dec 1; 95:43-47.
  621. Starosta AJ, Hastings J, Nazem S, Ronzitti S, Goulet JL. Impact of Opioid Prescriptions on Suicide Risk Among Veterans With Musculoskeletal Disorder (MSD) Diagnoses. [Abstract]. Archives of physical medicine and rehabilitation. 2018 Oct 1; 99(10):e63.
  622. Vanneman ME, Larson MJ, Chen C, Adams RS, Williams TV, Meerwijk E, Harris AHS. Treatment of Low Back Pain With Opioids and Nonpharmacologic Treatment Modalities for Army Veterans. Medical care. 2018 Oct 1; 56(10):855-861.
  623. Hanks D. In Progress-4: Improving Opioid Safety. 2018 Sep 24; 3(4).
  624. Wren AA, Bensen R, Sceats L, Dehghan M, Yu H, Wong JJ, MacIsaac D, Sellers ZM, Kin C, Park KT. Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015. Inflammatory Bowel Diseases. 2018 Sep 15; 24(10):2093-2103.
  625. Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder. Addictive Behaviors. 2019 Feb 1; 89:29-34.
  626. Carter JE, Pyati S, Kanach FA, Maxwell AMW, Belden CM, Shea CM, Van de Ven T, Thompson J, Hoenig H, Raghunathan K. Implementation of Perioperative Music Using the Consolidated Framework for Implementation Research. Anesthesia and analgesia. 2018 Sep 1; 127(3):623-631.
  627. Charokopos A, Card ME, Gunderson C, Steffens C, Bastian LA. The Association of Obstructive Sleep Apnea and Pain Outcomes in Adults: A Systematic Review. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S69-S75.
  628. Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". Journal of hospital medicine. 2018 Sep 1; 13(10):728.
  629. Lisi AJ, Corcoran KL, DeRycke EC, Bastian LA, Becker WC, Edmond SN, Goertz CM, Goulet JL, Haskell SG, Higgins DM, Kawecki T, Kerns RD, Mattocks K, Ramsey C, Ruser CB, Brandt CA. Opioid Use Among Veterans of Recent Wars Receiving Veterans Affairs Chiropractic Care. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S54-S60.
  630. Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee AK, Saini S, Schackman BR, Scherl E, Crawford C. The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients. Journal of Crohn's & colitis. 2018 Aug 29; 12(9):1030-1035.
  631. Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018 Oct 1; 108(10):1394-1400.
  632. Riddle DL, Slover JD, Ang DC, Bair MJ, Kroenke K, Perera RA, Dumenci L. Opioid use prior to knee arthroplasty in patients who catastrophize about their pain: preoperative data from a multisite randomized clinical trial. Journal of pain research. 2018 Aug 21; 11:1549-1557.
  633. Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI. Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2018 Dec 1; 13(4):488-497.
  634. Andrews CM, Grogan CM, Smith BT, Abraham AJ, Pollack HA, Humphreys K, Westlake MA, Friedmann PD. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. Health affairs (Project Hope). 2018 Aug 1; 37(8):1216-1222.
  635. Hayes CJ, Payakachat N, Li C. Evaluation of opioid use among patients with back disorders and arthritis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2018 Nov 1; 27(11):3021-3035.
  636. Giannitrapani KF, Ahluwalia SC, McCaa M, Pisciotta M, Dobscha S, Lorenz KA. Barriers to Using Nonpharmacologic Approaches and Reducing Opioid Use in Primary Care. Pain medicine (Malden, Mass.). 2018 Jul 1; 19(7):1357-1364.
  637. Thomas CP, Ritter GA, Harris AHS, Garnick DW, Freedman KI, Herbert B. Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data. Journal of addiction medicine. 2018 Jul 1; 12(4):287-294.
  638. Minegishi T, Garrido MM, Pizer SD, Frakt AB. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design. BMJ open. 2018 Jun 27; 8(6):e020097.
  639. Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry. 2019 Dec 1; 24(12):1868-1883.
  640. Klueh MP, Hu HM, Howard RA, Vu JV, Harbaugh CM, Lagisetty PA, Brummett CM, Englesbe MJ, Waljee JF, Lee JS. Transitions of Care for Postoperative Opioid Prescribing in Previously Opioid-Naïve Patients in the USA: a Retrospective Review. Journal of general internal medicine. 2018 Oct 1; 33(10):1685-1691.
  641. Darnall BD, Humphreys KN. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1552-1553.
  642. Haffajee RL, Bohnert ASB, Lagisetty PA. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment. American journal of preventive medicine. 2018 Jun 1; 54(6 Suppl 3):S230-S242.
  643. Minegishi T, Frakt A. Reducing Long-term Opioid Use in the Veterans Health Administration. [Editorial]. Journal of general internal medicine. 2018 Jun 1; 33(6):781-782.
  644. Saraswathula A, Chen MM, Mudumbai SC, Whittemore AS, Divi V. Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2019 Mar 1; 160(3):380-387.
  645. Dindo L, Zimmerman MB, Hadlandsmyth K, StMarie B, Embree J, Marchman J, Tripp-Reimer T, Rakel B. Acceptance and Commitment Therapy for Prevention of Chronic Postsurgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. The journal of pain : official journal of the American Pain Society. 2018 Oct 1; 19(10):1211-1221.
  646. Kligler B, Bair MJ, Banerjea R, DeBar L, Ezeji-Okoye S, Lisi A, Murphy JL, Sandbrink F, Cherkin DC. Clinical Policy Recommendations from the VHA State-of-the-Art Conference on Non-Pharmacological Approaches to Chronic Musculoskeletal Pain. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):16-23.
  647. Quinn PD, Hur K, Chang Z, Scott EL, Krebs EE, Bair MJ, Rickert ME, Gibbons RD, Kroenke K, D'Onofri o BM. Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents. JAMA pediatrics. 2018 May 1; 172(5):423-430.
  648. Shmagel A, Ngo L, Ensrud K, Foley R. Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study. The journal of pain : official journal of the American Pain Society. 2018 Oct 1; 19(10):1104-1112.
  649. Hah J, Mackey SC, Schmidt P, McCue R, Humphreys K, Trafton J, Efron B, Clay D, Sharifzadeh Y, Ruchelli G, Goodman S, Huddleston J, Maloney WJ, Dirbas FM, Shrager J, Costouros JG, Curtin C, Carroll I. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA surgery. 2018 Apr 1; 153(4):303-311.
  650. Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. Journal of hospital medicine. 2018 Apr 1; 13(4):263-271.
  651. Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain medicine (Malden, Mass.). 2018 Apr 1; 19(4):774-787.
  652. Mosher HJ, Hofmeyer BA, Hadlandsmyth K, Richardson KK, Lund BC. Predictors of Long-Term Opioid Use After Opioid Initiation at Discharge From Medical and Surgical Hospitalizations. Journal of hospital medicine. 2018 Apr 1; 13(4):243-248.
  653. Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ. Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1477-1487.
  654. Raffel KE, Beach LY, Lin J, Berchuck JE, Abram S, Markle E, Patel S. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic. The Permanente journal. 2018 Mar 30; 22.
  655. Lin LA, Lofwall MR, Walsh SL, Gordon AJ, Knudsen HK. Perceptions and practices addressing diversion among US buprenorphine prescribers. Drug and Alcohol Dependence. 2018 May 1; 186:147-153.
  656. Taylor SS, Hughes JM, Coffman CJ, Jeffreys AS, Ulmer CS, Oddone EZ, Bosworth HB, Yancy WS, Allen KD. Prevalence of and characteristics associated with insomnia and obstructive sleep apnea among veterans with knee and hip osteoarthritis. BMC musculoskeletal disorders. 2018 Mar 9; 19(1):79.
  657. Fassio V, Aspinall SL, Zhao X, Miller DR, Singh JA, Good CB, Cunningham FE. Trends in opioid and nonsteroidal anti-inflammatory use and adverse events. The American journal of managed care. 2018 Mar 1; 24(3):e61-e72.
  658. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 Mar 1; 159(3):451-459.
  659. Hayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health-Related Quality of Life among Chronic Opioid Users, Nonchronic Opioid Users, and Nonopioid Users with Chronic Noncancer Pain. Health services research. 2018 Oct 1; 53(5):3329-3349.
  660. Hadlandsmyth K, Mosher H, Vander Weg MW, Lund BC. Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010-2016. Journal of general internal medicine. 2018 Jun 1; 33(6):818-824.
  661. Bossi KE. HSR&D e-Pub Briefs-2: Summaries of select journal articles published by HSR&D investigators. 2018 Jan 22; 10(2).
  662. Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, Polomano RC, Webster LR. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain medicine (Malden, Mass.). 2018 Jan 1; 19(1):97-117.
  663. Wyse JJ, Gordon AJ, Dobscha SK, Morasco BJ, Tiffany E, Drexler K, Sandbrink F, Lovejoy TI. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Substance Abuse. 2018 Jan 1; 39(2):139-144.
  664. Zullo AR, Zhang T, Beaudoin FL, Lee Y, McConeghy KW, Kiel DP, Daiello LA, Mor V, Berry SD. Pain Treatments After Hip Fracture Among Older Nursing Home Residents. Journal of The American Medical Directors Association. 2018 Feb 1; 19(2):174-176.
  665. Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Gordon AJ, Suda KJ, Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ. Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use. American journal of public health. 2018 Feb 1; 108(2):248-255.
  666. Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedman n PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatric services (Washington, D.C.). 2018 Apr 1; 69(4):448-455.
  667. Mosher H, Herzig SJ, Danovitch I, Boutsicaris C, Hassamal S, Wittnebel K, Dashti A, Nuckols T. The Evaluation of Medical Inpatients Who Are Admitted on Long-term Opioid Therapy for Chronic Pain. Journal of hospital medicine. 2018 Apr 1; 13(4):249-255.
  668. Tedesco D, Gori D, Desai KR, Asch S, Carroll IR, Curtin C, McDonald KM, Fantini MP, Hernandez-Boussard T. Drug-Free Interventions to Reduce Pain or Opioid Consumption After Total Knee Arthroplasty: A Systematic Review and Meta-analysis. JAMA surgery. 2017 Oct 18; 152(10):e172872.
  669. Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 2017 Oct 17; 12(10):e0186315.
  670. Lovejoy TI, Morasco BJ, Kumthekar A, Shull S, Chang M, Barton J. Eradication of hepatitis C among US veterans: examination of changes in pain severity and prescription opioid use following treatment. [Abstract]. Arthritis + Rheuma.. 2017 Sep 27; 69(10):2221.
  671. Krebs EE, Jensen AC, Nugent S, DeRonne B, Rutks I, Leverty D, Gravely A, Noorbaloochi S, Bair MJ, Kroenke K. Design, recruitment outcomes, and sample characteristics of the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial. Contemporary clinical trials. 2017 Nov 1; 62:130-139.
  672. Gerlach LB, Olfson M, Kales HC, Maust DT. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. Journal of the American Geriatrics Society. 2017 Sep 1; 65(9):2052-2056.
  673. Hadlandsmyth K, Vander Weg MW, McCoy KD, Mosher HJ, Vaughan-Sarrazin MS, Lund BC. Risk for Prolonged Opioid Use Following Total Knee Arthroplasty in Veterans. Journal of Arthroplasty. 2018 Jan 1; 33(1):119-123.
  674. Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM. Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2017 Aug 22; 318(8):750-752.
  675. Balbale SN, Trivedi I, O'Dwyer LC, McHugh MC, Evans CT, Jordan N, Keefe r LA. Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review. Digestive diseases and sciences. 2017 Oct 1; 62(10):2668-2685.
  676. Ecker AH, Hundt N. Posttraumatic stress disorder in opioid agonist therapy: A review. Psychological trauma : theory, research, practice and policy. 2018 Nov 1; 10(6):636-642.
  677. Ruggles KV, Fang Y, Tate J, Mentor SM, Bryant KJ, Fiellin DA, Justice AC, Braithwaite RS. What are the Patterns Between Depression, Smoking, Unhealthy Alcohol Use, and Other Substance Use Among Individuals Receiving Medical Care? A Longitudinal Study of 5479 Participants. AIDS and behavior. 2017 Jul 1; 21(7):2014-2022.
  678. Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Stein BD. Association between process measures and mortality in individuals with opioid use disorders. Drug and Alcohol Dependence. 2017 Aug 1; 177:307-314.
  679. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA surgery. 2017 Jun 21; 152(6):e170504.
  680. Bastian LA, Driscoll MA, Heapy AA, Becker WC, Goulet JL, Kerns RD, DeRycke EC, Perez E, Lynch SM, Mattocks K, Kroll-Desrosiers AR, Brandt CA, Skanderson M, Bathulapalli H, Haskell SG. Cigarette Smoking Status and Receipt of an Opioid Prescription Among Veterans of Recent Wars. Pain medicine (Malden, Mass.). 2017 Jun 1; 18(6):1089-1097.
  681. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 Jun 1; 158(6):1039-1045.
  682. Demidenko MI, Dobscha SK, Morasco BJ, Meath THA, Ilgen MA, Lovejoy TI. Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General hospital psychiatry. 2017 Jul 1; 47:29-35.
  683. Gordon AJ, Harding JD. From education to practice: Addressing opioid misuse through health care provider training: A special issue of Substance Abuse journal. Substance Abuse. 2017 Apr 1; 38(2):119-121.
  684. Lovejoy TI, Demidenko MI, Morasco BJ, Meath T, Dobscha SK. Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users. [Abstract]. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):S36.
  685. Seal K, Becker W, Tighe J, Li Y, Rife T. Managing Chronic Pain in Primary Care: It Really Does Take a Village. Journal of general internal medicine. 2017 Aug 1; 32(8):931-934.
  686. Bohnert KM, Ilgen MA, Louzon S, McCarthy JF, Katz IR. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction (Abingdon, England). 2017 Jul 1; 112(7):1193-1201.
  687. Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ (Clinical research ed.). 2017 Mar 14; 356:j760.
  688. Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM. An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program. Medical care. 2017 Mar 1; 55(3):291-298.
  689. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. Journal of opioid management. 2017 Mar 1; 13(2):95-103.
  690. Jasuja GK, Bhasin S, Reisman JI, Hanlon JT, Miller DR, Morreale AP, Pogach LM, Cunningham FE, Park A, Berlowitz DR, Rose AJ. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study. Journal of general internal medicine. 2017 Mar 1; 32(3):304-311.
  691. Oliva EM, Christopher ML, Wells D, Bounthavong M, Harvey M, Himstreet J, Emmendorfer T, Valentino M, Franchi M, Goodman F, Trafton JA, Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. Journal of the American Pharmacists Association : JAPhA. 2017 Mar 1; 57(2S):S168-S179.e4.
  692. Hanks D. QUERI e-News-1: Pain Management and Opioid Use. [Newsletter] 2017 Feb 28. 9 (1). Available from: https://www.queri.research.va.gov/qnews/feb17/default.cfm.
  693. Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction (Abingdon, England). 2017 May 1; 112(5):838-851.
  694. Sachar H, Pichetshote N, Nandigam K, Vaidya K, Laine L. Continued midazolam versus diphenhydramine in difficult-to-sedate patients: a randomized double-blind trial. Gastrointestinal endoscopy. 2018 May 1; 87(5):1297-1303.
  695. Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, Rickert ME, Gibbons RD, Kroenke K, D'Onofri o BM. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017 Jan 1; 158(1):140-148.
  696. Stein BD, Mendelsohn J, Gordon AJ, Dick AW, Burns RM, Sorbero M, Shih RA, Liccardo Pacula R. Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities. Journal of addictive diseases. 2017 Jan 1; 36(1):14-22.
  697. Krebs E, Min JE, Evans E, Li L, Liu L, Huang D, Urada D, Kerr T, Hser YI, Nosyk B. Estimating State Transitions for Opioid Use Disorders. Medical Decision Making. 2017 Jul 1; 37(5):483-497.
  698. Gellad WF, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Mor M, Hale JA, Radomski T, Hausmann LR, Fine MJ, Good CB. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D. Substance Abuse. 2017 Jan 1; 38(1):22-25.
  699. Ducoffe AR, York A, Hu DJ, Perfetto D, Kerns RD. National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use. Pain medicine (Malden, Mass.). 2016 Dec 1; 17(12):2291-2304.
  700. Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health affairs (Project Hope). 2016 Dec 1; 35(12):2289-2296.
  701. Moore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O'Connor PG, Schottenfel d RS. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. Journal of substance abuse treatment. 2016 Dec 1; 71:54-57.
  702. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marsh all BD. Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. Addiction (Abingdon, England). 2016 Nov 1; 111(11):2021-2031.
  703. Bastian LA. Cigarette Smoking as a Risk Factor for Chronic Opioid Use. Spotlight on Pain Management [Cyberseminar]. 2016 Nov 1.
  704. Naples JG, Gellad WF, Hanlon JT. The Role of Opioid Analgesics in Geriatric Pain Management. Clinics in geriatric medicine. 2016 Nov 1; 32(4):725-735.
  705. Rogal S, Mankaney G, Udawatta V, Good CB, Chinman M, Zickmund S, Bielefeldt K, Jonassaint N, Jazwinski A, Shaikh O, Hughes C, Humar A, DiMartini A, Fine MJ. Association between opioid use and readmission following liver transplantation. Clinical Transplantation. 2016 Oct 1; 30(10):1222-1229.
  706. Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20; 316(11):1211-1212.
  707. Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder. The Journal of clinical psychiatry. 2016 Sep 1; 77(9):1182-1188.
  708. Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal of substance abuse treatment. 2016 Sep 1; 68:62-7.
  709. Hanks D. In Progress-2: Improving the Safety of Prescription Opioid Use among Veterans. 2016 Aug 3; 1(2).
  710. Chen JH, Hom J, Richman I, Asch SM, Podchiyska T, Johansen NA. Effect of opioid prescribing guidelines in primary care. Medicine. 2016 Aug 1; 95(35):e4760.
  711. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer. Journal of opioid management. 2016 Jul 1; 12(4):259-68.
  712. Krebs EE, Kroenke K, Wu J, Bair MJ, Kozak MA, Yu Z. Opioid Use as a Predictor of Health Care Use and Pain Outcomes: Analysis of Clinical Trial Data. Pain medicine (Malden, Mass.). 2016 Jul 1; 17(7):1261-1268.
  713. Lembke A, Humphreys K, Newmark J. Weighing the Risks and Benefits of Chronic Opioid Therapy. American Family Physician. 2016 Jun 15; 93(12):982-90.
  714. Bohnert AS, Bonar EE, Cunningham R, Greenwald MK, Thomas L, Chermack S, Blow FC, Walton M. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug and Alcohol Dependence. 2016 Jun 1; 163:40-7.
  715. Mosher HJ, Richardson KK, Lund BC. The One Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  716. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. Journal of general internal medicine. 2016 May 1; 31(5):478-85.
  717. Harris AH, Weisner CM, Chalk M, Capoccia V, Chen C, Thomas CP. Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care. Journal of addiction medicine. 2016 May 1; 10(3):148-55.
  718. Ilgen MA, Bohnert AS, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Opioid dose and risk of suicide. Pain. 2016 May 1; 157(5):1079-84.
  719. Krebs EE, Paudel M, Taylor BC, Bauer DC, Fink HA, Lane NE, Ensrud KE, Osteoporotic Fractures in Men (MrOS) Study Resea rch Group. Association of Opioids with Falls, Fractures, and Physical Performance among Older Men with Persistent Musculoskeletal Pain. Journal of general internal medicine. 2016 May 1; 31(5):463-9.
  720. McDonell MG, Graves MC, West II, Ries RK, Donovan DM, Bumgardner K, Krupski A, Dunn C, Maynard C, Atkins DC, Roy-Byrne P. Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders. Journal of addiction medicine. 2016 May 1; 10(3):196-201.
  721. Diulio AR, Demidenko MI, Lovejoy TI. Multidisciplinary pain clinics, in Treating comorbid opioid use disorder and dependence in chronic pain. Ed. Matthews, AM. Springer International Publishing, 2016: pp. 177-184. SpringerPlus. 2016 Apr 30.
  722. Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, Hatch-Maillette M, Jelstrom E, Wiest K, McLaughlin P, Ling W. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction (Abingdon, England). 2016 Apr 1; 111(4):695-705.
  723. Finlay AK, Binswanger I, Timko C, Rosenthal J, Clark S, Blue-Howells J, McGuire J, Hagedorn H, Wong J, Van Campen J, Sox-Harris AH. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. Paper presented at: Academic and Health Policy Conference on Correctional Health; 2016 Mar 18; Baltimore, MD.
  724. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. 2016 Mar 1; 160:222-6.
  725. Kroll-Desrosiers AR, Skanderson M, Bastian LA, Brandt CA, Haskell S, Kerns RD, Mattocks KM. Receipt of Prescription Opioids in a National Sample of Pregnant Veterans Receiving Veterans Health Administration Care. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2016 Mar 1; 26(2):240-6.
  726. Burgess DJ, Gravely AA, Nelson DB, Bair MJ, Kerns RD, Higgins DM, Farmer MM, Partin MR. Association between pain outcomes and race and opioid treatment: Retrospective cohort study of Veterans. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):13-24.
  727. Krein SL, Bohnert A, Kim HM, Harris ME, Richardson CR. Opioid use and walking among patients with chronic low back pain. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):107-16.
  728. Mohanty AF, Helmer DA, Muthukutty A, McAndrew LM, Carter ME, Judd J, Garvin JH, Samore MH, Gundlapalli AV. Fibromyalgia syndrome care of Iraq- and Afghanistan-deployed Veterans in Veterans Health Administration. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):45-58.
  729. Becker WC, Merlin JS, Manhapra A, Edens EL. Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic. Addiction science & clinical practice. 2016 Jan 28; 11(1):3.
  730. Carroll IR, Hah JM, Barelka PL, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas FM, Mackey SC. Pain Duration and Resolution following Surgery: An Inception Cohort Study. Pain medicine (Malden, Mass.). 2015 Dec 1; 16(12):2386-96.
  731. Lin LA, Bohnert AS, Price AM, Jannausch M, Bonar EE, Ilgen MA. Pain acceptance and opiate use disorders in addiction treatment patients with comorbid pain. Drug and Alcohol Dependence. 2015 Dec 1; 157:136-42.
  732. Sigmon SC, C Meyer A, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP. Bridging waitlist delays with interim buprenorphine treatment: initial feasibility. Addictive Behaviors. 2015 Dec 1; 51:136-42.
  733. Krans EE, Zickmund SL, Rustgi VK, Park SY, Dunn SL, Schwarz EB. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study. Substance Abuse. 2015 Nov 16; 37(1):88-95.
  734. Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD. Policies Related To Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013. Substance Abuse. 2015 Nov 13; 37(1):63-9.
  735. Bachhuber MA, Roberts CB, Metraux S, Montgomery AE. Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration. Journal of opioid management. 2015 Nov 1; 11(6):459-62.
  736. Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. Journal of addiction medicine. 2015 Nov 1; 9(6):470-7.
  737. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology and drug safety. 2015 Nov 1; 24(11):1180-8.
  738. Pacula RL, Stein B, Gordon AJ, Dick A, Burns RM, Leslie DL, Sorbero MS. The Impact of State Policies on the Use of Buprenorphine Among Medicaid Enrollees Identified with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  739. Stein B, Paula RL, Sorbero M, Gordon AJ, Leslie DL, Burns RM, Shih RA, Dick AW. Disparities in Opioid Agonist Therapy by Race/Ethnicity and HIV Status Among Medicaid-Enrollees with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  740. Finlay AK, Bowe T, Sox-Harris AH. Changes in receipt of pharmacotherapy for opioid use disorder among veterans from fiscal years 2012-2013. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina del Rey, CA.
  741. Stein BD, Mendelsohn J, Gordon A, Pacula RL, Burns RM, Sorbero M, Dick A. Physician Community Network Structure and Clinically Questionable Prescribing Practices for Medicaid-Enrollees With Opioid Use Disorder. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina Del Rey, CA.
  742. Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. The Milbank Quarterly. 2015 Sep 1; 93(3):561-83.
  743. Ashrafioun L, Bohnert AS, Jannausch M, Ilgen MA. Evaluation of the current opioid misuse measure among substance use disorder treatment patients. Journal of substance abuse treatment. 2015 Aug 1; 55:15-20.
  744. Suda KJ, Bailey LA, Smith BM, Gellad WF, Huo Z, Cunningham F, Burk M, Stroupe KT. Opioid use in Veterans eligible for VA and Medicare Part D and predictors for overlap within and among VA and Medicare Part D-reimbursed pharmacies. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  745. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Justice-involved Veterans with Other Veterans. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  746. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration. Psychiatry Research. 2015 Jun 30; 227(2-3):324-32.
  747. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Veterans in Veterans Justice Programs with other Veterans. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  748. Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health affairs (Project Hope). 2015 Jun 1; 34(6):1028-34.
  749. Comer S, Cunningham C, Fishman MJ, Gordon AJ, Kampman K, Langleben D, Nordstrom B, Oslin D, Woody G, Wright T, Wyatt S. American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. 2015 May 27.
  750. Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015 May 1; 13(5):1009-16.
  751. Becker W, Tate JP, Edelman EJ, Gaither J, Akgun K, Barry D, Crystal S, Gordon A, Merlin JS, Kerns RD, Justice AC, Fiellin DA. The Relationship Among Opioid Use, HIV, and Accidental Death: Is It In the Eye of the Beholder? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 24; Toronto, Canada.
  752. Krebs EE, Kroenke K, Wu J, Bair MJ, Yu Z. Baseline opioid use as a predictor of telecare collaborative pain management outcomes. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 23; Toronto, Canada.
  753. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA VISN 11 Opioid Safety Initiative and Pain Management Seminar; 2015 Apr 22; Fort Wayne, IN.
  754. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA Palo Alto Center for Innovation to Implementation Seminar Series; 2015 Apr 20; Palo Alto, CA.
  755. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: Kaiser Permanente Division of Research Annual Meeting; 2015 Apr 16; San Francisco, CA.
  756. Farmer CM, Lindsay D, Williams J, Ayers A, Schuster J, Cilia A, Flaherty MT, Mandell T, Gordon AJ, Stein BD. Practice guidance for buprenorphine for the treatment of opioid use disorders: results of an expert panel process. Substance Abuse. 2015 Apr 6; 1-8.
  757. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Medical care. 2015 Apr 1; 53(4 Suppl 1):S105-11.
  758. Finlay AK, Binswanger I, Frayne SM, Harris A. Receipt of pharmacotherapy for opioid use disorder: Comparing justice-involved Veterans with other Veterans. Presented at: Academic and Health Policy Conference on Correctional Health; 2015 Mar 19; Boston, MA.
  759. Lee JD, Friedmann PD, Boney TY, Hoskinson RA, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O'Brie n CP. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemporary clinical trials. 2015 Mar 1; 41:110-7.
  760. Larney S, Bohnert AS, Ganoczy D, Ilgen MA, Hickman M, Blow FC, Degenhardt L. Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011. Drug and Alcohol Dependence. 2015 Feb 1; 147:32-7.
  761. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Journal of substance abuse treatment. 2015 Jan 1; 48(1):128-31.
  762. Gordon AJ, Jenkins JA. The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder. [Editorial]. Substance Abuse. 2015 Jan 1; 36(2):127-8.
  763. Peng X, Robinson RL, Mease P, Kroenke K, Williams DA, Chen Y, Faries D, Wohlreich M, McCarberg B, Hann D. Long-term evaluation of opioid treatment in fibromyalgia. The Clinical Journal of Pain. 2015 Jan 1; 31(1):7-13.
  764. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:e107-e108.
  765. Stein BD, Gordon AJ, Dick AW, Burns RM, Pacula RL, Farmer CM, Leslie DL, Sorbero M. Supply of buprenorphine waivered physicians: the influence of state policies. Journal of substance abuse treatment. 2015 Jan 1; 48(1):104-11.
  766. Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, Williams JS, Hudson T. National study of discontinuation of long-term opioid therapy among veterans. Pain. 2014 Dec 1; 155(12):2673-9.
  767. Mudumbai S, Unger-Hu K, Oliva E, Lewis E, Trafton J, Mariano ER, Stafford RS, Wagner T, Clark D. Adverse Outcomes associated with Types of Postoperative Opioid Use: A Population-level Study of the Veterans Affairs Healthcare System. Paper presented at: American Society of Regional Anesthesia and Pain Medicine Annual Pain Medicine Meeting; 2014 Nov 13; San Francisco, CA.
  768. Lewis ET. What we know about opioid adherence might surprise you: findings from a qualitative study of opioid use behaviors. HSR&D Spotlight on Pain Management. [Cyberseminar]. 2014 Nov 4.
  769. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov 1; 155(11):2337-43.
  770. Morasco BJ, O'Hearn D, Turk DC, Dobsch a SK. Associations between prescription opioid use and sleep impairment among veterans with chronic pain. Pain medicine (Malden, Mass.). 2014 Nov 1; 15(11):1902-10.
  771. Stein BD, Dick SW, Sorbero M, Burns RM, Pacula RL, Gordon AJ, Leslie DL. Patterns of buprenorphine use among Medicaid-enrolled individuals with opioid use disorders. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  772. Cavanagh R, Gritzner S, Dobscha SK, Morasco BJ. Aberrant medication-related behaviors do not differ based on opioid dose: Results from a comprehensive medical record review. Presented at: International Association for the Study of Pain Annual Meeting; 2014 Oct 7; Buenos Aires, Brazil.
  773. Bohnert KM, Perron BE, Ashrafioun L, Kleinberg F, Jannausch M, Ilgen MA. Positive posttraumatic stress disorder screens among first-time medical cannabis patients: prevalence and association with other substance use. Addictive Behaviors. 2014 Oct 1; 39(10):1414-7.
  774. Morasco BJ, Lovejoy TI, Turk DC, Crain A, Hauser P, Dobscha SK. Biopsychosocial factors associated with pain in veterans with the hepatitis C virus. Journal of behavioral medicine. 2014 Oct 1; 37(5):902-11.
  775. Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal. 2014 Oct 1; 97(10):20-4.
  776. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014 Sep 15; 71(18):1539-54.
  777. Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? The Clinical Journal of Pain. 2014 Aug 1; 30(8):654-62.
  778. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 19; San Juan, Puerto Rico.
  779. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  780. Krein SL, Bohnert AS, Kim M, Harris ME, Richardson CR. Opioid Use and Walking Among Patients with Chronic Low Back Pain. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 10; San Diego, CA.
  781. Hudson TJ, Williams S, Austen MA, Martin B, Sullivan M, Fortney JC, Edlund MJ. Opioid use among OEF/OIF Veterans with Traumatic Brain Injury. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 9; San Diego, CA.
  782. Bachhuber MA, Southern WN, Cunningham CO. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States. Medical care. 2014 May 1; 52(5):428-34.
  783. Krebs EE, Paudel M, Taylor BC, Bauer D, Fink HA, Lane N, Ensrud KE. Association of opioid use with falls and fractures among older men. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 23; San Diego, CA.
  784. Hudson TJ, Martin BC, Sullivan M, Fortney JC, Austen MA, Williams S, Edlund MJ. Population-level analysis of opioid use among Veterans. Poster session presented at: Association for Clinical Research Training / Society for Clinical and Translational Science / American Federation for Medical Research Translational Science Meeting; 2014 Apr 11; Washington, DC.
  785. Donohue JM, Lo-Ciganic WH, Cochran G, Gordon AJ, Zemaitis MA, Gellad WF. Opioid use, opioid use disorder and buprenorphine use in Pennsylvania Medicaid. Philadelphia, PA: Commonwealth of Pennsylvania Department of Public Welfare, Office of Medical Assistance Programs; 2014 Mar 31. 42 p.
  786. Scherrer JF, Svrakic DM, Freedland KE, Chrusciel T, Balasubramanian S, Bucholz KK, Lawler EV, Lustman PJ. Prescription opioid analgesics increase the risk of depression. Journal of general internal medicine. 2014 Mar 1; 29(3):491-9.
  787. Mosher HJ, Jiang L, Vaughan Sarrazin MS, Cram P, Kaboli PJ, Vander Weg MW. Prevalence and characteristics of hospitalized adults on chronic opioid therapy. Journal of hospital medicine. 2014 Feb 1; 9(2):82-7.
  788. Bonar EE, Ilgen MA, Walton M, Bohnert AS. Associations among pain, non-medical prescription opioid use, and drug overdose history. The American journal on addictions. 2014 Jan 1; 23(1):41-7.
  789. Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, Jacobs P, Teruya C, McLaughlin P, Wiest K, Cohen A, Ling W. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction (Abingdon, England). 2014 Jan 1; 109(1):79-87.
  790. Saxon AJ, Hser YI, Woody G, Ling W. Medication-assisted treatment for opioid addiction: methadone and buprenorphine. Journal of food and drug analysis. 2013 Dec 1; 21(4):S69-S72.
  791. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Poster session presented at: International Society for Pharmacoepidemiology Annual Conference; 2013 Nov 3; Washington, DC.
  792. Babson KA, Boden MT, Bonn-Miller MO. The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt. Addictive Behaviors. 2013 Nov 1; 38(11):2707-13.
  793. Edlund MJ, Sullivan M, Martin BC, Fortney JC, Landes RD, Austen MA, Williams S, Hudson TJ. Patterns of opioid use among Veterans with chronic non-cancer pain. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  794. Hayes C, Phillips M, Martin BC, Bursac Z, Williams S, Hudson TJ. The influence of the propoxyphene withdrawal on opioid use and opioid related adverse events in Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  795. Hudson TJ, Edlund MJ, Martin BC, Sullivan M, Fortney JC, Landes RD, Austen MA, Williams S. National analysis of opioid use among Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  796. Hudson TJ, Pope R, Williams S, Martin BC, Sullivan M, Fortney JC, Landes RD, Edlund MJ. Opioid use among OEF/OIF/OND Veterans with traumatic brain injury. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  797. Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology. 2013 Sep 1; 38(10):2003-10.
  798. Roy-Byrne P, Sullivan MD, Sherbourne CD, Golinelli D, Craske MG, Sullivan G, Stein MB. Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety. The Clinical Journal of Pain. 2013 Sep 1; 29(9):800-6.
  799. Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). Journal of studies on alcohol and drugs. 2013 Jul 1; 74(4):605-13.
  800. Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, Petrik A, Morasco BJ, Dobscha SK. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Philadelphia, Pa. : 1986). 2013 May 15; 38(11):909-15.
  801. Mosher HJ, Kaboli PJ. Chronic Opioid Therapy of Hospitalized Patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  802. Bohnert AS, Eisenberg A, Whiteside L, Price A, McCabe SE, Ilgen MA. Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors. 2013 Mar 1; 38(3):1776-81.
  803. Carbone LD, Chin AS, Lee TA, Burns SP, Svircev JN, Hoenig HM, Akhigbe T, Weaver FM. The association of opioid use with incident lower extremity fractures in spinal cord injury. The journal of spinal cord medicine. 2013 Mar 1; 36(2):91-6.
  804. Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W. Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Contemporary clinical trials. 2013 Mar 1; 34(2):196-204.
  805. Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? The American journal of drug and alcohol abuse. 2013 Mar 1; 39(2):103-7.
  806. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2013 Mar 1; 19(2):72-7.
  807. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clinical therapeutics. 2013 Mar 1; 35(3):303-11.
  808. Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. The Clinical Journal of Pain. 2013 Feb 1; 29(2):102-8.
  809. Dobscha SK. Critical Review of Recent Research Findings—Opioid Use and Misuse. Presented at: Academy of Psychosomatic Medicine Annual Meeting; 2012 Nov 15; Atlanta, GA.
  810. Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas F, Whyte RI, Donington JS, Cannon WB, Mackey SC. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesthesia and analgesia. 2012 Sep 1; 115(3):694-702.
  811. Bohnert AS. Recent non-medical prescription opioid use among adult patients at an inner-city emergency department. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2012 Jun 11; Palm Springs, CA.
  812. Meis L, Griffin JM, Greer NL, Jensen AC, Carlyle M, MacDonald R, Rutks IR, Wilt TJ. Family Involved Psychosocial Treatments for Adult Mental Health Conditions: A Review of the evidence. VA-ESP Project #09-009. 2012 Jun 1.
  813. Oliva EM, Harris AH, Trafton JA, Gordon AJ. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Drug and Alcohol Dependence. 2012 May 1; 122(3):241-6.
  814. Skinner MA, Lewis ET, Trafton JA. Opioid use patterns and association with pain severity and mental health functioning in chronic pain patients. Pain medicine (Malden, Mass.). 2012 Apr 1; 13(4):507-17.
  815. Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, Neylan TC. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012 Mar 7; 307(9):940-7.
  816. Deyo RA, Smith DH, Johnson ES, Donovan M, Tillotson CJ, Yang X, Petrik AF, Dobscha SK. Opioids for back pain patients: primary care prescribing patterns and use of services. Journal of the American Board of Family Medicine : JABFM. 2011 Nov 1; 24(6):717-27.
  817. Broyles LM, Gordon AJ, Sereika SM, Ryan CM, Erlen JA. Do words matter? Incongruent responses to inconsistently worded AUDIT-C alcohol screening instruments. Substance Abuse. 2011 Oct 1; 32(4):202-9.
  818. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain. Pain medicine (Malden, Mass.). 2011 Oct 1; 12(10):1502-9.
  819. Carbone L, Chin A, Lee TA, Burns S, Svircev J, Hoening H, Akhigbe T, Weaver FM. Anticonvulsant and Opioid Use and Fractures in Veterans with Spinal Cord Injury. Poster session presented at: American Society for Bone and Mineral Research Annual Meeting; 2011 Sep 17; San Diego, CA.
  820. D'Amore MM, Cheng DM, Kressin NR, Jones J, Samet JH, Winter M, Kim TW, Sai tz R. Oral health of substance-dependent individuals: impact of specific substances. Journal of substance abuse treatment. 2011 Sep 1; 41(2):179-85.
  821. Awosika CO, Sanders SH, Clark ME, Banou E. The Effects of Opioid Use on Veterans with Primary Chronic Headaches Participating in Inpatient Chronic Pain Rehabilitation. Poster session presented at: American Headache Society Annual Meeting; 2011 Jun 4; Washington, DC.
  822. Chan G, Gelernter J, Oslin D, Farrer L, Kranzler HR. Empirically derived subtypes of opioid use and related behaviors. Addiction (Abingdon, England). 2011 Jun 1; 106(6):1146-54.
  823. Barry DT, Goulet JL, Kerns RK, Becker WC, Gordon AJ, Justice AC, Fiellin DA. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 2011 May 1; 152(5):1133-8.
  824. Trafton JA, Cucciare MA, Lewis E, Oser M. Somatization is associated with non-adherence to opioid prescriptions. The journal of pain : official journal of the American Pain Society. 2011 May 1; 12(5):573-80.
  825. Lewis ET, Trafton JA. Opioid use in primary care: asking the right questions. Current Pain and Headache Reports. 2011 Apr 1; 15(2):137-43.
  826. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and Correlates of Prescription Opioid Use in OEF/OIF Veterans. Poster session presented at: VA National Pain Management Conference; 2011 Mar 2; Jacksonville, FL.
  827. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010 Dec 1; 151(3):625-32.
  828. Hwang U, Richardson LD, Harris B, Morrison RS. The quality of emergency department pain care for older adult patients. Journal of the American Geriatrics Society. 2010 Nov 1; 58(11):2122-8.
  829. Krebs EE, Lurie JD, Fanciullo G, Tosteson TD, Blood EA, Carey TS, Weinstein JN. Predictors of long-term opioid use among patients with painful lumbar spine conditions. The journal of pain : official journal of the American Pain Society. 2010 Jan 1; 11(1):44-52.
  830. Helfand M, Freeman M. Assessment and management of acute pain in adult medical inpatients: a systematic review. Pain medicine (Malden, Mass.). 2009 Oct 1; 10(7):1183-99.
  831. Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, Sullivan MD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. Journal of pain and symptom management. 2008 Sep 1; 36(3):280-8.
  832. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of pain and symptom management. 2008 Jul 1; 36(1):39-45.
  833. Friedly J, Nishio I, Bishop MJ, Maynard C. The relationship between repeated epidural steroid injections and subsequent opioid use and lumbar surgery. Archives of physical medicine and rehabilitation. 2008 Jun 1; 89(6):1011-5.
  834. Phillips K, Gordon AJ, Walley AY. Patients in recovery and opioids. Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
  835. Tsao JC, Stein JA, Dobalian A. Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIV. Pain. 2007 Dec 15; 133(1-3):128-37.
  836. Pletcher MJ, Kertesz SG, Sidney S, Kiefe CI, Hulley SB. Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study. Drug and Alcohol Dependence. 2006 Nov 8; 85(2):171-6.
  837. Sullivan MD, Edlund MJ, Zhang L, Unützer J, Well s KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of internal medicine. 2006 Oct 23; 166(19):2087-93.
  838. Wu SM, Compton P, Bolus R, Schieffer B, Pham Q, Baria A, Van Vort W, Davis F, Shekelle P, Naliboff BD. The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. Journal of pain and symptom management. 2006 Oct 1; 32(4):342-51.
  839. Sullivan MD, Edlund MJ, Steffick D, Unütz er J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005 Dec 15; 119(1-3):95-103.
  840. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. Journal of general internal medicine. 2005 Nov 1; 20(11):1038-41.
  841. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine (Philadelphia, Pa. : 1986). 2005 May 1; 30(9):1075-81.
  842. Masson CL, Barnett PG, Sees KL, Delucchi KL, Rosen A, Wong W, Hall SM. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. 2004 Jun 1; 99(6):718-26.
  843. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Philadelphia, Pa. : 1986). 2003 Jan 15; 28(2):143-50.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.
<--- --->